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ABSTRACT: Poly(cyclic urea) compounds were synthesized and tested as substitutes of 
hexamethylphosphoramide (HMPA). HMPA is a potent carcinogen but demonstrates excellent 
properties as an additive in organometal chemistry. The poly(cyclic urea), which showed similar 
properties to HMPA in solution, was attached to a variety of resins in an effort to create a new 
polymer-supported reagent. Polymer-supported HMPA was also prepared by suspension 
polymerization. In diverse reactions, these reagents showed very similar properties to HMPA, 
were easily removed by filtration and could be recycled without loss of chemical activity. 
Highly functionalized spiroketals were designed and synthesized as mimics of calyculin 
A, a known protein phosphatase inhibitor. Regio- and stereoselective reductions, hetero-Diels-
Alder reactions and spiroketalizations gave eight diastereomeric spiroketal compounds. 
Additionally, through asymmetric crotylations, phosphorylations and cross-metathesis, a series 
of new phosphoric acid compounds were also synthesized.    
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1. Synthesis and Application of New Urea Additives for Solid and Solution Phase 
Organic Syntheses  
1.1. Introduction 
Solid phase reagents and scavengers have become powerful tools for organic synthesis.1 
By using solid phase reagents and scavengers, one is able to employ reaction conditions 
developed in solution phase, without the re-optimization necessary for solid phase reactions. This 
technology takes advantage of the unique nature of these solid phase reagents, e.g. the ability to 
use excess reagents for the complete conversion and avoid chromatographic purifications (Figure 
1). Reusable solid-supported reagents reduce the amount of waste and exposure to toxic reagents 
due to their simple removal by filtration. 
 
substrate
 +
excess of reactant
product 
 + 
remaining reactant
scavenger
filtration
product
substrate
 +
polymer-supported reagent
filtration
product
 
Figure 1. General concept for the use of solid phase reagents or scavengers. 
 
One can design solid-supported reagents based on solution phase reagents that suffer 
from high toxicity and difficult removal from the reaction medium. Hexamethylphosphoramide 
1 
 (HMPA) has been used catalytically, stoichiometrically or in excess to control the 
stereochemistry in the product or to bias the reaction selectivity. It has been extensively used in a 
variety of reactions due to its unique properties as a polar aprotic solvent and its superior ability 
to form cation-ligand complexes.2 HMPA coordinates very well to metal ions, increasing the 
nucleophilicity of their counter ions and influencing the reaction kinetics. For example, HMPA 
coordinates well to lithium, approximately 300 times better than tetrahydrofuran (THF).3 In the 
case of the nucleophilic addition to α,β-unsaturated carbonyl compounds, HMPA has been 
shown to alter the regioselectivity. In Figure 2, the proposed mechanisms for observed addition 
products are shown. Where contact ion pairs (CIP) exist with tightly associated C-Li species, the 
1,2-addition product (3) is formed via a four-centered transition state, whereas solvent-separated 
ion pairs (SIP) give the 1,4-addition product (2) predominantly. For well-stabilized anions, in the 
absence of HMPA, where lithium is a possible catalyst and SIPs are energetically accessible 
reactive intermediates, mixtures of 1,2- and 1,4-addition products are observed.4   
O O OLi
R
Li
R
Li(HMPA)n
R
A. Contact Ion Pair
     Lithium assisted
     
Et2O experiments and/or
poorly-stabilized anions
B. Separated Ion Pair
     Li+ catalysis
C. Separate Ion Pair
     No Li+ catalysis
     
HMPA experiments
S S
O
S
S
HO
S
Si) LDA, THF
ii) additive
iii) cyclohexenone
      temperature,  time
+
2 31
THF experiments
with stabilized anions  
Figure 2. Mechanistic proposal for additions to α,β-unsaturated carbonyl compounds. 
2 
 Reports surfaced in the literature in the early 1970’s attesting to the toxicity of HMPA. In 
animal studies, low to moderate toxicity was observed either by ingestion, inhalation, or skin 
absorption. Chronic toxicity by HMPA was believed to have led to rare forms of cancer 
produced in rats by inhalation of HMPA (concentration of about 400 ppb) over 8 months.5 Due 
to the toxicity and potential carcinogenicity of HMPA, its use has been restricted to small 
laboratory scale reactions. It therefore becomes necessary to find suitable alternatives to HMPA. 
 
N N
O
4 (DMPU)
N N
O
5 (DMEU)
N
O
6 (Quinuclidine N-oxide)
O
OO
O
8 (12-Crown-4)
N N
N
N
N N
N
N
N
9 (TMEDA)
10 (PMDTA) 11 (HMTTA)
N
H
O
7 (PS-Formamide)
O
P
NMe2
Me2N
Me2N
12 (HMPA)  
Figure 3. Examples of alternative additives to HMPA. 
 
Since Seebach reported the use of DMPU as a safe alternative to the carcinogenic HMPA 
in a variety of reactions,6 several research groups have shown that other types of compounds 
such as cyclic ureas 4 and 5,7 the N-oxide 6,8 amines 9–119 and formamide 710 have physical 
properties similar to those of HMPA (Figure 3). However, some of these have only limited uses. 
3 
 Among these compounds, cyclic ureas have been the most popular substitute. DMPU (4) and 
DMEU (5) possess physical properties quite similar to those of HMPA.6a In numerous reports, 
excess DMPU was necessary to elicit a similar effect like HMPA. Also, DMPU is hygroscopic 
and miscible with water at any ratio, thus it is easily removed from solutions of hydrocarbons or 
ether by washing with water. Additionally, although carrying a carbonyl group, DMPU is 
remarkably unreactive even in the presence of strong bases or nucleophiles at low temperatures 
(below –35 °C). The synthesis of this urea is quite simple and allows for modifications including 
the introduction of a chiral group on nitrogen or functional groups on the cyclic carbon chain.7  
Based on these considerations, our approach aims at the development of new cyclic urea 
derivatives as substitutes of HMPA, eventually leading to the preparation and application of new 
solid phase reagents. Our ideal urea derivatives in both solution phase and later on solid-support 
must allow for an effective chelation of metal ion as demonstrated by DMPU in solution. We 
assumed that poly(cyclic urea) structures could serve this purpose. Poly(cyclic urea) can increase 
the loading of urea units on the resin, where each unit on the resin functions as an additive.  
4 
 1.2. Results and Discussion 
1.2.1. Synthesis of new poly(cyclic urea)  
 
Poly(cyclic urea) compounds were synthesized to explore their properties as additives in 
solution and solid phase reactions. While DMPU (4) is the most popular alternative to HMPA 
and shows better solubility in common solvents at low temperatures, dimers containing DMEU 
(5) units were prepared more readily from commercially available reagents. The first generation 
of poly(cyclic urea) 16, a linear tetramer of DMEU units, was constructed from two dimers 15, 
joined by a flexible n-butyl linker as shown in Scheme 1.  
H2N NH2
O
BnN N N NH
O O
HN N N NH
O O
BnN N N N
O O
NBnNNN
OO
Triethylenetetramine
170 oC, 4 h
79%
NaH, DMF, BnBr
130 oC, 1 h
50%
Br(CH2)4Br, NaH
DMF, rt
49%
14
15 16
13
 
Scheme 1. Synthesis of tetracyclic urea 16. 
 
  Heating urea 13 and triethylenetetramine at 170 °C for 4 h and precipitation of the 
product with MeOH gave the DMEU dimer 14 in 79% yield.11 Monobenzylation of 14 was 
achieved only at high temperature (130 °C) in DMF due to the low solubility of 14. Trituration 
of the crude monobenzylated urea 15 with ethyl ether resulted in a 50% yield of pure material. 
Dialkylation of 15 with 1,4–dibromobutane and recrystallization from THF led to a 49% yield of 
5 
 the tetracyclic urea 16. Thus, the synthesis of tetramer 16 was achieved in 3 steps without any 
chromatography. However, both intermediate 15 and additive 16 demonstrated low solubility at 
low temperatures (–78 °C) in THF, which is often the solvent used for reactions with Li-reagents 
such as LDA, n-BuLi, and t-BuLi. Therefore, the benzyl group, which might be responsible for 
intermolecular stacking, was replaced by ethyl and propyl groups. These poly(cyclic urea)s also 
precipitated readily from THF at low temperature. The lack of solubility prevented proper 
investigations of poly(cyclic urea)s such as 16 as additives, despite their easy preparation on 
multigram scale. We envisioned that, alternatively, the use of the more popular DMPU unit, 
which has a lower freezing point and better solubility than DMEU, would improve the solubility 
of the prospective additive at low temperatures in organic solvents. Additionally, a branched 
structure was believed to better situate the urea units for chelation of metal ions than the 
previously shown linear structure. Conceivably, this structure could be expanded into a 
dendrimer to provide higher loadings. Thus, the readily functionalized pentaerythritol 1712 was 
used as the core upon which the star-like polyurea structures were built (Scheme 2). Allylation of 
pentaerythritol with allyl bromide in the presence of 50% aqueous NaOH under phase transfer 
catalysis furnished the tetraallyl ether 18 in 73% yield.12a Allyl ether 18 was converted by 
ozonolysis and subsequent NaBH4 treatment to the tetraalcohol 19 in 75% yield. Compound 19 
was then brominated to give the tetrabromide 20 in 68% yield.  
For the synthesis of the polyamine core of the DMPU dimer, numerous steps were 
necessary and the price of commercially available polyamines was prohibitive. Therefore, a 
monofunctionalized DMPU unit was prepared from readily available materials, as shown in 
Scheme 2. The DMPU unit 2113 was prepared in 65% yield by heating urea with 1,3-
diaminopropane at 170 °C, followed by recrystallization from EtOH. Monoalkylation of urea 21 
6 
 with iodoethane gave 2214 in 41% yield. Assembly of additive 23 was achieved by alkylation of 
22 with tetrabromide 20 in 45% yield. 
H2N NH2
O
1,3-Diaminopropane
170 oC, 4 h
65%
HN NH
O
N NH
O
N N
O
O C
4
NaH, DMF
20, 50 oC
45%
NaH, DMF, Iodoethane
120 oC
41%
HO
HO
OH
OH
O
O
O
O
O
O
O
O
HO
OH
OH
HO
O
O
O
O
Br
Br
Br
Br
50% NaOH,  AllylBr
TBAB
73%
1. O3, CH2Cl2/MeOH
   -78 oC, Me2S
2. NaBH4, 0 oC, EtOH
    75%
CH2Cl2, K2CO3
CBr4, PPh3
68%
18
19 20
21 22
23
17
12
 
Scheme 2. Synthesis of poly(cyclic urea) 23. 
 
Similarly, additive 25 containing dimeric DMEU units in the star-like structure was also 
synthesized (Scheme 3). Compound 24 was prepared by mono-alkylation of bridged urea 13 with 
7 
 bromopropane in 44% yield. Alkylation of 24 with tetrabromide 20 gave poly(cyclic urea) 25 in 
49% yield as outlined in Scheme 3. 
 
N N N N
O O
O C
4
HN N N NH
O O
N N N NH
O O
Bromopropane
NaH, DMF, 130 oC
44%
24
25
20, NaH, DMF
49%
13
 
 
Scheme 3. Synthesis of poly(cyclic urea) 25. 
 
To reduce the steric hindrance around the carbonyl moiety by the linker chains in the 
poly(cyclic urea)s and to better mimic DMPU, poly(cyclic urea) 32 was synthesized as shown in 
Scheme 4. Tosylation, followed by bromination of pentaerythritol, provided the known 
compound 27 as the template for the new additive 32 in 72% yield over 2 steps.15 N-3-
Butenylurea 29 was prepared from 3-butenyl bromide (28) by successive treatment with 
methylamine (neat), phosgene and a solution of methylamine in THF in 66% yield over 2 steps. 
The synthesis of cyclic urea 30 was achieved by a Pd(II)-catalyzed intramolecular 
amidocarbonylation of 29 in 89% yield.16  
 
8 
 Br
HO
HO
OH
OH
TsO
TsO
OTs
OTs
N N
O
OH
N N
O
CO2Me
N N
O
O C
N N
H
O
Br
Br
Br
Br
Pyridine, TsCl
rt, overnight
88%
NaBr, 140 oC
diethyene glycol
82%
1. MeNH2, rt
2. Phosgene, DIPEA, CH2Cl2;
    MeNH2, DIPEA
    66%
NaBH4, EtOH,
CuSO4/H2O, reflux, 3 h
71%
27, KH, DMF, 50 oC
72%
4
26 27
29
30 31
32
PdCl2, CuCl2
CO, MeOH
89%
17
28
 
Scheme 4. Synthesis of poly(cyclic urea) 32. 
 
Reduction of the methylester 30 with NaBH4 proceeded slowly and after 24 h gave only 
low yields of the expected alcohol. However, addition of an aqueous CuSO4 solution (10 
mol%)17 accelerated the reaction rate and within 3 h alcohol 31 was obtained in 71% yield. 
Alkylation of 31 with compound 27 using KH, a more effective base in this case than NaH, gave 
a 72% yield of poly(cyclic urea) 32. While no improvement in the solubility of additive 24 in 
THF at lower temperature was observed, poly(cyclic urea)s 23 and 32 readily dissolved in THF 
9 
 at –78 °C at concentrations of up to 0.02 M. These polyureas were examined for their properties 
as alternatives to HMPA. 
 
1.2.2. Application of additives in solution phase reactions 
 
Three reactions, in which HMPA was previously used as an additive, were selected and 
studied in the presence of the new poly(cyclic urea)s. 
Table 1. Aldol reaction in the presence of poly(cyclic urea)s. 
 
CN
Ar
CN
OH
Ar
Ar
CN
OH
Ar
i) LDA, THF, -78 oC
ii) additive, -78 oC
iii) 1-naphthaldehyde, 30 min, -78 oC
+
Syn-34                        Anti-3433  
 
Entry Additive Ratio (Syn:Anti)a Yield (%)b
1 - 32:68 91 
2 6 eq HMPA 91:9 97 
3 6 eq DMEU 67:33 58 
4 20 eq DMEU 81:19 83 
5 2 eq 16 47:53 73 
6 1 eq 25 52:48 80 
                         a) Determined by 1H NMR; b) isolated yield. 
 
The influence of additives on the aldol reaction of 1-naphthylacetonitrile and 1-
naphthaldehyde was examined first. Carlier and co-workers reported that lithiated 1-
naphthylacetonitrile underwent highly syn-selective addition to aromatic aldehydes in an HMPA-
10 
 THF solution.18 They suggested that the selectivity attained was traced to an HMPA-facilitated 
retro-aldol reaction under thermodynamic control. DMEU-based poly(cyclic urea)s 16 and 25 
were tested as additives in this aldol reaction. The results are shown in Table 1. We observed an 
increase in the syn-selectivity of the addition to 1-naphthaldehyde in the presence of HMPA and 
DMEU (entries 2 to 4). However, in the presence of poly(cyclic urea) additives 16 and 25, only 
low selectivity was observed after 30 min (entries 5 and 6). Larger equivalents of the additives 
would be necessary to show high syn-selectivity but the usage of these poly(cyclic urea)s was 
limited by their low solubilities. 
The regiochemistry of addition to α,β-unsaturated carbonyl compounds can be altered in 
the presence of HMPA. The suppression of the 1,2-addition in favor of the 1,4-addition of 
lithiodithiane to 2-cyclohexen-1-one has been effectively demonstrated. A number of groups 
have also shown that DMPU was almost as efficient as HMPA in this reaction.6 Also, they have 
directed extensive efforts at elucidating the effects that changes in solvent, temperature, and 
steric bulk on the carbonyl site have on the regioselectivity of these additions.19 The effects of 
our poly(cyclic urea)s on the regiochemical outcome of the condensation of 1,3-dithiane anion 
and 2-cyclohexen-1-one are summarized in Table 2.  
In the absence of any additives, the 1,2-addition product was obtained exclusively (entry 
1). The addition of 2 equivalents of HMPA demonstrated a strong regiochemical bias towards 
the 1,4-addition of 1,3-dithiane (entry 2). While varying the reaction time had little effect on the 
regiochemical outcome and the yield of the addition, the presence of additives and lowering the 
reaction temperatures kinetically favored the 1,4-addition product. At high temperatures (entries 
3 to 7), all cyclic urea additives (0.5 eq to 8 eq) performed poorly compared to HMPA. However, 
at –78 °C, along with DMPU (8 eq, entry 9), our additives 23 and 32 (1 eq, entries 10 and 11, 
11 
 respectively) drove the reactions to give the 1,4-addition product predominantly. Generally, the 
use of excess 1,3-dithiane anion improved the yield of both regioisomers. 
 
Table 2. Regioselective addition of 1,3-lithiodithiane to cyclohexenone in the presence of 
poly(cyclic urea)s. 
S S
O
S
S
HO
S
Si) LDA, THF
ii) additive
iii) cyclohexenone
      temperature, time
+
2                                     31  
 
Entry DS:CY:additivea Additive 2 : 3b Yield (%)c mmol/mLd
1 2:1:0 - 0:100 83 0.02 
2 2:1:2 HMPA 94 : 6 92 0.2 
3 2:1:1 16 79 : 21 31 0.02 
4 2:1:8 DMEU 35: 65 82 0.04 
5 2:1:8 DMPU 42:58 88 0.04 
6 2:1:0.5 25 28:72 71 0.04 
7 2:1:2 23 67:33 72 0.02 
8 2:1:8 DMEU 60:40 87 0.04 
9 2:1:8 DMPU 92:8 72 0.02 
10 2:1:1 23 87:13 94 0.02 
11 2:1:1 32 90:10 90 0.02 
                     a) DS = 1,3-dithiane, CY = 2-cyclohexen-1-one; b) ratio determined by 1H NMR; c) isolated; d) 
concentration of 2-cyclohexen-1-one; e) reaction conditions; entries 1 and 2, –78 °C, 2 h; entries 3 to 7, –22 °C to 0 
°C, 2 h; entries 8 to 10, –78 °C, 15 min; entry 11, –78 °C, 25 min.  
 
The number of urea units in 1 equivalent of 23 or 32 is matched by 4 equivalents of 
DMPU. Interestingly, using only 1 equivalent of the synthetic additives 23 or 32 produced a 
12 
 similar bias to the 1,4-addition product, as compared with 8 equivalents of either DMEU or 
DMPU (entries 8 to 11). Poly(cyclic urea) 32, with its markedly improved solubility and reduced 
steric hindrance about the carbonyl site, provided the best regioselective outcome and yield 
comparable to HMPA.  
Table 3. Carbonyl-selective allylation of an α,β-epoxy ketone with poly(cyclic urea)s. 
 
Ph Ph
O
O
Ph Ph
O
OH
PbI2, THF, additive
tri-n-butylallyltin,  reflux, 1 d
+     SM
3635  
 
 
                                     a) Determined by 1H NMR  
Entry Additive 36 (%)a SM (%)a
1 1 eq DMPU 41 57 
2 0.2 eq HMPA 78 25 
3 0.2 eq 16 38 51 
4 0.2 eq 25 6 87 
5 0.2 eq 23 5 95 
6 0.2 eq 37 16 80 
7 1 eq 37 57 37 
N N
O O
N NH
O
NaH, DMAP
CH3COCl, THF, 50 oC
79%
3721  
 
Since there are a number of examples to use HMPA as a catalyst in organometallic 
reactions,2 we investigated whether the poly(cyclic urea)s could be used as catalytic additives. 
Baba and co-workers used PbI2-HMPA as a catalyst for chemo- and diastereoselective carbonyl 
13 
 allylation of α,β-epoxy ketones with allylic stannanes.2b When 0.2 equivalent of HMPA (entry 2) 
were added to the reaction mixture, high yields of the allylated product were obtained, almost as 
a single diastereoisomer, with an anti-relationship between the hydroxyl and epoxy groups. 
Table 3 shows our results with several poly(cyclic urea) additives (entries 3 to 6). Unfortunately, 
these poly(cyclic urea) compounds did not catalyze this reaction efficiently. According to Baba 
et al,2b HMPA increased the solubility of PbI2 in THF. Even when up to 1 equivalent of DMPU 
was used, complete dissolution of PbI2 was not observed (entry 1). This may account for the 
lower yields obtained with our poly(cyclic urea)s. Compound 37, which has an additional 
carbonyl site on the urea, was prepared by acylation of 21 to examine whether this modification 
of the urea unit could improve its properties. Even though this compound gave a lower yield of 
product compared to HMPA, 37 proved more effective than DMPU (entry 7) in this reaction. We 
assume that the additional carbonyl group in 37 strengthened the chelating property of the urea. 
 
1.2.3. Synthesis and application of new additives in solid phase synthesis 
 
Based on the results obtained with poly(cyclic urea) 32, a polymer-supported additive 
was designed that incorporated units of polycyclic urea 31 as shown in Scheme 5. This polymer-
supported reagent consisted of the solid support, a linker and the poly(cyclic urea). The linker 41 
was prepared by alkylation of the tetrabromide compound 27 with the alcohol 40, which was 
obtained from 4-hydroxy cinnamic acid 38 by a known procedure in 52% yield over 2 steps.11 
The linker 41 and the urea 31 were coupled using KH in DMF to give polyurea 42 in high yield. 
14 
 NaOH, BnBr, EtOH
82%
LAH, THF
63%
31, KH, DMF, 70 oC, 36 h, quant.
27, KH, DMF, rt, 48 h
53%
BnO
O
HO
CO2H
BnO
CO2H
BnO
OH
39
40 41
42
43
Pd/C, H2, MeOH, 50%
Br
Br
Br
NN
O
O
R =
BnO
O
R
R
R
HO
O
R
R
R
O
O
R
R
R
44
38
Cs2CO3, THF, 1 h;
ArgoporeCl, DMF, 3 d
59%
 
Scheme 5. Synthesis of polymer-supported poly(cyclic urea) 44. 
 
Pd-catalyzed deprotection of the benzyl group led to compound 43 in 53% yield. 
ArgoPore® resins are macroporous beads characterized by high internal surface and cross-linking 
levels. This macroporous resin thus offers advantages such as compatibility with a wide range of 
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 solvents, low and predictable swelling in all solvents and accessibility to the polymer-supported 
intermediates under low-temperature reaction conditions. We anticipated that these properties of 
the ArgoPore® resin would be beneficial for our purposes. Compound 43 was attached to 
commercially available ArgoPore®-Cl resin (1.2 mmol/g) using Cs2CO3 to give polymer-
supported polyurea 44. We then performed the addition of 1,3-dithiane to 2-cyclohexen-1-one 
using the polymer-supported additive 44 (Table 4). The use of LDA as base with 44 showed only 
moderate regioselectivity and low yields (entry 1). However, while higher yields were obtained 
with t-BuLi, the regioselectivity was the same (entry 2). Using an excess of 44 led to an 
improvement in the regioselectivity (entry 3). Though 44 showed only moderate chemical utility 
as an additive, this polymer-supported urea could be easily recovered and recycled without 
decrease in efficacy. 
 
Table 4. Regioselective addition of 1,3-lithiodithiane to cyclohexenone in the presence of 44.  
S S
O
S
S
HO
S
S
i) LDA, THF
ii) additive
iii) cyclohexenone
     -78 oC, 2 h
+
2                                     31  
Entry DS:CY:additivea Additive 2 : 3b Yield (%)c Base 
1 2:1:1.2 44 54:46 <52 LDA 
2 2:1:1.2 44 53:47 96 t-BuLi 
3 2:1:2.4 44 63:37 85 t-BuLi 
                      a) DS = 1,3-dithiane, CY = 2-cyclohexen-1-one; b) determined by 1H NMR; c) isolated. 
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 1.2.4. Ring opening metathesis polymerization (ROMP) 
 
45 47
46
n
O
NO O
O
R
O N
O O
O
R
O
OPh
n
Ru
Cl
Cl
PCy3
PCy3
Ph
48 49  
Figure 4. Ring opening metathesis polymerization (ROMP). 
 
Most polymer-supported reagents to date have used cross-linked polystyrene as the 
insoluble support due to its commercial availability. With polystyrene, all synthetic 
modifications are invariably carried out post-polymerization. The quality of the resin is therefore 
an important consideration, since monitoring reactions on-resin is not straightforward and 
purification is generally not possible. Several groups have found an alternate method in the use 
of the ring opening metathesis polymerization (ROMP).25 Monomer units containing all the 
desired functionality for the reagent and a strained alkene are synthesized in solution and are 
then polymerized using the Grubbs’ catalyst 46. The resulting polymers are soluble in the 
reaction solvent and thus reaction conditions optimized for solution phase can be applied without 
17 
 reoptimization of the polymer-supported versions.24 After the reaction is complete, the ROMP 
polymer is simply precipitated by the addition of the appropriate solvents and removed by 
filtration. In examples of ROMP in Figure 4,25 the ROMP polymers are of excellent quality and 
provide quantitative loading; the polymer loading being equal to the molarity of the monomer. 
Increasing the amount of Grubbs’ catalyst had a detrimental effect on the quality of the polymer 
with regards to its coloration and solubility. In some cases, a larger quantity of cross-linker had 
to be added to obtain a polymer of satisfactory insolubility. 
51
53
50
O
O C O
N N
O
3 Grubbs' reagent (2 mol%)CH2Cl2, 3 d
(100 mol%)
Thick oil
PolyDMPU
n
N N
O
N N
O
with or 
without
54 Thick oil
PolyDMEU
n
Grubbs' reagent (2 mol%)
CH2Cl2, 1 d
52
 
Scheme 6. Synthesis of poly(cyclic urea) polymer by ROMP. 
 
To apply ROMP in our chemistry, monomer 50 was prepared via a Heck coupling26 of 
the 4-bromophenyl analog to norbornadiene (52). Subsequently, polymerization of 50 in the 
presence of Grubbs’ catalyst (2 mol%) and termination with ethyl vinyl ether afforded the brown 
oil 51 in 53% yield. This polymer was dissolved in CH2Cl2 and precipitated as an oil with the 
addition of ethyl ether or EtOAc. When a solution of polymer 51 in THF was mixed with Li-base 
18 
 (n-BuLi), the polymer immediately aggregated and the reaction was unproductive. This flexible 
linear structure might be not suitable as a cation-chelating reagent. However, when polymer 51 
was used in the carbonyl-selective allylation of an α,β-epoxy ketone, the reaction was slow, but 
still gave a 65% conversion after 4 d in the presence of 20 mol% of additive. No conversion was 
observed in the absence of the additive. To induce better precipitation by the addition of ethyl 
ether, 1 equivalent of norbornadiene 52 was added as the cross-linker to transform the linear 
structure to a cross-linked one. Unfortunately the cross-linked polymer showed very similar 
physical properties to linear-polymer 51. The less flexible monomer 53 was also prepared and 
polymerized to give polymer 54 in 37% yield. This polymer was also soluble in CH2Cl2 and 
precipitated by the addition of ethyl ether. We expected that the polymer 54 could be precipitated 
better in ethyl ether for the easier isolation of the polymer. There was, however, no observed 
difference in the physical properties of polymer 54 as compared to 51.  
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 2. Synthesis and Application of New HMPA Additives for Solid Phase Organic 
Synthesis 
2.1. Introduction 
Hexamethylphosphoramide (HMPA) is a highly polar aprotic solvent and has been used 
extensively as a co-solvent or catalytic additive in organic chemistry. HMPA coordinates very 
well to metal ions, thus increasing the nucleophilicity of the counter ion and influencing reaction 
kinetics. However, HMPA is also a highly toxic mutagen and the use of HMPA has been limited 
in both industry and academia. Several groups have used a range of other substances, such as 
DMPU,6 N-oxides,8 and formamides10 to replace HMPA. We have previously studied the use of 
polyureas and their solid-supported analogs as replacements for HMPA. Overall, they showed 
lower activities as additives compared to HMPA.  
The driving force for the development of new additive reagents is to avoid contact with 
the carcinogenic HMPA. Benzyltrichloroacetimidate should be distilled before usage and kept 
under an inert atmosphere. However, polymer-supported benzyltrichloroacetimidate could be 
stored on the bench for 3 month without loss of activity.27 We envisioned that the incorporation 
of HMPA into a polymer could be a way not only to maintain the activity of HMPA but also to 
reduce toxicity. As shown in Figure 5, the dimethyl moiety of HMPA has been replaced by other 
less volatile and less toxic diamines. Also many chiral HMPA derivatives28 have been prepared 
and used in enantioselective synthesis. It is possible to use these chiral HMPA derivatives to 
generate polymer-supported chiral HMPA.  
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Figure 5. HMPA derivatives. 
In the late 1970’s, Tomoi and co-workers demonstrated the utility of polymer-supported 
phosphoric triamide 63 as a phase transfer catalyst.29 They showed that immobilized phosphoric 
triamides such as 63 are better catalysts than the corresponding non-immobilized phosphoric 
triamides in biphasic reactions. However, HMPA was used as the solvent and heated at 100 °C to 
prepare these polymer-supported phosphoric triamides 63, without consideration of the toxicity 
of HMPA (Figure 6). In 1981, Nee also reported the cooperative effect of 63 in the reaction of 
the Li-enolate of ethylacetoacetate with diethylsulfate (Scheme 7).30 
Cl
NaN
P
R
O
NMe2
NMe2
HMPA, 100  oC N
P
R
O
NMe2
NMe2
R = CH3, 1.6 mmol/g
R = H, 0.48 mmol/g64
6362
 
Figure 6. Early example of polymer-supported phosphoric triamide. 
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 OEt
O O Li
OEt
O O
THF, Et2SO4
Et
OEt
OEt O
+
65 66 67  
Entry cosolvent Temp. (ºC) 66 (%) 67 (%) 
1 - 50 - - 
2 1 eq polymer-supported HMPA 24 34 66 
3 1 eq HMPA 24 41 59 
 
Scheme 7. Early application of polymer-supported HMPA. 
 
In a recent example of polymer-supported HMPA, Flowers used a polymer-supported 
phosphoramide as a Lewis-base catalyst in an aldol reaction (Scheme 8). Though this aldol 
reaction could occur in the absence of the catalyst, the process was accelerated in the presence of 
the PS-phosphoramide catalyst 68, which was prepared from aminomethyl resin SS, and the 
yield was also increased.31  
 
OSiCl3
+ ArCHO
N
H
P
O
NMe2
NMe2
68 (10 mol%)
CH2Cl2, -23  oC
Ar
OH O
64-85 %
syn:anti = 1:1 ~ 10:1  
Scheme 8. Recent application of polymer-supported HMPA as a catalyst. 
 
To avoid the use of HMPA as a solvent29 and to manage the property of the polymer, we 
decided to prepare a polymer-supported HMPA by polymerization. We anticipated this polymer-
22 
 supported reagent would demonstrate the beneficial additive characteristics of HMPA along with 
the common advantages of a polymer-supported reagent, such as reusability and increased 
stability.  
69
O N O NO N
O N
R
R
R
n
cooling
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7574
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Figure 7. Solid-supported living free radical polymerization (LFRP); Rasta resins. 
 
We considered performing a living free radical polymerization (LFRP)32 and a 
suspension polymerization33,34 to obtain polymer-supported HMPA. First, solid-supported living 
23 
 free radical polymerization (LFRP) is initiated thermally by exposure of TEMPO-methyl resin to 
styrene monomers. The benzylic nitroxides reversibly thermolyze above 123 °C, generating 
benzyl radicals and nitroxyl radicals. The benzyl radicals are free to react with the styrene 
monomer, and the polymerization ensues. Chain termination reactions such as the condensation 
of two benzyl radicals are inhibited by the presence of nitroxyl radicals. Upon cooling, the 
nitroxyl radicals recombine with the benzyl radical at the polymer terminus to generate a 
polymer that can serve as an initiator in subsequent rounds of polymerization (Figure 7).32a This 
process can be described as a solvent-free suspension polymerization. These “Rasta resin” were 
believed to have a unique macromolecular architecture typified by long straight chain polymers 
bearing the desired functional groups that emanate from the phenyl groups of a cross-linked 
polystyrene core. With appropriate choice of the co-monomers and the polymerization strategy, 
the solvent affinity, loading capacity, and distance of functionality from the cross-linked core 
may be controlled giving beads with properties that are tailored to specific uses as polymer-
supported reagents. 
We expected that these unique structures, in which each monomer is connected linearly 
but each elongated oligomer is isolated from other oligomers, might help to solve the 
aggregation problems seen with the ROMP polymer. Examples of living free radical 
polymerization using styrene showed that an overall loading of 6~7 mmol/g was easily achieved 
from 1 mmol/g loading of the initial resin. If this range of high loading is achieved with actual 
monomers, then the amount of polymer-supported reagent can be reduced in the reactions (0.72 g 
of previous polymer-supported urea and 0.13 g of DMPU are matched with 1 mmol of urea unit).  
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Figure 8. Cross-linkers in suspension polymerization. 
 
Many commercially important polymers and co-polymers are manufactured by the 
suspension polymerization process. This process allows for easy control of the properties of the 
polymer by changing factors, such as the additives, ratio of reagents, concentrations, 
temperature, reaction time, and stirring speed. Janda and co-workers have studied the role of 
cross-linkers to devise new polymer-supports. The resins predominantly used are divinylbenzene 
(76) cross-linked polystyrenes (DVB-PS). Polyester, polyamide, poly(ethylene glycol) (PEG, 
77), or polysaccharide matrices have been used to make the polymers more compatible with 
highly polar solvents and reagents. For example, a new gel-type polymer resin was introduced by 
Itsuno in which polystyrenes were lightly cross-linked by PEG derivatives.35 Resins 
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 incorporating PEG derivatives were found to be superior to DVB-PS in terms of their ability to 
swell in common organic solvents and their mechanical stability. But PEG is a very hydrophilic 
material, and has a strong tendency to form helical structures that can bind metal cations. It is 
only sparingly soluble in cold THF. These properties can limit the utility of PEG in 
organometallic and anionic reactions performed at low temperatures.  
Janda and co-workers have examined the use of polytetrahydrofuran (PTHF) based cross-
linkers in gel-type polystyrene resins (JandaJel). These cross-linkers were designed to render the 
resins more ‘organic solvent-like’. The amount of swelling decreased as the level of cross-
linking increased, although even the 10 mol% cross-linked resin swelled significantly. These 
resins also showed good chemical stability. Resins cross-linked with 1 mol% or 2 mol% of 78 
were degraded upon treatment with n-BuLi. Resins cross-linked with 5 mol% or 10 mol% of 78 
were unaffected by this treatment. Furthermore, resins cross-linked with 1 mol% or 2 mol% of 
79 also exhibited stability to n-BuLi. Finally, all resins were mechanically stable to magnetic 
stirring over a 48 h period.34d
After careful examination, we choose the PTHF (79) cross-linked polystyrene resin.34a 
We planned to utilize the solid-supported living free radical polymerization and JandaJel cross-
linked with PTHF 79 as the new structure for our polymer-supported HMPA 
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 2.2. Results and Discussion 
2.2.1. Living polymerization 
1. MeNH2, rt, 6 h
2. (Me2N)2P(=O)Cl
    TEA, ether, reflux
    73%, 2 steps81 82
Cl N
P
O
NMe2
NMe2
 
Scheme 9. Synthesis of monomer 82. 
To perform the polymerization, monomers were prepared from the reaction of 4-
vinylbenzyl chloride 81 with methylamine followed by bis(dimethylamino)phosphorochloride to 
give the desired styrene derivative 8236 in 73% yield (Scheme 9). This monomer was purified by 
chromatography and kept at 0 °C for 1 month without self-polymerization.  
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Scheme 10. Synthesis of HMPA Rasta resin 86. 
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 As shown in Scheme 10, reduction of commercially available TEMPO radical (70) by 
treatment with sodium ascorbate followed by deprotonation with NaH in DMF gave the sodium 
salt of TEMPO 83. Addition of this sodium salt solution in DMF to ArgoPoreCl resin 84 (1.18 
mmol/g) afforded the TEMPO-methyl resin 85.32a Heating the TEMPO-methyl resin with an 
excess of monomer 82 under an inert atmosphere at 130 °C for 16 h led to the nearly complete 
solidification of the reaction mixture. After cooling the resulting polymeric mass, CH2Cl2 was 
added to dissolve any remaining monomer and soluble polymer. Filtration and washing with 
several cycles of alternating portions of diethyl ether and CH2Cl2 and drying under reduced 
pressure gave resin beads 86. These beads 86, which were visibly larger than the TEMPO-methyl 
resins and remained round in shape with a brown color, showed consistently about a 4-fold 
increase in mass (2.3 mmol/g to 2.7 mmol/g). We then investigated the addition of lithio-1,3-
dithiane to 2-cyclohexen-1-one in the presence of Rasta resin 86. Unfortunately, these polymers 
didn’t show consistent activity, even when the loadings and appearance of polymers were 
similar; each batch gave different results. We are not sure if these derivatives can participate as 
additives, but we suspect the cause of the varied results was due to decomposition under the hash 
reaction conditions (at 130 °C for 16 h). To reduce the reaction time, microwave technology (130 
°C, 30 min) was applied to prepare the Rasta HMPA 86. The microwave-produced Rasta resin 
also gave inconsistent results. While living polymerization could be applied to synthesize the 
new polymer-supported HMPA, the new solid reagent did not show the desired properties as 
additives.  
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2.2.2. Synthesis of polymer-supported HMPA by suspension polymerization 
 
To avoid the thermal decomposition of the HMPA moiety in Rasta resins, the 
polymerization temperature has to be low. The common temperature used for suspension 
polymerization is about 80 °C. As shown earlier, the JandaJel is a novel insoluble support that 
contains a flexible tetrahydrofuran-derived cross-linker offering several advantages over other 
commercially available polystyrene resins. The interior of the bead is more “organic solvent-
like” than that of divinyl benzene cross-linked resins, demonstrates increased swelling/solvation 
in common solvents, improved chemical stability, increased site accessibility and increased 
homogeneity.  
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Scheme 11. Synthesis of polymer-supported HMPA 87 by suspension polymerization. 
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 We applied the same monomer 82 to the suspension polymerization process. In the 
synthesis of the cross-linker 90,34d 1,4-dibromobutane was alkylated with sodium 4-
vinylphenoxide.34d Following the protocol described by Janda and co-workers,34a all reagents 
were added in a Morton flask equipped with a mechanical stirrer. Subsequent suspension 
copolymerization of styrene 82 and cross-linker 90 provided polymer-supported HMPA 87a and 
87b with two different cross-linking ratio of 4 mmol% and 10 mmol% of 90, respectively. Based 
on a nitrogen content of 6.40% and 7.22% determined by elemental analysis and assuming 
17:7:1 and 12:5:2 ratio of styrene:82:90, the loadings 87a and 87b were calculated as 1.7 mmol/g 
and 1.5 mmol/g, respectively. These new resins demonstrated excellent swelling in THF and 
CH2Cl2, which are common reaction solvents in the model system. As expected, this gel 
structure was mechanically stable during magnetic stirring. Additionally, these polymer-
supported reagents 87 were found to maintain their activity after storing on the bench for 2 
months, and their properties remained the same after being reused 8 times in different reactions. 
They were also successfully applied over a wide range of temperatures from 75 °C to –78 °C. 
 
2.2.3. Application of polymer-supported HMPA  
 
First, we investigated the addition of lithio-1,3-dithiane to 2-cyclohexen-1-one in the 
presence of polymer-supported HMPA 87a and 87b (Table 5). Addition of HMPA demonstrated 
a strong regiochemical bias towards 1,4-addition of dithiane (entry 3). The addition of 1.3 and 
1.5 equivalents of our synthetic derivatives 87a and 87b, with LDA as base, showed only a 
moderate regioselectivity bias (entries 4 and 5). The use of an excess of polymers gave lower 
yields, but certainly improved the regioselectivity of addition (entries 6, 7 and 8). The use of t-
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 BuLi as base and 2~4 equivalents of the polymer reagent provided a higher yield of the 1,4-
addition product as compared to LDA. These results certainly suggest that the polymer-
supported HMPA reagents are promising alternatives to HMPA. To ascertain the reliability of 
the data, each polymer was prepared 3 times and each batch was tested 3 times under the same 
conditions. In these experiments, polymer 87 showed consistent data. Additionally, the cross-
linking ratio didn’t alter the activity of the resin.  
 
Table 5. Regioselective addition of 1,3-lithiodithiane to cyclohexenone in the presence of 87. 
S S
O
S
S
HO
S
S
i) base, THF
ii) additive
iii) cyclohexenone
     -78 oC, 2 h
+
2                                     31  
Entry DS:CY:additivea Additive 2 : 3b Yield (%)c Basee
1 2:1:0 - 0:100 83 LDA 
2 2:1:1 HMPA 52 : 48 –d LDA 
3 2:1:2 HMPA 94 : 6 92 LDA 
4 2:1:1.4 87a 64:36 92 LDA 
5 2:1:1.2 87b 60:40 82 LDA 
6 2:1:1.8 87bf 73:27 92 t-BuLi 
7 2:1:2.7 87bf 84:16 68 t-BuLi 
8 2:1:3.6 87bf 87:13 78 t-BuLi 
                 a) DS = 1,3-dithiane, CY = 2-cyclohexen-1-one; b) ratio determined by 1H NMR; c) isolated; d) no isolation;    
           e) reaction run at 0.02 M concentration based on 2-cyclohexen-1-one; f) recycled resin was used. 
 
Polymers 87a and 87b were also tested in the aldol reaction between 1-
naphthylacetonitrile and 1-naphthaldehyde (Table 6). We observed excellent syn-selective 
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 addition to 1-naphthaldehyde in the presence of HMPA versus in the absence of the additive 
(entries 1 and 2). In the presence of equal equivalents of polymers 87a and 87b, respectively, 
good syn-selectivity was also observed (entries 3 and 4) but with a decrease of the yield. Again 
no difference in activity was noticed between 87a and 87b.  
 
Table 6. Aldol reaction in the presence of 87. 
CN
Ar
CN
OH
Ar
Ar
CN
OH
Ar
i) LDA, THF, -78 oC
ii) additive, -78 oC
iii) 1-naphthaldehyde, 30 min, -78 oC
+
Syn-34                        Anti-3433  
Entry Additive Ratio (Syn:Anti)a Yield (%)b
1 - 36:64 90 
2 6 eq HMPA 92:8 97 
3 6.3 eq 87a 85:15 57 
4 5.3 eq 87b 82:18 61 
                                               a) ratio determined by 1H NMR; b) isolated. 
 
To examine the use of polymer-supported HMPA as a catalyst, we tested two model 
reactions. First, we examined the effect of polymer-supported HMPA on the chemo- and 
diastereoselective carbonyl allylation of α,β-epoxy ketone with allylic stannane. As shown in 
Table 8, no addition proceeded without any additives, where both substrates were recovered 
quantitatively (entry 1).2b When HMPA (entry 2) was added to the reaction mixture, high yields 
of the allylated product were obtained, and the single diastereoisomer with the anti-relationship 
32 
 between the hydroxyl and epoxy groups was predominated. Polymer 87a also catalyzes this 
reaction in as high a yield and with the same diastereoselectivity as HMPA (entry 3). 
Table 7. Carbonyl-selective allylation of α,β-epoxy ketone in the presence of 87. 
Ph Ph
O
O Ph Ph
O
OH
PbI2, THF, additive
tri-n-butylallyltin, 24 h, 70  oC +     SM
3635  
Entry Additive 36 (%)a SM (%)a
1 - 0 100 
2 0.2 eq HMPA 75 25 
3 0.18 eq 87a 78 22 
                             a) ratio determined by 1H NMR and isolated yield. 
 
Finally, the allylation of aldehydes with allyltrichlorosilane in the presence of Lewis base 
was explored (Table 8). Denmark and co-workers37 used chiral phosphoramides to promote the 
asymmetric allylation of aldehydes with allyltrichlorosilane while Kobayashi and co-workers 
used DMF and polymer-supported formamides in a similar context.10 In the absence of additives, 
no adduct was obtained (entry 1).10b However, 1 equivalent of HMPA could promoted efficient 
conversion (entry 2).37a In the presence of catalytic amounts of polymer-supported HMPA 87a, 
allylation of benzaldehyde occurred in high yields (entry 3). Increasing the number of 
equivalents saw a consistent increase in the conversion of 87a (entry 4). 
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 Table 8. Allylation of benzaldehyde and allyltrichlorosilane in the presence of 87. 
91
SiCl3 PhCHO
OH
+
CH2Cl2/DIPEA = 4/1, rt, 
additive, 24 h
9392  
Entry Additive Yield (%)a
1b - 0 
2c 1 eq of HMPA 85 
3 0.27 eq 87a 74 
4 0.54 eq 87a 82 
                                           a) isolated. b) in CH2Cl2/Et3N as solvent. c) in CDCl3 as solvent. 
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 3. Synthesis of derivatives of calyculin A 
3.1. Introduction 
The reversible phosphorylation of proteins serine, threonine, and tyrosine amino acids is 
an essential regulatory mechanism in many cellular processes such as glycogen synthesis, cell 
division, gene expression, neurotransmission, muscle contraction, and a lot of other secondary 
messenger and signal transduction pathways (Figure 1). The phosphorylation level of a given 
protein is governed by the balance between protein kinases and protein phosphatase. These 
hydroxyl-bearing amino acid side chains are phosphorylated by protein kinases (PKs) using ATP 
as a phosphoryl donor, whereas dephosphorylations are catalyzed by protein phosphatases 
(PPs).38 
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Figure 9. Phosphatase/kinase cycle. 
 
This simple molecular 'on-off' switch modulates selectively the action of over 30 % of all 
cellular proteins and is ubiquitous in eukaryotic cells.39b,40 Protein (de)phosphorylation induces 
changes in protein conformation, protein-protein interactions, protein-ligand interactions, 
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 membrane permeability, and solute gradients, among others. Because the kinases and 
phosphatases affect other proteins and literally have hundreds of substrates, it has been a 
formidable challenge to decipher these complex pathways. 
Protein PPs have been classified in two major families: the PTPases specific for tyrosine 
residues, the PSTPases specific for serine/threonine residues. The major representatives of the 
phosphoproteinphosphatase (PPP) family comprise PP1, PP2A, and PP2B, while the principal 
member of the metal-dependent protein phosphatase (PPM) family is PP2C. The latter family is 
characterized by an absolute requirement for a metal ion, particularly magnesium, for activity. 
While these protein phosphatases constitute the majority of serine/threonine dephosphorylation 
in all eukaryotic cells, a number of additional novel members of the PSTPase family have been 
discovered. These PPs differ in structure, substrate specificity, response to divalent cations, and 
sensitivity to inhibitors. 39 
In contrast to many enzymes, including the kinases, the Ser-Thr-specific PP family 
exhibits broad and overlapping substrate specificity (especially PP1 and PP2A) with no apparent 
substrate consensus sequence. Thus, discerning which phosphatase is responsible for controlling 
a particular cellular pathway has not been a trivial task, and naturally occurring small molecule 
toxins are often used on to achieve this goal. 
PP1 and PP2A are stringently regulated by six endogenous protein inhibitors. Inhibitor-1 
(I-1), Inhibitor-2 (I-2), dopamine and camp-regulated phosphoprotein (DARPP-32), and nuclear 
inhibitor of protein phosphatase 1 (NIPP-1) specifically inhibit PP1. Two proteins, I-1PP2A and I-
2PP2A inhibit only PP2A without affecting the other phosphatases. Although the protein inhibitors 
give mechanistic information about how the protein phosphatases might be inhibited, they have 
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 the inherent shortcomings of peptides, such as proteolytic degradation, poor membrane (blood-
brain barrier) permeability, high molecular weight, and potential instability.  
However, without the problems faced by protein inhibitors, several natural products have 
been identified as potent inhibitors of PSTPases (Figure 10). Microcystins,41 nodularins,42 and 
motuporin43 are potent cyclic peptide toxins (IC50 of about 1 nM against both PP1 and PP2A, 
respectively), which were isolated from marine sponges. The microcystins are cyclic 
heptapeptides that possess several D-amino acids. The nodularins and motuporin are analogous 
cyclic pentapeptides. These cyclic peptides are ‘suicide’ inhibitors since they covalently modify 
the phosphatase via Michael addition of a nucleophilic cysteine in the protein to the 
dehydroalanine in the inhibitors. Thyrsiferyl-23-acetate44 and cantharidin45 were shown to be 
selective PP2A inhibitors, though less potent than the other inhibitors. Fostriecin46 is the most 
selective small molecule inhibitor of the serine/threonine phosphatases and displays 40000-fold 
selectivity for PP2A over PP1. 
The most interesting and complex inhibitors are the polyketides including okadaic acid,47 
dinophysistoxin-4, calyculin A-H, tautomycin,47 and tautomycetin. These inhibitors have been 
the focus of considerable synthetic efforts and many groups have reported total syntheses of 
these polyketides.49,50 Okadaic acid was the first of these inhibitors discovered and shown to be a 
potent and selective inhibitor of PP1 and PP2A, while PP2B is weakly inhibited and PP2C is not 
effected. This selectivity has made okadaic acid a powerful tool for the study of biological 
processes mediated by protein phosphorylation. Tautomycin inhibits PP1 with an IC50 of 0.2 nM 
and PP2A with an IC50 of 1 nM: it is the only small molecule inhibitor that is selective for PP1, 
albeit only 4 fold. 
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Figure 10. Natural products as inhibitors of PSTPases. 
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 As one of the most potent inhibitors of PSTPases, calyculin A was isolated from the 
marine sponge Discodermia calyx. This natural product demonstrated antitumor activity and 
inhibition of PP1 and PP2A with IC50 values of 0.5-2 and 0.1-1 nM, respectively.38 Interest in the 
biological activity of calyculin A has led to three total syntheses and extensive SAR studies.50 
The crystal structure of the complex between calyculin A and the catalytic subunit of PP151 and 
SAR data52 have suggested the binding mode of calyculin A to PP1. The SAR data has shown 
that the C(17)-phosphoric acid, C(13)-OH and the hydrophobic tetraene moieties of calyculin A 
were essential for binding to the protein target. Though an earlier report suggested that 
dephosphorylated calyculin A remained biological activity,53 the recent SAR data from 
Fusetani’s group strongly supported the significance of the phosphoric acid moiety for the 
biological activity.52 Also, many other natural phosphatase inhibitors such as okadaic acid, 
microcystin LR, nodularin and motuporin possess either a carboxylic acid or a phosphoric acid. 
Among the hydroxy groups of calyculin A, the protection of the C(13)-OH resulted in significant 
loss of the biological activity. The hydrophobic tetraene side chain was shown to fit into a 
hydrophobic pocket of the enzyme. Subtle changes of the structure of this side chain resulted in 
modest decreases of IC50. However, the elimination of the side chain resulted in loss of activity. 
After consideration of all available data, we planned to synthesize a truncated core fragment of 
calyculin A in order to develop small molecules, selective serine/threonine inhibitors.  
Our target structure 95 was an analog of the C(8)-C(24) fragment of calyculin A lacking 
the C(15)-methoxy group and the C(22)-methyl group because these structural features were 
shown not to be essential for enzyme inhibition (Figure 11). However, the C(13)-OH, phosphoric 
acid and the rigid skeleton of the spiroketal system were conserved to retain and ensure the 
biological activity. Diversity was introduced into compound 95 through the modification of the 
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 hydrophobic tail (C1 to C7). Aromatic and aliphatic alkenes were appended to the core structure 
by cross metathesis.60 The diastereomer of the 6-membered ring in the spiroketal backbone was 
initially synthesized to determine the effect of this change on the rigid backbone eventually on 
the biological activity. 
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Figure 11. Calyculin A and target structure for inhibitor optimization. 
 
The natural product phosphatase inhibitors except fostriecin normally show a similar 
activity between PP1 and PP2A.46 From the SAR data of calyculin A, we can observe that 10-
fold selectivity between PP1 and PP2A can be observed by the modification of calyculin A or 
other natural products in same family.52 We aimed to identify potent small molecules and also 
examine whether these newly synthesized small molecules could increase the selectivity between 
PP1 and PP2A. 
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 3.2. Retrosynthetic Analysis 
Retrosynthetically, the side chain including the 1,3-diol of 95 could be installed by an 
asymmetric crotylation via Brown’s or Roush’s methodology54 on the spiroketal 96. The 
spiroketal segment of 96 would be prepared from bicyclic 97 by an intramolecular hydrogen 
abstraction reaction promoted by an alkoxy radical.55 Bicyclic 97 could be derived from the 
aldehyde 98 by a hetero-Diels-Alder reaction with Danishefsky’s diene.56 An indium–mediated 
asymmetric prenylation of the hydroxy aldehyde 99 was anticipated to yield the dihydroxy 
aldehyde 98.57 Finally, the α-hydroxy aldehyde 99 would be formed by methanolysis and 
regioselective DIBAL reduction58 of the commercially available (R)-(–)-5-oxotetrahydrofuran-2-
carboxylic acid (100) as shown in Figure 12.  
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Figure 12. Retrosynthetic approach to 95. 
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 3.3. Previous Work in the Wipf group 
To synthesize the truncated calyculin A derivatives, Dr. Wakimoto had launched the 
initial study as shown below.59 The aldehyde 98 was prepared in 6 steps and a hetero-Diels-Alder 
reaction with Danishefsky’s diene 101 provided 102 in 20-30% yield. The pyrone 102 was 
converted to the bicycle 103 in 33% yield over 4 steps. Spiroketalization of 103 yielded two 
isomers in 83% yield (Scheme 12). The analysis of the NMR data disclosed that the major 
product 104 exhibited different stereochemistry from that of calyculin A.  
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Scheme 12. Synthesis of two spiroketal isomers. 
 
After the TBS-deprotection of 104 and 105, the treatment of a mixture of 106 and 107 
with TsOH in CH2Cl2 afforded the desired isomers 107 in 55% yield as the major product 
(Scheme 13). Unfortunately, the desired spiroketal compound was re-isomerized to the undesired 
epimer during the next transformations and the overall yield of this approach was too low to 
warrant further study.   
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Scheme 13. Isomerization of spiroketals. 
 
In the initial route, the most critical step was the hetero-Diels-Alder reaction. After an 
extensive study of hetero-Diels-Alder conditions, the diene 10961 was found to provide the 
desired lactone 110 in 60% yield. The spiroketalization of 111, which was obtained in 43% yield 
over 4 steps, gave two isomers 112 and 113 in 65% yield (Scheme 14). A more detailed 
discussion of the second route is given in the next chapter. 
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Scheme 14. Synthesis of 112 and 113. 
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 3.4. Results and Discussion 
3.4.1.  Synthesis of the first derivative of calyculin A  
 
Based on Dr. Wakimoto’s approach,59 the synthesis of spiroketal compounds 115 and 116 
was revisited with minor modifications. Methanolysis of (R)-(–)-5-oxotetrahydrofuran-2-
carboxylic acid (100), followed by protection of the secondary alcohol with BOMCl, afforded 
the desired diester 114 in 85% yield over two steps. Chelation controlled regioselective reduction 
of 114 with DIBAL in the presence of MgBr2•Et2O was then explored. According to the original 
report,57 this reaction was initially conducted in CH2Cl2. However, the regioselectivity was low 
in our hands. Therefore, CH2Cl2 was replaced by toluene. Unfortunately, compound 114 was 
insoluble in toluene and required a mixture of both solvents.59    
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Scheme 15. Synthesis of aldehyde 98. 
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Compound 114 and MgBr2•Et2O were found to dissolve well in a mixture of 
CH2Cl2:toluene (3:2). Using only 1 equivalent of DIBAL resulted in the recovery of unreacted 
starting material. Optimally, 1.5 equivalents of DIBAL ensured the reduction of 114 to the 
desired aldehyde 99 in 38% yield along with unreacted starting material (15%) and over-reduced 
alcohol product (37%). The alcohol was converted to desired aldehyde 99 by a variety of 
oxidation conditions in moderate yield. Prenylation of compound 99 with indium and 
prenylbromide gave the desired product 115 in 76% yield. The hydroxylmethylester 115 was 
readily converted to the corresponding lactone 118 during work-up. However, the lactone 118 
was easily converted to the desired hydroxylmethylester 115 by careful methanolysis. This 
indium-mediated prenylation was first reported to give a stereoselective addition in the presence 
of chiral additives such as (–)-cinchonidine or (+)-cinchonine.57 However, we were able to obtain 
a single diastereomer without any chiral ligand. We assume that the high diastereoselectivity was 
achieved through the chelation control of the BOM-protected alcohol group of 117 (Figure 13). 
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Figure 13. Postulated transition state for 117. 
  As shown in Figure 14, the stereochemistry of the secondary alcohol 115 was confirmed 
by coupling constants and NOE correlations of the δ-lactone 118 derived from 115.59 Thus, as a 
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 result of the chelation-controlled homoallylation, the desired isomer of the alcohol was obtained. 
The secondary alcohol 115 was subsequently protected with the TES group and then ozonolysis 
gave us the aldehyde 98 in a yield of 83% (Scheme 15). 
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Figure 14. NOE analysis of compound 118. 
 
 
The methyl-substituted diene 109 was selected for the hetero-Diels-Alder reaction since 
this diene is more stable than the original Danishefsky’s diene56 and resulted in much higher 
yield of the cycloadduct. Additionally, we anticipated that the methyl group in the spiroketal 
would have no deleterious effects on enzyme inhibition based on the SAR data.52 This hetero-
Diels-Alder reaction proceeded in a stepwise rather than a concerted fashion. Initially, the aldol 
product 123 was obtained which could be cyclized to the dihydropyrone in the presence of TFA. 
Under these conditions, the TES group was removed, and the spontaneous ring closure led to the 
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 lactone 110 as a single diastereomer in 60% yield over 2 steps. The high diastereoselectivity of 
the aldol reaction will be postulated in Figure 17. 
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Scheme 16. Synthesis of compound 111. 
 
With compound 110 in hand, we then examined the synthesis of the spiroketal 
intermediate. The conjugated olefin of γ-pyrone 110 was first reduced by hydrogenation. During 
the hydrogenation under various conditions, we observed partial deprotection of the BOM group. 
However, the loss of the BOM group was minimized by using 3% Pd on charcoal as the catalyst 
in THF under 1 atmosphere of hydrogen. The resulting ketone of 119 was then reduced with 
NaBH4 to give a single diastereomer 120, whose stereochemistry could be predicted by the axial 
attack of a small reducing reagent and was confirmed later by the X-ray structure of 111, in good 
yield. The secondary alcohol of 120 was protected with TBSCl and then the BOM group of 121 
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 was removed in quantitative yield by hydrogenation (Scheme 16). In Figure 15, the X-ray 
structure of compound 111 confirms the relative stereochemistry of 111 and the absolute 
stereochemistry of 111 was determined via the (R)-OH group originated from the chiral starting 
material 100. Clearly, during the hetero-Diels-Alder reaction, the newly formed stereocenter 
assumed the (R)-configuration. Also, as we expected, the three substituents on the 
tetrahydropyran ring are in the equatorial position.  
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Figure 15. X-ray structure of 111. 
 
The spiroketalization was effected by irradiating the substituted tetrahydropyran 111 in 
the presence of (diacetoxyiodo)benzene (DIB)/iodine.55 This process afforded two spiroketal 
isomers (112:113 = 2.4:1) in 67% yield (Scheme 17). Due to the inability to determine the 
conformation of the major isomer by NOE, we determined the stereochemistry of the major 
product 112 indirectly based on the structure of the minor product 113.59 The key NOE data used 
for the elucidation of the stereochemistry of 113 are shown in Figure 16. In the desired 
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 conformation 122 (Figure 16), the spiroketal segment is stabilized by two anomeric effects but 
also destabilized by the A1,3-interaction among axial substituents on the tetrahydropyran ring. 
NOE analysis59 of 113 indicated that the conformation of O-silylated spiroketal positioned both 
the methyl and the silyloxy group into an equatorial orientation most likely to avoid a serious 
A1,3-interaction and anomeric stabilization was only partially obtained. Based on the analysis of 
113, the stereochemistry of 112 was inferred as shown in Scheme 17. This conformation of 112 
is highly stabilized by two anomeric effects and three equatorial substituents on the 
tetrahydropyran ring. 
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Scheme 17. Synthesis of spiroketals 112 and 113. 
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Figure 16. NOE analysis of compound 113. 
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Scheme 18. The first attempt to introduce the phosphoric acid ester. 
 
With the major spiroketal 112 in hand, we proceeded to the next steps necessary for the 
construction and the installation of the side chain 1,3-diol, which is one of the essential structural 
features for the enzyme inhibition by calyculin A. DIBAL reduction of 112 yielded a mixture of 
lactol and aldehyde. The crude lactol was first subjected to a Roush asymmetric 
crotylboration,54c which resulted in a mixture of two crotylated compounds in about a 1:1 ratio. 
The precise ratio was not determined due to the difficult separation. However, Brown 
asymmetric crotylboration54a,b afforded the desired product 127 in 77% yield along with a trace 
amount of another diastereomer (Scheme 19). The crotylated product 127 matched one of two 
products from a Roush asymmetric crotylation. Regioselective alcohol protection of 127 was 
successfully achieved with TBSCl without silylation of the sterically hindered hydroxy group on 
the spiroketal ring. The first approach to synthesize the phosphoric acid ester 125 from 123 
involved an ozonolysis, a second crotylation, an anticipated regioselective mono TBS-protection 
of the resulting alcohol, and the final phosphorylation (Scheme 18). The alcohols in 124 were 
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 unreactive toward TBSCl due to high steric hindrance. No selectivity between the two hydroxy 
groups of this intermediate 124 was observed with the more reactive TBSOTf.  
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Scheme 19. Synthesis of the first analog 131. 
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 In our second approach shown in Scheme 19, the phosphoric acid ester was introduced 
earlier to give 128 in 69% yield. Phosphoric acid ester 128 was then subjected to ozonolysis and 
Roush asymmetric crotylation to give the final intermediate 130 as a single diastereomer in 75% 
yield over the 2 steps. The newly formed stereocenters of 130 were assumed as the (R)-OH and 
(R)-methyl groups based on the known induction of the chiral reagent.54c However, from the 
information of the X-ray structure of 152 (Figure 19), the possibility of (S)-(OH) and (S)-methyl 
groups in 130 could not be excluded. Further study is necessary to reveal the correct 
stereochemistry of the second crotylation. Global deprotection of 130 was achieved with HF in 
CH3CN/H2O over 7 d to yield the phosphoric acid 131.50 The first phosphoric acid analog 131 
was thus obtained in 20 steps in a 1.4% overall yield. 
 
3.4.2. Introduction of hydrophobic tail by cross-metathesis 
 
SAR data52 indicated that the hydrophobic tetraene moiety (C1 to C9) of calyculin A was 
very important for the inhibitor to bind to a hydrophobic pocket of the enzyme. We used the 
cross-metathesis protocol60 to modify and extend the terminal alkene of 130. Six alkene 
derivatives, in which R was phenyl, 4-methoxy phenyl, 4-chloro phenyl, cyclohexyl, n-butyl, and 
n-octyl, were successfully introduced in moderate yields as shown in Scheme 20. Global 
deprotections of 132 analogs were achieved with HF in CH3CN/H2O over 7 d to yield the 
phosphoric acids 133 analogs. 
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Scheme 20. Introduction of the hydrophobic tail by cross-metathesis. 
 
3.4.3. Biological activity of synthetic derivatives 
 
The enzyme inhibitory activities of analogs 127, 128, 131, and 133 analogs (Table 9) 
were tested against the PP2A catalytic domain.62 The ProFluorTM assay kit from Promega63 was 
used for this assay. The ProFluor™ PKA assay measures cAMP-dependent protein kinase (PKA, 
serine/threonine protein kinase) activity using purified kinase to find compounds that inhibit 
kinase activity. Using the ProFluor™ PKA Assay, compounds that inhibit the kinase result in 
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 increased fluorescence and are easily distinguishable from compounds that only inhibit protease 
activity, which decreases fluorescence.63 
 
Table 9. IC50 values of synthesized analogs against the PP2A catalytic domain. 
Analog IC50 (µM) 
127 28.1 ± 0.8 
128 24.4 ± 0.1 
131 23.3 ± 7.1 
133a 23.4 ± 3.2 
133b 32.9 ± 6.6 
133c 30.7 ± 6.7 
133d 27.4 ± 1.5 
133e 29.4 ± 0.9 
133f 57.6 ± 16 
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IC50 values showed that the compounds in Table 9 were essentially inactive. The alcohol 
127 and the protected phosphoric acid ester 128 were expected to be inactive due to the absence 
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 of the phosphoric acid group. However, from the inactivity of 131 and 133 analogs, we could 
conclude that the configuration of the spiroketal ring and the specific hydrophobic tail is 
important for retaining biological activity. Even though 131 and 133 had the correct phosphoric 
acid and C(13)-OH, the improper orientation of other functional groups, compared with the 
calyculin A core, could prohibit their binding on the enzyme. The presence of different aliphatic 
or aromatic tails did not induce a higher inhibition. In order to choose the proper hydrophobic 
tails, not only the hydrophobicity but also the specificity should be considered. Significantly, 
geometrical isomers of the tetraene terminus of calyculin A were less potent.52 These results 
motivated us to synthesize close structural analogs of calyculin A. 
 
3.4.4.  Synthesis of diastereomeric spiroketal compounds 
 
As mentioned previously, the hydroxyl group of the tetrahydropyran ring should be 
placed in an axial orientation to maintain the natural conformation of the spiroketal compounds. 
To introduce an axial OH and obtain other diastereomers of the spiroketal quickly, compound 
119 was modified systematically (Scheme 21). In compounds 112 and 113, methyl and hydroxyl 
groups were placed in a syn-orientation. To obtain an anti-relationship between methyl and 
hydroxyl groups in the tetrahydropyran ring, compound 119 was reduced with L-Selectride, a 
bulkier reducing reagent, to afford a 1.6:1 mixture of diastereomers in 71% yield. The minor 
product of the reduction matched compound 120 and the stereochemistry of major product was 
easily postulated as 134. Though the diastereoselectivity was moderate, the major product 
possessed the desired configuration. The secondary alcohol of 134 was protected with TBSCl, 
followed by BOM deprotection using hydrogenation in the presence of Pd(OH)2. 
55 
 Spiroketalization of 135 was performed as previously described with DIB and iodine, which 
produced 3.4:1 mixture of two separable spiroketals 136 and 137 in 74% yield over 2 steps.  
The conformations of the two spiroketals were presumed to be as shown in Scheme 21. A 
methyl or OTBS group in either diastereomer is placed in an axial position. Both conformations 
are stabilized by anomeric effects. However, the amount of the new spiroketals was not sufficient 
to allow for further conversion to the phosphoric acid derivatives. 
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Scheme 21. Synthesis of spiroketals 136 and 137. 
 
Although spiroketals 136 and 137 possess the anti-relationship of methyl and OTBS 
groups on the tetrahydropyran ring, the stereochemistry of these groups does not match the 
spiroketal core of calyculin A. In the correct structure, the methyl and hydroxyl groups on the 
tetrahydropyran ring should have (S)-configurations. To obtain the (S)-configuration of the 
methyl group on the tetrahydropyran ring, we explored a copper-mediated 1,4-addition, in which 
the alkyl group was added from the sterically less hindered α-face of 139 (Scheme 22). As 
56 
 mentioned earlier, the original Danishefsky’s diene56 gave poor yields in our hetero-Diels-Alder 
reactions, which prevented further study of the intermediate 102 (Scheme 12). Additionally, the 
sterically hindered aldehyde 98 was less reactive and the extended reaction time led to the rapid 
decomposition of Danishefsky’s diene. Even with other Lewis acids including AlCl3, Et2AlCl, 
TMSOTf or Sc(OTf)3, there were no improvements in the yield of the cycloadduct.59 Rawal’s 
diene,64 1-amino-3-siloxy-1,3-diene, was also examined in this reaction. However, Rawal’s diene 
decomposed in the presence of Lewis acid. Under thermal conditions with hydrogen-bonding 
solvents such as 2-butanol,64 the desired product was obtained in about 30% yield. However, no 
facial selectivity was observed, and a mixture of the two diastereomers prevailed. A more stable 
diene was sought to prevent the rapid decomposition during the extended reaction time. To 
conserve the excellent stereoselectivity in the hetero-Diels-Alder reaction, the thermal conditions 
were avoided. The diene 13865 showed the best outcome. Employing the bulky silyloxy diene 
138 with BF3•OEt2 and aldehyde 98 at –78 °C in toluene, followed by treatment with TFA, gave 
the desired product 139 reproducibly in <30% yield (Scheme 22).  
To introduce alkyl substituents on the dihydropyrone ring of 139, Cu-mediated 1,4-
addition was tested. Methyl or vinyl cuprate reagents gave poor yields of the addition products. 
However, the butyl cuprate reagent, which was prepared from a 1:2 mixture of CuI and n-BuLi, 
gave the desired product 140 as a single diastereomer in 51% yield. Incoming nucleophile should 
approach from less hindered α-face of 139 to give an anti-relationship of two alkyl groups on the 
tetrahydrofuran ring. NaBH4 reduction of 140 yielded a mixture of two diastereomers (141:159 = 
1:1) in 81% yield based on recovered starting material. To improve the diastereoselectivity of the 
reduction and reduce the reaction time for the formation of the alcohol 141, several reducing 
conditions, including LiBH4 at diverse temperatures and NaBH4 with CeCl3•7H2O, were 
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 exploded. However, the lactone moiety of 140 was sensitive to these conditions, and the 
stereoselectivity and the yield were not improved. Each stereochemistry of two diastereomers 
from the NaBH4 reduction was postulated by comparison with 141 (Scheme 23) and 159 
(Scheme 29), which were prepared through alternative routes, and confirmed later by the X-ray 
structure of 147 (Figure 18). The desired secondary alcohol 141 was protected with a TBS group 
to give 142 in quantitative yield. Though we were able to access the desired intermediate 142, 
the overall route was inefficient and produced 141 in 6% yield over 3 steps from 98. Alternative 
routes to 141 were therefore examined. 
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Scheme 22. Synthesis of compound 142. 
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Scheme 23. Alternative route for synthesis of compound 141. 
 
During the hetero-Diels-Alder reaction, the use of PPTS instead of TFA gave the 
dihydropyrone but did not lead to concomitant lactonization. Since the lactone was proven to be 
sensitive to subsequent transformations of the dihydropyrone ring, we postponed the introduction 
of the lactone to a later step. Cu-mediated 1,4-addition to the dihydropyrone 144 proceeded in 
high yields to give the 3,5-dialkylated tetrahydropyrone 145 as a single diastereomer. The 
incoming butyl cuprate reagent should approach from the less hindered face of 144 to give an 
anti-relationship of the two alkyl groups on the tetrahydrofuran ring of 145. The reduction of the 
tetrahydropyrone 145 with NaBH4 in the presence of CeCl3•7H2O resulted in an improved 
diastereoselectivity from 1:1 to 3.7:1 with a shorter reaction time and higher yield. Deprotection 
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 of the TES group in 146 with the HF•pyridine complex, followed by spontaneous lactonization, 
gave the bicyclic compound 141 in quantitative yield as depicted in Scheme 23. This alternative 
strategy provided the bicyclic alcohol 141 in better selectivity and higher yield of up to 19% over 
4 steps.  
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Figure 17. Postulated transition state for 143. 
 
We propose a model for 1,3-asymmetric induction of the Mukaiyama aldol reaction 
during hetero-Diels-Alder reactions (Scheme 16, Scheme 22, and Scheme 23). With a β-
substitute aldehyde containing two α-hydrogens, the formation of the 1,3-anti product 
diastereomer is generally preferred and this aldehyde face selectivity is governed by steric and 
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 electrostatic effects in the aldehyde that originate from interactions between the β-substituents 
and the carbonyl reaction center.  In that case, the transition state can be postulated like C in 
Figure 17.66 However, with the aldehyde 98, the geometry in transition state A reduces 
nonbonded interactions between α- and β-substituents and provides 1,3-syn product 143. In 
transition state B, a destabilizing dipolar interaction between the C-X and the C=O bonds is 
present. In the case of R=Me, gauche interactions between RL and two other groups are assumed 
to be larger in transition state C than transition state B.  
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Scheme 24. Synthesis of spiroketals 147 and 148. 
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Figure 18. X-ray structure of 147. 
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 As shown in Scheme 24, the deprotection of the BOM group of 142, followed by 
spiroketalization, gave a 2.5:1 ratio of two diastereomers 147 and 148 in 88% yield. The relative 
configuration of the major spiroketal compound 147 was determined by the X-ray structure. The 
configuration and conformation of 147 matched those predicted (Figure 18). The conformation 
of the spiroketal segment was stabilized by an anomeric effect, and butyl and silyloxy groups 
were placed in axial and equatorial orientations, respectively. Based on the X-ray 
crystallographic information of 147, the stereochemistry of the minor product 148 was assigned 
as shown in Scheme 24, and was later confirmed by the X-ray structure of 152. The minor 
diastereomer 148 shows the same configuration as the spiroketal core of calyculin A. 
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Scheme 25. Synthesis of compound 152. 
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 Spiroketal product 148 was further functionalized by DIBAL reduction and subsequent 
Brown asymmetric crotylation to give the bicyclic 149 as a single diastereomer in 78% yield 
(Scheme 25). The expected stereochemistry from crotylation of 149 was confirmed by the X-ray 
structure of 152. The diol 149 was protected regioselectively with TBSCl to give 150 in 90% 
yield. The alcohol 150 was converted to the phosphoric acid ester 151 in 70% yield following the 
established procedure. The ozonolysis of 151 and the subsequent crotylation with Roush 
crotylation reagent afforded the 1,3-diol 152 as a single diastereomer in 48% yield over 2 steps. 
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Figure 19. X-ray structure of 152.  
 
In Figure 19, the relative stereochemistry of 152 is shown as determined by the X-ray 
structure. The conformation of the spiroketal segment and the stereochemistry of initial 
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 crotylation were thus confirmed as originally assigned. This structure matched the most 
important functional groups of the calyculin A core; C(13)-OH, phosphoric acid ester and the 
rigid spiroketal segment. However, the second crotylation produced an undesired diastereomer. 
This result can be explained through a Felkin transition state.67 In order to give the desired 
stereochemistry of 152, the combination of aldehyde 151 and chiral reagent 129 is referred to as 
a “mismatched pair”.68 High levels of diastereofacial selectivity in the mismatched direction are 
observed with α-methyl-β-alkoxy aldehydes without β stereocenter.69 It is unclear why the chiral 
reagent 129 failed to show the expected chiral induction.  
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Scheme 26. Deprotection of 152. 
 
Global deprotection of 152 was achieved with HF in CH3CN/H2O over 8 d to yield the 
phosphoric acid 153 (Scheme 26). Unlike the deprotection of 130 (Scheme 19), the deprotection 
of 152 was not completed in 8 d and led to an inseparable mixture of 153, which was identified 
by HRMS, and side products. We suspected an isomerization of spiroketals occurred under the 
strong acidic reaction conditions. The mixture of phosphoric acids could be purified by 
chromatography on SiO2 (CH3CN:MeOH = 3:1) but was not separable. 
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 Using the Brown crotylation reagent instead of Roush’s reagent, the resulting product 
154 decomposed under basic hydrogen peroxide conditions during work-up. When only an 
excess of H2O2 was used to oxidize the borate, the conversion to the desired compound 154 
occurred very slowly under reflux condition (Scheme 27) 
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Scheme 27. Synthesis of compound 154. 
 
In contrast to 148, DIBAL reduction and crotylation of the major spiroketal product 147 
gave a separable mixture of diastereomers. One of the diastereomers from the crotylation of 147 
matched the spectral data of the compound 149. This could be due to isomerization of the 
spiroketal segment of 147 during the crotylation; the boron species might act as a Lewis acid and 
catalyze the isomerization. The compound 155 was converted to the phosphoric acid ester 157 
via TBS protection and phosphorylation as shown in Scheme 28. 
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Scheme 28. Synthesis of compound 157. 
 
To synthesize spiroketals with (R)-OH and (S)-butyl groups on the tetrahydropyran ring, 
the TES group of the minor reduction product 158 was deprotected to give the bicyclic 
compound 159 in 88% yield. To obtain 159 more efficiently, compound 145 was reduced with 
L-Selectride and the subsequent TES deprotection gave the desired product 159 as a single 
diastereomer in good yield (Scheme 29). Unlike the reduction of 119 with L-Selectride (Scheme 
21), the bulky reducing reagent was able to approach from the opposite side of the axial butyl 
group to avoid the amplified steric hindrance, which resulted in excellent diastereoselectivity. 
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 The stereochemistry of 159 was postulated by the comparison of 141 and 159 prepared under 
different conditions, and later confirmed by the X-ray structure of 166 (Figure 20). 
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Scheme 29. Alternative routes for the synthesis of 159. 
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Scheme 30. Synthesis of spiroketals 161 and 162. 
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 Scheme 30 shows the conversion of compound 159 to the two new spiroketal lactones 
161 and 162 in 94% yield over 3 steps. The relative stereochemistry of 162 was elucidated via X-
ray crystallography (Figure 20). In the X-ray structure, the butyl group in the tetrahydropyran 
ring was disordered. However, the relative stereochemistry of tricyclic rings was able to be 
determined as shown below. The major spiroketal lactone 161 was then converted to the 
phosphoric acid ester 165 through a standard reaction sequence (Scheme 31). 
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Figure 20. X-ray structure of 162. 
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Scheme 31. Synthesis of compound 165. 
68 
 In future work, other crotylation methods should be tested to more efficiently synthesize 
154, and efficient deprotection conditions of 154 should be studied to obtain the desired 
calyculin A analog. After the biological data of the correct 153 is obtained, further modification 
of spiroketals can be studied. 
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 4. Conclusion 
 
In summary, we synthesized a number of poly(cyclic urea) compounds and investigated 
them as possible alternatives to the dipolar solvent HMPA. In a series of test reactions, these 
additives showed similar or better effects than the monocyclic urea compounds DMPU and 
DMEU. The additive 32 was particularly good and gave results similar to HMPA in the addition 
of lithiated 1,3-dithiane to cyclohexenone. The corresponding solid-supported reagent 44 was 
also prepared and showed moderate additive properties. Poly(cyclic urea) polymers with linear 
structure were prepared by ROMP. Although these polymers precipitated from the reaction 
solution upon addition of excess ethyl ether and could be recovered, their physical properties 
were inadequate. These materials were not easily crystallized and formed aggregates with the 
metal cation of the reaction mixture, preventing their use in Li-base reaction. However, we have 
shown that by careful assembly of functionalized urea-monomers into linear, and eventual star-
shaped structures, additives with improved properties could be prepared. Also polymer-
supported urea 44 showed a moderate success as an additive. 
 
Polymer-supported HMPA reagents were synthesized as safe and reusable alternatives to 
liquid HMPA using solid-supported living free radical polymerization or suspension 
polymerization with tetrahydrofuran-derived cross-linkers. Polymer 86 was easily obtained in 
high loading and its physical appearance was very promising. Unfortunately, this polymer did 
not show consistent results during both its synthesis and application. We observed a 
decomposition of this polymer evidenced by changes in color and smell under harsh reaction 
conditions. Microwave irradiation did not improve the synthesis. Alternatively, JandaJel-type 
HMPA polymers were synthesized and applied as additives. These reagents showed very 
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 promising properties as compared to HMPA.  We have demonstrated the general usage of our 
polymer-supported HMPA in a variety of reactions. While an excess of the polymer was required 
in most cases, we have found that the resin could be recovered and reused at least 8 times 
without any loss of activity. Also, the resin showed consistent activity after it was used in 
different reactions. In the future, the synthesis of polymer-supported HMPA can certainly be 
optimized to improve the yield and loading. The replacement of the dimethyl amine moiety with 
bulkier amines such as piperidine could lead to even less toxic materials. Also, the introduction 
of chiral HMPA moieties may give rise to chirality-inducing polymer-supported HMPA analogs.    
 
The synthesis of substituted spiroketal derivatives as mimics of the calyculin A core was 
achieved in 20-22 steps for the longest linear sequence. The design of these simplified analogs of 
calyculin A was based on SAR data, which pointed toward the structural features necessary for 
inhibitor activity. The highlights of our approach were regio- and stereoselective reductions, 
hetero-Diels-Alder reactions, intramolecular hydrogen abstractions and asymmetric crotylations. 
This synthetic strategy provided a ready access to structural analogs of interest for 2nd 
generation structure-activity relationships in phosphatase inhibition. 
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 5. Experimental Section 
 
General. All moisture-sensitive reactions were performed under an atmosphere of N2 or 
Ar and all glassware was dried in an oven at 130 °C prior to use. THF was dried by distillation 
over Na/benzophenone. Et2O, Toluene, DMF and CH2Cl2 were obtained by distillation from 
CaH2. Other solvents or reagents were used without further purification unless otherwise stated.  
Analytical thin layer chromatography (TLC) was performed on pre-coated silica gel 60 F-254 
plates (particle size 0.040-0.055 mm, 230-400 mesh) and visualization was accomplished with a 
254 nm UV light or by staining with a basic KMnO4 solution (1.5 g of KMnO4, 10 g of K2CO3 
and 2.5 mL of 5% aqueous NaOH in 150 mL of water) or PMA solution (5 g of PMA and 100 
mL of EtOH). Flash chromatography was performed using silica gel 60 (230-400 mesh) 
available from EM. 
NMR spectra were recorded in CDCl3 at either 300 MHz (1H NMR) or 75 MHz (13C 
NMR) using a Bruker Avance 300 with XWINNMR software (unless otherwise noted). 
Chemical shifts (δ) were reported in parts per million and the residual solvent peak was used as 
an internal standard. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, qn = quintet, sx = sextet, m = multiplet, br = broad), integration, 
and coupling constants. IR spectra were obtained on a Nicolet Avatar 360 FT-IR spectrometer. 
Mass spectra were obtained on a Waters Autospec double focusing mass spectrometer (EI) or a 
Waters Q-Tof mass spectrometer (ESI). 
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O O
 
1,2-Bis-1-(2-imidazolidonyl)ethane (14).11 A mixture of triethylenetetramine (72.0 g, 492 
mmol) and urea (40.0 g, 666 mmol) was heated to 180 °C and stirred until the generation of 
ammonia gas ceased. After the suspension was cooled to room temperature, the residue was 
suspended in MeOH, filtered, and washed with MeOH. The resulting colorless solid was 
recrystallized from MeOH to give 14 (52.3 g, 26.4 mmol, 79%) as a white solid: Mp 246-249 °C; 
IR (KBr film) 3226, 3085, 2867, 1681, 1504, 1445, 1276, 1104, 965, 764 cm-1; 1H NMR (D2O) δ 
4.66 (s, 2 H), 3.39 (dd, 4 H, J = 7.6, 8.6 Hz), 3.22(dd, 4 H, J = 7.6, 8.6 Hz), 3.15 (s, 4 H). 
BnN N N NH
O O
 
1-(1-(Benzyl)-2-imidazolidonyl)-2-(1’-(2’-imidazolidonyl))ethane (15). A suspension of 14 
(8.00 g, 40.4 mmol) and NaH (60% dispersion in mineral oil, 1.94 g, 48.5 mmol) in DMF (70 
mL) was heated to 130 °C, stirred for 30 min, and treated slowly with a solution of benzyl 
bromide (5.53 g, 32.3 mmol) in DMF (5 mL). The reaction mixture was stirred at 130 °C for 1 h, 
cooled to room temperature, stirred overnight, and quenched with MeOH (10 mL). DMF was 
distilled off under vacuum and water (100 mL) was added. The aqueous layer was extracted with 
CH2Cl2 (3×50 mL). The combined organic extracts were dried (MgSO4) and concentrated. The 
residue was triturated with ethyl ether (50 mL) and filtration gave 15 (4.64 g, 16.1 mmol, 50%) 
as a white solid: Mp 65-68 °C; IR (KBr film) 3441, 3234, 3085, 2931, 2870, 1674, 1498, 1440, 
1363, 1283, 1255, 1241, 1106, 758 cm-1; 1H NMR δ 7.30-7.15 (m, 5 H), 5.20 (br. s, 1 H), 4.31 (s, 
2 H), 3.49 (dd, 2 H, J = 6.8, 8.4 Hz), 3.36-3.20 (m, 8 H), 3.14 (dd, 2 H, J = 7.3, 8.4 Hz); 13C 
NMR δ 163.1, 161.1, 137.3, 128.6, 128.0, 127.3, 48.2, 44.5, 42.2, 42.0, 41.3, 40.6, 38.2; MS (EI) 
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 m/z (relative intensity) 288 (M+, 4), 202 (70), 189 (37), 177 (6), 112 (12), 99 (22), 91 (100); 
HRMS (EI) m/z calculated for C15H20N4O2 288.1586, found 288.1573.    
BnN N N N
O O
NBnNNN
OO  
1,4-Bis-(1-(3-(2-(1-benzyl-2-imidazolidonyl))ethyl-2-imidazolidonyl))butane (16). To a 
suspension of NaH (60% dispersion in mineral oil, 0.832 g, 20.8 mmol) in DMF (8 mL) at 0 °C 
was added a solution of 15 (2.00 g, 6.94 mmol) in DMF (8 mL). The reaction mixture was stirred 
at room temperature for 30 min and a solution of 1,4-dibromobutane (0.800 g, 3.71 mmol) in 
DMF (2 mL) was added slowly. The reaction mixture was stirred at room temperature overnight 
and quenched with MeOH (5 mL). The solvents were distilled off under vacuum and water (50 
mL) was added. The aqueous layer was extracted with CHCl3 (3×30 mL). The combined organic 
extracts were dried (MgSO4) and concentrated. The residue was purified by chromatography on 
SiO2 (CHCl3/MeOH, 100:1) and the resulting solid was recrystallized from THF to give 16 (1.06 
g, 1.68 mmol, 49%) as a white solid: Mp 108-113 °C; IR (KBr film) 3459, 3358, 3026, 2935, 
2866, 1685, 1501, 1441, 1377, 1363, 1259, 1107, 983, 778, 754 cm-1; 1H NMR δ 7.35-7.23 (m, 
10 H), 4.35 (s, 4 H), 3.42-3.34 (m, 16 H), 3.31-3.26 (m, 4 H), 3.20-3.15 (m, 8 H), 1.50 (br, 4 H); 
13C NMR δ 161.4, 161.2, 137.4, 128.6, 128.1, 127.4, 48.4, 44.1, 42.8, 42.34, 42.26, 42.0, 41.4, 
25.1; MS (EI) m/z (relative intensity) 630 (M+, 8), 539 (10), 455 (15), 441 (83), 278 (24), 252 
(43), 227 (31), 202 (33), 189 (39), 91 (100); HRMS (EI) m/z calculated for C34H46N8O4 
630.3642, found 630.3684. 
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3-(3-Allyloxy-2,2-bisallyloxymethylpropoxy)propene (18).12a A suspension of a 50% aqueous 
NaOH solution (58.0 g, 725 mmol) and pentaerythritol (5.00 g, 36.7 mmol) was stirred at 50~70 
°C until a homogeneous solution formed, and cooled to room temperature. To this mixture were 
added tert-butyl ammonium bromide (5.92 g, 18.4 mmol) and allyl bromide (26.6 g, 220 mmol). 
The reaction mixture was stirred at room temperature for 5 h and at 55 °C for 1 d, and cooled to 
room temperature. The aqueous layer was extracted with ethyl ether (3×60 mL). The combined 
organic layers were washed with brine (50 mL), dried (Na2SO4), and concentrated. The residue 
was purified by chromatography on SiO2 (hexane/EtOAc, 25:1) to give 18 (8.00 g, 27.0 mmol, 
73%) as a colorless oil: IR (neat) 3477, 3080, 2909, 2868, 1731, 1646, 1478, 1421, 1350, 1266, 
1137, 1093, 991, 923 cm-1; 1H NMR δ 5.89 (ddt, 4 H, J = 5.4, 10.4, 17.3 Hz), 5.26 (dq, 4 H, J = 
1.6, 17.2 Hz), 5.14 (dq, 4 H, J = 1.5, 10.4 Hz), 3.96 (dt, 8 H, J = 1.4, 5.4 Hz), 3.47 (s, 8 H); 13C 
NMR δ 135.5, 116.2, 72.4, 69.6, 45.6. 
O
O
O
O
HO
OH
OH
HO
 
2-[3-(2-Hydroxyethoxy)-2,2-bis-(2-hydroxyethoxymethyl)propoxy]ethanol (19). O3 was 
bubbled through a solution of 18 (6.00 g, 20.2 mmol) in CH2Cl2/MeOH (100/100 mL) at –78 °C 
until the solution was saturated. N2 was bubbled through the solution for 15 min to remove the 
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 residual ozone and methyl sulfide (11.9 mL, 162 mmol) was added. The mixture was allowed to 
warm to room temperature and concentrated to a syrup, that then was dissolved in EtOH (100 
mL). NaBH4 (6.13 g, 162 mmol) was added slowly to the cooled solution at 0 °C. After stirring 
for 18 h at room temperature, the reaction mixture was acidified with 20% HCl to pH 6. All 
solvents were removed and the residue was purified by chromatography on SiO2 (CHCl3/MeOH, 
10:1) to give 19 (4.73 g, 15.1 mmol, 75%) as a colorless oil: IR (neat) 3374, 2925, 2875, 1653, 
1456, 1362, 1309, 1228, 1172, 1117, 1067, 886 cm-1; 1H NMR δ 3.71-3.68 (m, 8 H), 3.57-3.54 
(m, 8 H), 3.49 (s, 8 H), 3.30 (br, 4 H); 13C NMR δ 72.9, 70.5, 61.6, 45.6; MS (EI) m/z (relative 
intensity) 313 ([M+H]+, 0.4), 282 (0.4), 188 (3), 145 (3), 135 (5), 113 (28), 83 (29), 73 (100); 
HRMS (EI) m/z calculated for C13H29O8 (M+H) 313.1862, found 313.1850. 
O
O
O
O
Br
Br
Br
Br
 
1,3-Bis-(2-bromoethoxy)-2,2-bis-(2-bromoethoxymethyl)propane (20). A solution of 19 (5.90 
g, 18.9 mmol) was cooled to 0 °C, and treated with K2CO3 (102 g, 756 mmol), CBr4  (50.0 g, 151 
mmol), and PPh3 (59.5 g, 227 mmol). After stirring for 24 h, the cold mixture was filtered 
through a pad of SiO2. The filtrate was concentrated and purified by chromatography on SiO2 
(hexane/EtOAc, 10:1) to give 20 (7.27 g, 12.9 mmol, 68%) as a yellow oil: IR (neat) 2962, 2915, 
2875, 1480, 1454, 1441, 1423, 1367, 1275, 1185, 1100, 1044, 1007, 961, 823 cm-1; 1H NMR δ 
3.76 (t, 8 H, J = 5.9 Hz), 3.51 (s, 8 H), 3.48 (t, 8 H, J = 6.0 Hz); 13C NMR δ 71.2, 69.1, 45.9, 
31.0; MS (EI) m/z (relative intensity) 565 ([M+H]+, 0.1), 441 (0.4), 403 (0.1), 314 (50), 301 (18), 
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 285 (10), 261 (94), 207 (38), 163 (44), 137 (42), 107 (58), 73 (100); HRMS (EI) m/z calculated 
for C11H20Br3O3 (M-BrC2H4O) 436.8963, found 436.8953.    
HN NH
O
 
Tetrahydropyrimidin-2-one (21).13 A mixture of 1,3-diaminopropane (21.0 g, 283 mmol) and 
urea (10.0 g, 167 mmol) was heated to 180 °C and stirred until the generation of ammonia gas 
ceased. After the suspension was cooled to room temperature, the residue was suspended in 
EtOH (150 mL), filtered, and washed with EtOH. The resulting colorless solid was recrystallized 
from EtOH to give 21 (10.9 g, 109 mmol, 65%) as a white solid: Mp 260-263 °C; IR (KBr film) 
3333, 3238, 3085, 2944, 2850, 1685, 1540, 1437, 1312, 1181, 1006, 968, 786 cm-1; 1H NMR 
(D2O) δ 4.65 (s, 2 H), 3.07 (t, 4 H, J = 5.5 Hz), 1.66 (qn, 2 H, J = 5.5 Hz). 
N NH
O
 
1-Ethyltetrahydropyrimidin-2-one (22).14 A suspension of 21 (10.0 g, 999 mmol) and NaH 
(60% dispersion in mineral oil, 4.79 g, 120 mmol) in DMF (125 mL) was heated to 110~120 °C, 
stirred for 30 min, and treated slowly with a solution of iodoethane (6.40 mL, 800 mmol) in 
DMF (25 mL). The reaction mixture was stirred at 110 °C for 3 h, cooled to room temperature, 
and stirred overnight. DMF was distilled off under vacuum and quenched with ice water (50 
mL). The aqueous layer was extracted with CHCl3 (4×50 mL). The combined organic extracts 
were dried (MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(CHCl3/MeOH, 25:1) to give 22 (4.20 g, 32.8 mmol, 41%) as a white solid: Mp 87-90 °C; IR 
(KBr film) 3290, 3210, 3059, 2966, 2864, 1653, 1525, 1380, 1347, 1306, 1236, 1196, 1112, 
1079, 758 cm-1; 1H NMR δ 4.80 (br, 1 H), 3.38 (q, 2 H, J = 7.1 Hz), 3.31-3.23 (m, 4 H), 1.98-
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 1.89 (m, 2 H), 1.12 (t, 3 H, J = 7.1 Hz); 13C NMR δ 156.6, 44.8, 42.1, 40.4, 22.3, 13.0; MS (EI) 
m/z (relative intensity) 128 (M+, 100), 113 (90), 99 (31), 85 (49), 71 (22), 58 (42); HRMS (EI) 
m/z calculated for C6H12N2O 128.0950, found 128.0944. 
N N
O
O C
4  
1,3-Bis-(2-(1-ethyltetrahydropyrimidin-2-onyl)ethoxy)-2,2-bis-(2-(1-
ethyltetrahydropyrimidin-2-onyl)ethoxymethyl)propane (23). To a suspension of NaH (60% 
dispersion in mineral oil, 920 mg, 23.0 mmol) in DMF (3 mL) was added a solution of 22 (1.48 
g, 11.5 mmol) in DMF (7 mL) slowly at 0 °C. The mixture was stirred at 0 °C for 1 h and a 
solution of 20 (1.08 g, 1.92 mmol) in DMF (5 mL) was added. After stirring at 50 °C overnight, 
the reaction mixture was cooled to room temperature and quenched with ice. The aqueous layer 
was extracted with CH2Cl2 (3×30 mL). The combined organic layers were washed with brine (30 
mL), dried (MgSO4), and concentrated. The residue was purified by chromatography on SiO2 
(CH2Cl2/MeOH, 10:1) to give 23 (650 mg, 0.864 mmol, 45%) as a white solid: Mp 85-90 °C; IR 
(neat) 3435, 3227, 3030, 2933, 2874, 1788, 1676, 1481, 1448, 1408, 1357, 1280, 1205, 1106, 
991 cm-1; 1H NMR δ 3.54-3.46 (m, 16 H), 3.41-3.34 (m, 24 H), 3.24 (t, 8 H, J = 5.8 Hz), 1.93 
(qn, 8 H, J = 5.9 Hz), 1.10 (t, 12 H, J = 7.1 Hz); 13C NMR δ 155.8, 71.5, 70.4, 48.4, 47.8, 45.35, 
45.3, 42.8, 22.8, 13.1; MS (EI) m/z (relative intensity) 753 (M+, 13), 624 (1), 597 (8), 469 (1), 
443 (5), 155 (100), 70 (10); HRMS (EI) m/z calculated for C37H68N8O8 752.5160, found 
752.5184.       
N N N NH
O O
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 1-(1-(Propyl)-2-imidazolidonyl)-2-(1’-(2’-imidazolidonyl))ethane (24). A suspension of 14 
(9.33 g, 471 mmol) and NaH (60% dispersion in mineral oil, 2.12 g, 529 mmol) in DMF (90 mL) 
was heated to 130 °C, stirred for 30 min, and treated slowly with a solution of propyl iodide (2.9 
mL, 29 mmol) in DMF (5 mL). The reaction mixture was stirred at 130 °C for 1 h and at room 
temperature overnight. DMF was distilled off under vacuum and the mixture was quenched with 
ice. The aqueous layer was extracted with CH2Cl2 (5×50 mL). The combined organic layers were 
dried (MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(CHCl3/MeOH, 25:1) to give 24 (3.14 g, 13.1 mmol, 44%) as a white solid: Mp 225-229 °C; IR 
(KBr film) 3229, 3086, 2968, 2928, 2871, 1674, 1504, 1445, 1278, 1104, 763 cm-1; 1H NMR δ 
3.57-3.53 (m, 2 H), 3.44-3.27 (m, 10 H), 3.14 (t, 2 H, J = 7.1 Hz), 1.56-1.48 (m, 2 H), 0.90 (t, 3 
H, J = 7.3 Hz); 13C NMR δ 163.1, 161.5, 45.9, 44.6, 42.7, 42.3, 41.4, 40.8, 38.4, 21.0, 11.3; MS 
(EI) m/z (relative intensity) 240 (M+, 2), 211 (2), 182 (3), 154 (52), 141 (100), 125 (26), 112 
(26), 99 (75); HRMS (EI) m/z calculated for C11H20N4O2 240.1586, found 240.1583. 
N N N N
O O
O C
4  
1,3-Bis-(2-(1-(1-(propyl)-2-imidazolidonyl)-2-(1’-(2’-imidazolidonyl))ethyl)ethoxy)-2,2-bis-
(2-(1-(1-(propyl)-2-imidazolidonyl)-2-(1’-(2’-imidazolidonyl))ethyl)ethoxymethyl)propane 
(25). To a suspension of NaH (60% dispersion in mineral oil, 1.36 g, 340 mmol) in DMF (5 mL) 
was added a solution of 24 (4.09 g, 170 mmol) in DMF (21 mL) slowly at 0 °C. The mixture was 
stirred at 0 °C for 1 h and a solution of 20 (1.92 g, 340 mmol) in DMF (4 mL) was added. After 
stirring at 50 °C overnight, the reaction mixture was cooled to room temperature and quenched 
with ice. The aqueous layer was extracted with CH2Cl2 (3×40 mL). The combined organic layers 
were washed with brine (40 mL), dried (MgSO4), and concentrated. The residue was purified by 
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 chromatography on SiO2 (CH2Cl2/MeOH, 10:1) to give 25 (1.99 g, 1.65 mmol, 49%) as a 
colorless gel: IR (neat) 3365, 2956, 2934, 2873, 1682, 1495, 1445, 1359, 1260, 1111, 901, 758 
cm-1; 1H NMR δ 3.55-3.20 (m, 72 H), 3.09 (t, 8 H, J = 7.1 Hz), 1.93 (sx, 8 H, J = 7.3 Hz), 0.85 
(t, 12 H, J = 7.3 Hz); 13C NMR δ 161.5, 161.3, 70.8, 70.2, 45.9, 44.3, 42.7, 42.5, 42.3, 41.5, 21.0, 
11.4; MS (FAB+) m/z (relative intensity) 1201.5 (M+, 100), 1059.9 (10), 979.8 (18), 792.4 (15), 
643.4 (34), 523.2 (44). 
TsO
TsO
OTs
OTs  
Tetrakis(toluenesulfonylacidmethylester)methane (26).15 To a solution of pentaerythritol 
(5.00 g, 367 mmol) in pyridine (12 mL) was added a solution of TsCl (30.8 g, 161 mmol) in 
pyridine (40 mL) dropwise at 0 °C. After stirred at 0 °C overnight, the reaction mixture was 
added slowly to a vigorously stirred solution of HCl (50 mL), water (70 mL), and MeOH (100 
mL). The resulting suspension was cooled and filtered. The filtrate was washed with water (50 
mL) and MeOH (100 mL) and triturated in MeOH. The filtration gave 26 (24.2 g, 32.2 mmol, 
88%) as a white solid: 1H NMR δ 7.69 (d, 8 H, J = 8.3 Hz), 7.37 (d, 8 H, J = 8.1 Hz), 3.82 (s, 8 
H), 2.48 (s, 12 H); MS (EI) m/z (relative intensity) 752 (M+, 1), 580 (3), 427 (3), 225 (7), 155 
(42) 107 (5), 91 (100), 65 (14); HRMS (EI) m/z calculated for C33H36O12S4 752.1090, found 
752.1086.  
Br
Br
Br
Br  
1,3-Dibromo-2,2-bisbromomethylpropane (27).15 To a solution of 26 (24.2 g, 321 mmol) in 
diethylene glycol (110 mL) was added NaBr (26.5 g, 257 mmol) and the reaction mixture was 
heated to 140 °C with slow stirring overnight. The resulting orange mixture was allowed to cool 
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 to 90 °C, diluted with ice water (170 mL), and cooled by the direct addition of ice. The 
precipitate was filtered and washed with water (250 mL) to give 27 (10.3 g, 26.4 mmol, 82%) as 
a white solid: 1H NMR δ 3.60 (s, 8 H). 
N N
H
O
 
1-But-3-enyl-1,3-dimethylurea (29).16 3-butenylbromide (6.38 g, 47.3 mmol) was added to 
methylamine (20 mL, 0.44 mol) at 0 °C. After the addition was completed, the ice bath was 
removed and the mixture was stirred at room temperature for 1 d. The excess of methylamine 
was evaporated. To a solution of phosgene (5.85 g, 59.1 mmol) in CH2Cl2 (120 mL) was added a 
solution of crude but-3-enylmethylamine and DIPEA (20.6 mL, 118 mmol) in CH2Cl2 (120 mL) 
at 0 °C. After stirring at 0 °C for 30 min, a solution of methylamine (2 M in THF, 47.3 mL, 94.6 
mmol)) and DIPEA (8.2 mL, 47 mmol) were added to this mixture. The reaction mixture was 
stirred at room temperature overnight and quenched with ice. All solvents and excess DIPEA 
were evaporated and the residue was purified by chromatography on SiO2 (CHCl3/EtOAc, 1:2) to 
give 29 (4.41 g, 32.0 mmol, 66%) as a yellow oil: IR (neat) 3348, 3077, 2974, 2934, 1633, 1538, 
1412, 1378, 1289, 1224, 1159, 914, 770 cm-1; 1H NMR δ 5.84-5.70 (m, 1 H), 5.09-4.99 (m, 2 H), 
4.45 (br, 1 H), 3.31 (t, 2 H, J = 7.1 Hz), 2.85 (s, 3 H), 2.78 (s, 3 H), 2.26 (q, 2 H, J = 7.1 Hz); 13C 
NMR δ 158.8, 135.5, 116.7, 48.5, 34.4, 32.7, 27.7; MS (EI) m/z (relative intensity) 142 (M+, 7), 
101 (100) 58 (28); HRMS (EI) m/z calculated for C7H14N2O 142.1106, found 142.1102.    
N N
O
CO2Me  
(1,3-Dimethyl-4-[(methoxycarbonyl)methyl]-3,4,5,6-tetrahydro-2-(1H)-pyrimidinone (30).16 
A flask containing CuCl2 (9.76 g, 72.6 mmol) and PdCl2 (429 mg, 2.42 mmol) was filled with 
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 carbon monoxide gas. At 0 °C, a solution of 29 (3.44 g, 24.2 mmol) in MeOH (80 mL) was 
added dropwise. The reaction mixture was stirred at 0 °C for 18 h and at room temperature for 4 
h. After the evaporation of MeOH, the mixture was diluted with EtOAc and filtered through a 
celite pad. The filter cake was washed several times with EtOAc and the filtrate was washed with 
saturated aqueous NaHCO3 solution, dried (MgSO4), and concentrated. The residue was purified 
by chromatography on SiO2 (CHCl3/MeOH, 25:1) to give 30 (4.32 g, 21.6 mmol, 89%) as a 
yellow oil: IR (neat) 3453, 2949, 2865, 1736, 1631, 1514, 1440, 1413, 1316, 1235, 1166, 1055, 
752 cm-1; 1H NMR δ 3.80-3.73 (m, 1 H), 3.70 (s, 3 H), 3.40 (dt, 1 H, J = 4.4, 12.2 Hz), 3.15 
(ddd, 1 H, J = 2.5, 5.6, 11.9 Hz), 2.94 (s, 6 H), 2.72 (dd, 1 H, J = 4.7, 15.4 Hz), 2.44 (dd, 1 H, J = 
9.4, 15.4 Hz), 2.15 (tt, 1 H, J = 5.4, 13.1 Hz), 1.87-1.79 (m, 1 H); 13C NMR δ 171.7, 156.0, 54.0, 
52.1, 44.2, 37.0, 35.8, 34.7, 25.6; MS (EI) m/z (relative intensity) 200 (M+, 24), 127 (100), 84 
(20), 70 (28), 58 (10); HRMS (EI) m/z calculated for C9H16N2O3 200.1161, found 200.1163.       
N N
O
OH 
4-(2-Hydroxyethyl)-1,3-dimethyltetrahydropyrimidin-2-one (31). To a solution of 30 (4.32 g, 
21.6 mmol) in EtOH (100 mL) was added 2 M aqueous CuSO4 solution (1.08 mL, 2.16 mmol). 
After the mixture was cooled to 0 ºC, NaBH4 (4.08 g, 108 mmol) was added portionwise. The 
reaction mixture was heated at reflux for 3 h and cooled to room temperature. The mixture was 
diluted with EtOAc (400 mL) and the organic layer was washed with water (100 mL). The 
aqueous layer was extracted with EtOAc (3×50 mL). The combined organic layers were dried 
(MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(CHCl3/MeOH, 20:1) to give 31 (2.72 g, 15.8 mmol, 71%) as a colorless oil: IR (neat) 3374, 
2936, 2871, 1614, 1526, 1415, 1317, 1237, 1063, 1018, 925, 880, 754 cm-1; 1H NMR δ 3.73 (dt, 
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 2 H, J = 1.2, 6.2 Hz), 3.54-3.48 (m, 1 H), 3.40 (dt, 1 H, J = 4.6, 12.0 Hz), 3.16 (ddd, 1 H, J = 2.0, 
5.0, 12.1 Hz), 3.01 (s, 3 H), 2.98 (s, 3 H), 2.46 (br, 1 H), 2.10 (tt, 1 H, J = 5.5, 13.3 Hz), 2.01-
1.90 (m, 1 H), 1.89-1.82 (m, 1 H), 1.73-1.65 (m, 1 H); 13C NMR δ 156.5, 59.7, 54.2, 44.6, 35.8, 
35.3, 29.9, 25.3; MS (EI) m/z (relative intensity) 172 (M+, 13), 127 (100), 84 (20), 70 (25), 55 
(5); HRMS (EI) m/z calculated for C8H16N2O2 172.1212, found 172.1211.       
N N
O
O C
4  
1,3-Bis-(4-(1,3-dimethyltetrahydropyrimidin-2-onyl)-2-ethoxy)-2,2-bis-(4-(1,3-
dimethyltetrahydropyrimidin-2-onyl)-2-ethoxymethyl)propane (32). To a suspension of KH 
(362 mg, 9.02 mmol) in DMF (5 mL) was added a solution of 31 (400 mg, 2.26 mmol) in DMF 
(5 mL) dropwise at 0 °C. After stirring at 0 °C for 30 min, 27 (158 mg, 0.407 mmol) was added. 
The reaction mixture was stirred at 60 °C for 36 h and quenched with ice. All solvents were 
evaporated and the residue was extracted with CHCl3 (3×30 mL). The combined organic layers 
were dried (MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(CHCl3/MeOH, 10:1) to give 32 (220 mg, 0.292 mmol, 72%) as a yellow oil: IR (neat) 3462, 
1965, 2930, 2865, 1630, 1509, 1452, 1357, 1292, 1212, 1110, 1079, 1050, 753 cm-1; 1H NMR 
(CD2Cl2) δ 3.40-3.26 (m, 24 H), 3.05 (ddd, 4 H, J = 2.3, 5.2, 11.6 Hz), 2.83 (s, 12 H), 2.81 (s, 12 
H), 2.03-1.91 (m, 4 H), 1.90-1.80 (m, 4 H), 1.80-1.72 (m, 4 H), 1.65-1.53 (m, 4 H); 13C NMR 
(CD2Cl2) δ 156.0, 71.0, 70.0, 54.8, 45.4, 44.6, 35.5, 34.9, 32.6, 25.5; MS (EI) m/z (relative 
intensity) 752 (M+, 4), 625 (25), 597 (19), 471 (8), 455 (15), 397 (10), 285 (6), 243 (5), 171 (13), 
155 (45), 127 (100), 96 (15), 70 (30); HRMS (EI) m/z calculated for C37H68N8O8 752.5160, 
found 752.5160.       
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 General procedure for aldol reaction of 1-naphthylacetonitrile with 1-naphthaldehyde in 
the presence of additives (Table 1).18 To a solution of LDA (2.0 M in THF/n-heptanes, 0.12 
mL, 0.24 mmol)) in THF (2 mL) was added a solution of 1-naphthylacetonitrile (40 mg, 0.24 
mmol) in THF (1.5 mL) at –78 °C. After 30 min, a solution of 24 (288 mg, 0.240 mmol) in THF 
(6 mL) was added and after an additional 30 min, a solution of 1-naphthaldehyde (38 mg, 0.24 
mmol) in THF (1.5 mL) was added. The reaction mixture was stirred for 30 min at –78 °C and 
quenched with saturated aqueous NH4Cl solution. 1 M HCl solution was added and the aqueous 
layer was extracted with ethyl ether (2x20 mL). The combined organic layers were washed with 
brine, dried (MgSO4), and concentrated. The residue was purified by chromatography on SiO2 
(hexane/EtOAc/CH2Cl2, 10:2:1) to give a mixture of syn-34 and anti-34 (63 mg, 0.19 mmol, 
80%, 52:48) as a white solid. syn-3410: 1H NMR δ 7.95-7.60 (m, 6 H), 7.55-7.10 (m, 8 H), 6.07 
(d, 1 H,  J = 3.4 Hz), 5.29 (d, 1 H,  J = 5.4 Hz), 2.92 (d, 1 H,  J = 2.0 Hz). 
General procedure for the reaction between 1,3-lithiodithiane and 2-cyclohexen-1-one in 
the presence of additives (Table 2).6a,19 To a solution of 1,3-dithiane (48 mg, 0.40 mmol) in 
THF (2 mL) was added LDA (2 M in THF/n-heptane, 0.21 mL, 0.42 mmol) at –78 °C. The 
reaction mixture was warmed to –22 °C over 1 h, and treated with a solution of 32 (150 mg, 
0.199 mmol) in THF (6 mL) and a solution of 2-cyclohexen-1-one (20 mg, 0.20 mmol) in THF 
(2 mL). The reaction mixture was stirred for 25 min at –78 °C and quenched with saturated 
aqueous NH4Cl solution. The aqueous layer was extracted with ethyl ether (2x20 mL). The 
combined organic layers were washed with water and brine, dried (MgSO4), and concentrated. 
The residue was purified by chromatography on SiO2 (hexane/EtOAc, 10:1) to give of a mixture 
of 23a, 11 and 33a,11 (40.3 mg, 0.186 mmol, 90%, 9:1) as a colorless oil. 2: 1H NMR δ 4.10 (d, 1 H, 
J = 4.9 Hz), 2.95-2.85 (m, 4 H), 2.61-2.32 (m, 4 H), 2.30-2.05 (m, 4 H), 1.95-1.80 (m, 1 H), 
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 1.75-1.60 (m, 2 H); 3: 1H NMR δ 6.00-5.92 (m, 1 H), 5.80-5.70 (m, 1 H), 4.24 (s, 1 H), 3.00-2.80 
(m, 4 H), 2.33 (s, 1 H), 2.15-1.90 (m, 4 H), 1.90-1.70 (m, 4 H).  
General procedure for the reaction between allyltributyltin and α,β-epoxy ketone in the 
presence of PbI2-additive (Table 3).2b A solution of PbI2 (23 mg, 0.050 mmol) in THF (2 mL) 
was treated with DMPU (64 mg, 0.50 mmol). After 30 min, a solution of chalcone oxide (112 
mg, 0.500 mmol) and allyltri-n-butyltin (166 mg, 0.500 mmol) in THF (1.5 mL) was added. The 
reaction mixture was heated at reflux for 24 h. After quenching with MeOH, volatiles were 
removed under reduced pressure. The residue was purified by chromatography on SiO2 
(hexane/EtOAc, 10:1) to give 362b (54 mg, 0.20 mmol, 41%) and chalcone oxide (64 mg, 0.29 
mmol, 57%); 1H NMR δ 7.55-7.20 (m, 10 H), 5.95-5.75 (m, 1 H), 5.30-5.15 (m, 2 H), 3.99 (d, 1 
H, J = 1.8 Hz), 3.44 (d, 1 H, J = 2.0 Hz), 2.86 (d, 2 H, J = 7.2 Hz), 2.53 (s, 1 H). 
N N
O O
 
1-Acetyl-3-ethyltetrahydropyrimidin-2-one (37). To a suspension of KH (156 mg, 1.56 mmol) 
in THF (5 mL) was added a solution of 22 (200 mg, 1.56 mmol) in THF (5 mL) at 0 °C. After 
stirring at 0 °C for 30 min, acetyl chloride (0.55 mL, 7.8 mmol) was added. The reaction mixture 
was stirred at 55 °C overnight, cooled, and quenched with ice. The aqueous layer was extracted 
with CHCl3 (3×30 mL). The combined organic layers were dried (MgSO4) and concentrated. The 
residue was purified by chromatography on SiO2 (CHCl3/EtOAc, 20:1) to give 37 (210 mg, 1.23 
mmol, 79%) as a colorless oil: IR (neat) 2971, 2938, 2875, 1734, 1683, 1490, 1451, 1431, 1369, 
1317, 1292, 1241, 1200, 1114, 1027, 932 cm-1; 1H NMR δ 3.78 (t, 2 H, J = 6.0 Hz), 3.44 (q, 2 H, 
J = 7.1 Hz), 3.33 (t, 2 H, J = 6.1 Hz), 2.55 (s, 3 H), 2.00-1.92 (m, 2 H), 1.19 (t, 3 H, J = 7.1 Hz); 
13C NMR δ 173.4, 153.5, 45.9, 43.6, 41.8, 27.1, 26.7, 22.5, 12.6; MS (EI) m/z (relative intensity) 
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 170 (M+, 48), 127 (44), 113 (100), 100 (77), 70 (7), 59 (13); HRMS (EI) m/z calculated for 
C8H14N2O2 170.1055, found 170.1053. 
BnO
CO2H 
3-(4-Benzyloxyphenyl)acrylic acid (39). Prepared according to literature procedures:11 1H NMR 
(acetone-d6) δ 7.66-7.33 (m, 7 H), 7.09 (d, 2 H, J = 8.7 Hz), 6.41 (d, 2 H, J = 8.8 Hz), 5.20 (s, 2 
H). 
BnO
OH 
3-(4-Benzyloxyphenyl)propan-1-ol (40). Prepared according to literature procedures:11 1H 
NMR δ 7.45-7.26 (m, 5 H), 7.13 (d, 2 H, J = 8.5 Hz), 6.92 (d, 2 H, J = 8.5 Hz), 5.06 (s, 2 H), 
3.68 (t, 2 H, J = 6.4 Hz), 2.67 (t, 2 H, J = 7.6 Hz), 1.88 (qn, 2 H, J = 7.0 Hz). 
BnO
O
Br
Br
Br  
1-{3-[2-(3-Bromo-2,2-bisbromomethylpropoxy)propyl}-4-benzyloxy benzene (41). To a 
suspension of NaH (60% dispersion in mineral oil, 1.17 g, 29.2 mmol) in DMF (30 mL) was 
added a solution of 40 (3.54 g, 14.6 mmol) in DMF (20 mL) dropwise at 0 °C. After stirring at 0 
°C for 1 h, 27 (6.80 g, 17.5 mmol) was added. The reaction mixture was stirred at 65 ºC for 20 h, 
cooled to room temperature, and quenched with ice. The aqueous layer was extracted with 
EtOAc (3x30 ml). The combined organic layers were washed with brine, dried (MgSO4), and 
concentrated. The residue was purified by chromatography on SiO2 (hexane/EtOAc, 25:1) to 
give 41 (4.07 g, 7.46 mmol, 51%) as a white solid: Mp 93°C; IR (KBr film) 3028, 2953, 2931, 
2861, 2793, 1610, 1581, 1513, 1453, 1429, 1382, 1297, 1275, 1239, 1173, 1121, 1012, 910, 832 
cm -1; 1H NMR δ 7.48-7.33 (m, 5 H), 7.15 (d, 2 H, J = 8.6 Hz), 6.95 (d, 2 H, J = 8.7 Hz), 5.08 (s, 
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 2 H), 3.57 (s, 6 H), 3.50 (t, 2 H, J = 6.2 Hz), 3.49 (s, 2 H), 2.68 (t, 2 H, J = 7.3 Hz), 1.94-1.85 (m, 
2 H); 13C NMR δ 157.2, 137.3, 134.2, 129.6, 128.7, 128.1, 127.6, 114.9, 70.7, 70.2, 69.4, 43.9, 
35.1, 31.6, 31.4; MS (EI) m/z (relative intensity) 548 (M+, 1), 224 (6), 134 (8), 91 (100); HRMS 
(EI) m/z calculated for C21H25Br3O2 545.9405, found 545.9419.    
BnO
O C O
NN
O
3 
1-{3-[2-(3-(4-(1,3-Dimethyltetrahydropyrimidin-2-onyl)-2-ethoxy)-2,2-bis-(4-(1,3-
dimethyltetrahydropyrimidin-2-onyl)-2-ethoxy)methylpropoxy)propyl}-4-
benzyloxybenzene (42). To a suspension of KH (1.02 g, 25.5 mmol) in DMF (15 mL) was 
added a solution of 31 (1.63 g, 9.18 mmol) in DMF (20 mL) dropwise at 0 °C. The mixture was 
stirred at 0 °C for 1 h and treated with a solution of 41 (1.40 g, 2.55 mmol) in DMF (35 mL). 
The reaction mixture was stirred at 70 °C for 36 h, cooled to room temperature, and quenched 
with ice. The solvents were distilled off and the residue was purified by chromatography on SiO2 
(CHCl3/MeOH, 20:1) to give 42 (1.20 g, 1.46 mmol, 57%) as a colorless oil: IR (neat) 3445, 
3027, 2932, 2865, 2225, 1633, 1513, 1469, 1403, 1368, 1315, 1235, 1175, 1103, 1035, 925, 834 
cm-1; 1H NMR δ 7.43-7.30 (m, 5 H), 7.07 (d, 2 H, J = 8.6 Hz), 6.88 (d, 2 H, J = 8.7 Hz), 5.03 (s, 
2 H), 3.42-3.30 (m, 22 H), 3.09 (ddd, 3 H, J = 2.2, 5.3, 11.3 Hz), 2.93 (s, 9 H), 2.91 (s, 9 H), 2.59 
(dd, 2 H, J = 7.2, 8.0 Hz), 2.04 (tt, 3 H, J = 5.4, 12.9 Hz), 1.92-1.74 (m, 8 H), 1.68-1.58 (m, 3 H); 
13C NMR δ 157.2, 156.2, 137.3, 134.4, 129.4, 128.7, 128.1, 127.6, 114.9, 70.7, 70.2, 70.1, 69.6, 
68.3, 54.6, 45.4, 44.5, 35.7, 35.2, 32.6, 31.6, 25.4; MS (ESI) m/z (relative intensity) 846 ([M-
H+Na]+, 100), 824 (25); HRMS (ESI) m/z calculated for C45H69N6O8Na (M-H+Na) 845.5092, 
found 845.5081.  
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1-{3-[2-(3-(4-(1,3-Dimethyltetrahydropyrimidin-2-onyl)-2-ethoxy)-2,2-bis-(4-(1,3-
dimethyltetrahydropyrimidin-2-onyl)-2-ethoxy)methylpropoxy)propyl}-4-hydroxybenzene 
(43). A suspension of 42 (1.20 g, 1.46 mmol) and Pd/C (10 wt%, 120 mg) in MeOH (10 mL) was 
stirred at room temperature overnight under H2 gas. The reaction mixture was filtered through 
celite pad and washed with MeOH. The filtrate was concentrated and the residue was purified by 
chromatography on SiO2 (CH2Cl2/MeOH, 10:1) to give 43 (1.00 g, 1.37 mmol, 93%) as a brown 
oil: IR (neat) 3411, 3195, 2933, 2866, 1615, 1516, 1470, 1414, 1368, 1316, 1236, 1170, 1103, 
925, 834, 753, 729 cm-1; 1H NMR δ 8.78 (s, 1 H), 6.96 (d, 2 H, J = 8.4 Hz), 6.79 (d, 2 H, J = 8.4 
Hz), 3.41-3.29 (m, 22 H), 3.09 (ddd, 3 H, J = 2.3, 3.2, 11.8 Hz), 2.92 (s, 9 H), 2.91 (s, 9 H), 2.54 
(t, 2 H, J = 7.1 Hz), 2.05-1.93 (m, 3 H), 1.91-1.73 (m, 8 H), 1.67-1.58 (m, 3 H); 13C NMR δ 
156.3, 155.6, 132.4, 129.3, 115.5, 70.5, 70.0, 69.5, 68.2, 54.6, 45.3, 44.5, 35.8, 35.3, 32.6, 31.4, 
25.3; MS (ESI) m/z (relative intensity) 755 ([M-H+Na]+, 100), 733 (40); HRMS (ESI) m/z 
calculated for C38H63N6O8Na (M-H+Na) 755.4608, found 755.4612.     
O
O C O
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Polymer-supported DMPU (44). The mixture of 43 (1.53 g, 2.07 mmol) and Cs2CO3 (0.884 g, 
2.71 mmol) in THF (8 mL), which was placed in a flask equipped with a mechanical stirrer, was 
stirred at room temperature for 1 h and THF was evaporated. The residue was dissolved in DMF 
(7 mL) and ArgoPoreCl (0.494 g, 0.593 mmol, 1.20 mmol/g loading) was added. The resulting 
mixture was stirred at 70°C for 3 d and quenched with ice. The resin was filtered and washed 
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 with 20 mL portions of water, DMF, MeOH, toluene, CH2Cl2, and ethyl ether. The resin was 
dried in vacuo to give 44 (0.75 g, 59%, 0.46 mmol/g loading) as a yellow bead: IR (KBr film) 
3427, 3027, 2925, 2863, 1638, 1511, 1452, 1413, 1368, 1315, 1235, 1173, 1105, 1035, 892, 828 
cm -1. 
General procedure for the reaction between 1,3-lithiodithiane and 2-cyclohexen-1-one in 
the presence of polymer-supported additive 44 (Table 4). Using LDA as base: To a solution 
of 1,3-dithiane (60 mg, 0.50 mmol) in THF (1.5 mL) at –78 °C was added LDA (0.93 M in THF, 
0.60 mL, 0.55 mmol). After warming to –20 °C for 1 h, this solution was added via cannula to a 
suspension of polymer-supported additive 44 (685 mg, 0.32 mmol, 0.46 mmol/g loading) in THF 
(3.5 mL), which was placed in a flask equipped with a mechanical stirrer, and cooled to –78 °C. 
After an additional 30 min at –78 °C, a solution of 2-cyclohexen-1-one (24 mg, 0.25 mmol) in 
THF (0.2 mL) was added. The reaction mixture was stirred for 2 h at –78 °C and quenched with 
saturated aqueous NH4Cl solution. The polymer was filtered and washed with water and ethyl 
ether (3x20 mL). The aqueous layer was extracted with ethyl ether (3x20 mL). The combined 
organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography on SiO2 (hexane/EtOAc, 4:1) to give a mixture of 2 and 3 (28 mg, 0.13 mmol, 
52%, 54:46) as a colorless oil, which was analyzed by 1H NMR. 
with t-BuLi as base: To a solution of 1,3-dithiane (6o mg, 0.50 mmol) in THF (1.5 mL) at –78 
°C was added t-BuLi (1.7 M in pentane, 0.32 mL, 0.55 mmol). After 15 min at –78 °C, this  
solution was added via cannula to a suspension of polymer-supported additive 44 (650 mg, 0.30 
mmol, 0.46 mmol/g loading) in THF (3.5 mL), which was placed in a flask equipped with a 
mechanical stirrer, and cooled to –78 °C. After an additional 10 min at –78 °C, the solution of 2-
cyclohexen-1-one (24 mg, 0.25 mmol) in THF (0.2 mL) was added. The reaction mixture was 
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 stirred for 2 h at –78 °C and quenched with saturated aqueous NH4Cl solution. The polymer was 
filtered and washed with water and ethyl ether (3x20 mL). The aqueous layer was extracted with 
ethyl ether. The combined organic layers were dried (MgSO4) and concentrated. The residue was 
purified by chromatography on SiO2 (hexane/ EtOAc, 4:1) to give a mixture of 2 and 3 (51 mg, 
0.24 mmol, 96%, 53:47) as a colorless oil, which was analyzed by 1H NMR. 
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1-{3-[2-(3-(4-(1,3-Dimethyltetrahydropyrimidin-2-onyl)-2-ethoxy)-2,2-bis-(4-(1,3-
dimethyltetrahydropyrimidin-2-onyl)-2-ethoxy)methylpropoxy)ehoxypropyl}-4-
bicyclo[2.2.1]hept-5-en-2-ylbenzene (50): IR (neat) 3441, 2935, 2866, 1621, 1516, 1471, 1366, 
1316, 1235, 1104, 1059 cm-1; 1H NMR δ 7.20 (d, 2 H, J = 8.1 Hz), 7.11 (d, 2 H, J = 8.0 Hz), 
6.25 (dd, 1 H, J = 3.2, 5.7 Hz), 6.16 (dd, 1 H, J = 2.8, 5.8 Hz), 3.55 (s, 4 H), 3.49-3.31 (m, 22 H), 
3.10 (ddd, 3 H, J = 2.3, 5.4, 11.6 Hz), 2.98-2.95 (m, 1 H), 2.94 (s, 9 H), 2.93 (s, 9 H), 2.88 (br, 1 
H), 2.72-2.58 (m, 1 H), 2.66 (t, 2 H, J = 7.4 Hz), 2.04 (tt, 3 H, J = 5.2, 12.8 Hz), 1.93-1.85 (m, 5 
H), 1.83-1.75 (m, 3 H), 1.72-1.56 (m, 6 H), 1.44-1.40 (m, 1 H); MS (EI) m/z (relative intensity) 
852 (M+, 1), 787 (1), 725 (1), 699 (1.2), 155 (63), 127 (100); HRMS (EI) m/z calculated for 
C47H76N6O8 852.5725, found 852.5718. 
General procedure for ROMP of 50. To a solution of 50 (215 mg, 0.252 mmol) in CH2Cl2 (0.5 
ml) was added a solution of Grubbs’ catalyst (3.1 mg, 1.5 mol%) in CH2Cl2 (0.5 mL) dropwise. 
After stirring for 2 d at room temperature, additional CH2Cl2 (1 mL) was added and the reaction 
mixture was stirred for additional 1 d at room temperature. After the addition of ethyl vinyl ether 
(1 mL) and CH2Cl2 (1.5 mL), the reaction mixture was diluted with EtOAc and decanted 
repeatedly to obtain the polymer 51 (113 mg, 53%) as a brown gel: IR (neat) 3412, 2935, 2867, 
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 1618, 1522, 1469, 1414, 1366, 1316, 1237, 1104, 1058 cm-1; 1H NMR δ 7.20-7.05 (m, 2 H), 5.62 
(br, 1 H), 5.35 (br, 1 H), 3.55 (s, 4 H), 3.49-3.31 (m, 22 H), 3.16-3.00 (m, 4 H), 2.94 (s, 9 H), 
2.93 (s, 9 H), 2.72-2.63 (m, 2 H), 2.10-1.96 (m, 3 H), 1.93-1.84 (m, 7 H), 1.83-1.74 (m, 4 H), 
1.70-1.59 (m, 6 H). 
N N
O
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1-(1-(Benzyl)-2-imidazolidonyl)-2-(1’(4-bicyclo[2.2.1]hept-5-en-2-ylbenzyl)-(2’-
imidazolidonyl))ethane (53): IR (neat) 3474, 3054, 2967, 2935, 1686, 1492, 1448, 1357, 1260, 
1110 cm-1; 1H NMR δ 7.22 (d, 2 H, J = 8.2 Hz), 7.16 (d, 2 H, J = 8.1 Hz), 6.25 (dd, 1 H, J = 3.1, 
5.6 Hz), 6.16 (dd, 1 H, J = 2.8, 5.6 Hz), 4.31 (s, 2 H), 3.46-3.33 (m, 8 H), 3.32-3.14 (m, 6 H), 
2.96 (br. s, 1 H), 2.88 (br. s, 1 H), 2.69 (dd, 1 H, J = 4.8, 8.5 Hz), 1.72 (ddd, 1 H, J = 3.6, 4.6, 
11.9 Hz), 1.64 (dd, 1 H, J = 2.2, 8.7 Hz), 1.59-1.53 (m, 1 H), 1.44-1.40 (m, 1 H), 1.09 (t, 3 H, J = 
7.2 Hz); 13C NMR (acetone-d6) δ 162.0 (2C), 146.2, 138.6, 138.5, 136.6, 129.3, 129.0, 49.7, 
48.8, 46.8, 44.7, 43.5, 43.4, 43.3, 43.2, 43.0, 42.5, 42.4, 39.9, 34.6, 13.6; MS (ESI) m/z (relative 
intensity) 840 ([2M+Na]+, 100), 431(94), 409 (100); HRMS (ESI) m/z calculated for C24H33N4O2 
(M+H) 409.2604, found 409.2618. 
General procedure for ROMP of 53. To a solution of 53 (190 mg, 0.465 mmol) in CH2Cl2 (1 
mL) was added a solution of Grubbs’ catalyst (5.9 mg, 1.5 mol%) in CH2Cl2 (1 mL) dropwise. 
After stirring for 1 d at room temperature, the reaction mixture was quenched by the addition of 
ethyl vinyl ether (1 mL) and CH2Cl2 (3 mL). After an additional 2 h, all volatiles were removed. 
The residue was washed with EtOAc and diluted with CH2Cl2. The organic layer was washed 
with saturated aqueous NaHCO3 and brine, dried (MgSO4), and concentrated to give the polymer 
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 54 (70 mg, 37%) as a brown gel: IR (neat) 2931, 2861, 1694, 1493, 1448, 1358, 1261, 1108, 968 
cm-1; 1H NMR δ 7.12 (br, 4 H), 5.31 (br, 2 H), 4.30 (s, 2 H), 3.45-3.10 (m, 14 H), 2.70 (br, 2 H), 
2.43 (br, 1 H), 1.90 (br, 4 H), 1.09 (t, 3 H, J = 6.9 Hz). 
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Bis(dimethylamino)-(methyl-4-vinylbenzylamino)phosphoroamide (82). 4-Vinylbenzyl 
chloride (4.62 g, 30.3 mmol) was added to condensed methylamine (10 mL) at –78 °C. After the 
addition, a cooling bath was removed and the mixture was stirred at room temperature for 6 h. 
An excess of methylamine was evaporated and the reaction was quenched with 50% aqueous 
NaOH (4 mL). The aqueous layer was extracted with ethyl ether (3x20 mL). The combined 
organic layers were washed with brine, dried (MgSO4), and concentrated. The residue was 
diluted in ethyl ether (20 mL) and the activated 4 Å MS (2 g), triethylamine (6.27 mL, 45.0 
mmol), and bis(dimethylamino)phosphorochloride (4.34 mL, 30.0 mmol) were added. The 
reaction mixture was refluxed for 12 h and a white precipitate was removed by filtration. The 
filtrate was diluted in ethyl ether (100 mL), washed with brine (3x30 mL), dried (MgSO4), and 
concentrated. The residue was purified by chromatography on SiO2 (CHCl3/acetone, 4:1) to give 
the desired monomer 82 (6.12 g, 21.8 mmol, 73%) as a colorless oil: IR (neat) 3438, 2999, 2885, 
2845, 2804, 1629, 1511, 1460, 1296, 1205, 989, 936, 855, 827 cm-1; 1H NMR δ 7.39 (d, 2 H, J = 
8.2 Hz), 7.32 (d, 2 H, J = 8.2 Hz), 6.72 (dd, 1 H, J = 10.9, 17.6 Hz), 5.75 (dd, 1 H, J = 0.9, 17.6 
Hz), 5.24 (dd, 1 H, J = 0.9, 10.9 Hz), 4.14 (d, 2 H, J = 8.3 Hz), 2.68 (d, 12 H, J = 9.4 Hz), 2.54 
(d, 3 H, J = 9.1 Hz); 13C NMR δ 138.5, 138.4, 136.7, 136.6, 128.4, 126.3 113.6, 53.03, 52.97, 
37.04, 36.99, 34.04, 33.99; MS (EI) m/z (relative intensity) 281 (M+, 33), 236 (9), 221 (8), 192 
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 (10), 146 (100), 135 (30), 117 (50), 91 (13); HRMS (EI) m/z calculated for C14H24N3OP 
281.1657, found 281.1662.    
O N
  
TEMPO-methyl resin 85.32a A solution of Na ascorbate (4.8 g, 24.2 mmol) in water (60 mL) 
was stirred vigorously with a solution of TEMPO (3.12 g, 20 mmol) in ethyl ether (50 mL) until 
the deep burgundy color faded to pure orange. The organic layer was dried (MgSO4) and 
concentrated under 20 ºC to give an orange oil. After drying under vacuum, this oil was 
dissolved in DMF (10 mL) and added to a suspension of NaH (60% dispersion in mineral oil, 1.2 
g, 30 mmol) in DMF (10 mL) at 0 ºC dropwise. After the mixture was stirred for an additional 30 
min at room temperature, ArgoPoreCl resin (1.29 g, 1.53 mmol, 1.18 mmol/g loading) was 
quickly added. Stirring was continued for 20 h at room temperature with mechanical stirrer and 
the reaction mixture was quenched with ice at 0 ºC. The resin was filtered and washed 
successively with 20 mL portions of H2O, DMF (x3), MeOH (x3), toluene, CH2Cl2, and ethyl 
ether (x3). The resulting resin was dried under vacuum to give TEMPO-methyl resin 85 (1.08 g).  
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N
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General procedure for the synthesis of Rasta resin 86. Using oil bath; A suspension of 
TEMPO-methyl resin 85 (310 mg) and the monomer 82 (1.6 g, 5.69 mmol) was stirred at 125 ºC 
for 16 h and cooled to room temperature. The reaction mixture was diluted with CH2Cl2. The 
93 
 solid was filtered and washed with 10 mL portions of CH2Cl2, ethyl ether, and THF repeatedly to 
give HMPA rasta resin 86 (1.3 g, 2.71 mmol/g loading) as a dark brown bead: IR (neat) 3422, 
2996, 2921, 2803, 1655, 1605, 1510, 1453, 1297, 1202, 1067, 989, 933, 813 cm-1. 
Using microwave reactor; the suspension of TEMPO-Methyl resin 85 (134 mg) and the 
monomer 82 (600 mg, 2.13 mmol) was treated on microwave at 135 ºC for 30 min (x2) and 
cooled to room temperature. The reaction mixture was diluted with CH2Cl2. The solid was 
filtered and washed with 10 mL portions of MeOH, CH2Cl2, and acetone repeatedly to give 
HMPA rasta resin 86 (376 mg, 2.29 mmol/g loading) as a dark brown bead: IR (neat) 3424, 
2923, 2842, 2807, 1604, 1510, 1454, 1297, 1202, 1067, 990, 933, 823 cm-1. 
O
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Cross-Linker (90). Prepared according to literature procedures:34a 1H NMR δ 7.35 (d, 4 H, J = 
8.7 Hz), 6.86 (d, 4 H, J = 8.7 Hz), 6.67 (dd, 2 H, J = 10.9, 17.6 Hz), 5.62 (dd, 2 H, J = 0.7, 17.6 
Hz), 5.13 (dd, 2 H, J = 0.6, 10.9 Hz), 4.05 (t, 4 H, J = 5.7 Hz), 1.99 (qn, 4 H, J = 3.0 Hz). 
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General procedure for the preparation of polymer (87a and 87b). A solution of acacia gum 
(1.80 g) and NaCl (1.13 g) in water (45 mL) was placed in a Morton flask equipped with a 
mechanical stirrer and deoxygenated by purging with N2. A solution of 82 (0.96 g, 3.4 mmol), 
styrene (0.71 g, 6.8 mmol), 90 (0.12 g, 0.41 mmol), and benzoyl peroxide (0.09 g) in 
chlorobenzene (5 mL) was added into the vigorously stirred aqueous solution. The mixture was 
heated at 85°C for 20 h. The polymer was filtered and washed with 20 mL portions of water, 
THF, and hexanes. The polymer was dried in vacuo to give 87a (1.31 g, 73%, loading of 1.7 
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 mmol/g) as a white solid: IR (KBr film) 3431, 3024, 2921, 2801, 1719, 1602, 1509, 1493, 1452, 
1334, 1297, 1210, 1067, 988, 932, 826 cm-1; Anal. Calcd for 1.7 mmol/g loading and a 17:7:1 
ratio of styrene:82:90: C, 75.32; H, 8.38; N, 7.32. Found: C, 72.55; H, 8.01; N, 7.22. 
10 mmol% of 90 was used to prepare 87b (loading of 1.5 mmol/g): IR (KBr film) 3422, 3025, 
2920, 2802, 1719, 1606, 1510, 1493, 1452, 1297, 1210, 1067, 988, 932, 827 cm-1; Anal. Calcd 
for 1.5 mmol/g loading and a 12:5:2 ratio of styrene:82:90: C, 76.24; H, 8.08; N, 6.47. Found: C, 
70.78; H, 7.90; N, 6.40. 
General procedure for the reaction between 1,3-lithiodithiane and 2-cyclohexen-1-one in 
the presence of additives (Table 5). Using LDA as base: To a solution of 1,3-dithiane (60 mg, 
0.50 mmol) in THF (1.5 mL) at –78 °C was added LDA (0.94 M in THF, 0.60 mL, 0.55mmol), 
which was freshly prepared. After warming to –20 °C for 1 h, this solution was added via 
cannula to a suspension of polymer-supported HMPA 87a (200 mg, 0.34 mmol) in THF (10 
mL), which was placed in a flask equipped with a mechanical stirrer and cooled to –78 °C. After 
an additional 30 min at –78 °C, a solution of 2-cyclohexen-1-one (25 mg, 0.25 mmol) in THF 
(0.2 mL) was added. The reaction mixture was stirred for 2 h at –78 °C and quenched with 
saturated aqueous NH4Cl solution. The polymer was filtered and washed with water and ethyl 
ether. The aqueous layer was extracted with ethyl ether (3x20 mL). The combined organic layers 
were dried (MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(hexane/EtOAc, 4:1) to give a mixture of 2 and 3 (49 mg, 0.23 mmol, 92%, 64:36) as a colorless 
oil, which was analyzed by 1H NMR.  
With t-BuLi as base: To a cold solution of 1,3-dithiane (60 mg, 0.50 mmol) in THF (2 mL) at –
78 °C was added t-BuLi (1.7 M in pentane, 0.32 mL, 0.55 mmol). After 15 min at –78 °C, this 
solution was added via cannula to a suspension of polymer-supported HMPA 87b (300 mg, 0.46 
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 mmol) in THF (10 mL), which was placed in a flask equipped with a mechanical stirrer and 
cooled to –78° C. After an additional 10 min at –78 °C, the solution of 2-cyclohexen-1-one (24 
mg, 0.25 mmol) in THF (0.2 mL) was added. The reaction mixture was stirred for 2 h at –78 °C 
and quenched with saturated aqueous NH4Cl solution. The polymer was filtered and washed with 
water and ethyl ether. The aqueous layer was extracted with ethyl ether (3x20 mL). The 
combined organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography on SiO2 (hexane/EtOAc, 4:1) to give a mixture of 2 and 3 (50 mg, 0.23 mmol, 
92%, 73:27) as a colorless oil, which was analyzed by 1H NMR. 
General procedure for aldol reaction of 1-naphthylacetonitrile and 1-naphthaldehyde in 
the presence of additives (Table 6). To a solution of LDA (2 M in THF/n-heptane, 0.12 mL, 
0.24 mmol) was added a solution of naphthylacetonitrile (36 mg, 0.22 mmol) in THF (2 mL) at –
78 °C. After 30 min at –78 °C, this solution was added via cannula to a suspension of polymer-
supported HMPA 87b (700 mg, 1.06 mmol) in THF (11 mL), which was placed in a flask 
equipped with a mechanical stirrer and cooled to –78 °C. After an additional 10 min, a solution 
of naphthaldehyde (28 mg, 0.18 mmol) in THF (1 mL) was added. The reaction mixture was 
stirred for 30 min at –78 °C and quenched with saturated aqueous NH4Cl. The polymer was 
filtered and washed with water and ethyl ether. The aqueous layer was extracted with ethyl ether 
(3x20 mL). The combined organic layers were washed with brine, dried (MgSO4), and 
concentrated. The residue was purified by chromatography on SiO2 (hexane/EtOAc, 10:1-4:1) to 
give a mixture of syn-34 and anti-34 (35 mg, 0.11 mmol, 61%, 82:18) as a white solid, which 
was analyzed by 1H NMR. 
General procedure for the reaction between allyltributyltin and α,β-epoxy ketonein in the 
presence of PbI2-additive (Table 7). A suspension of PbI2 (30 mg, 0.065 mmol) and polymer-
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 supported HMPA 87a (60 mg, 0.10 mmol) in THF (4 mL) was stirred at 70 °C for 30 min. a 
solution of α,β-epoxy ketone (146 mg, 0.65 mmol) in THF (2 mL) and allyltri-n-butyltin (0.20 
mL, 0.65 mmol) were added to this suspension. The mixture was stirred under reflux condition 
for 3 d. The polymer was filtered and washed with THF. All volatiles were removed under 
reduced pressure. The residue gave a mixture of the starting epoxy ketone and the desired 
product 36 (78% conversion after 1 d, 81% conversion after 2 d, and 86% conversion after 3 d), 
which was analyzed by 1H NMR. 
General procedure for allylation of benzaldehyde with allytrichlorosilane in the presence of 
additives (Table 8). To a suspension of polymer-supported HMPA 87a (78 mg, 0.13 mmol) in 
CH2Cl2 (2 mL) and N,N-diisopropylethylamine (0.5 mL) at –78 °C was added allyltrichloro-
silane (0.26 g, 1.5 mmol). The reaction mixture was shaken at –78 °C for 5 min before 
benzaldehyde (53 mg, 0.50 mmol) was added. The resulting suspension was shaken at room 
temperature for 1 d and poured into an ice water. The polymer was filtered and washed with 
water and ethyl ether. The combined organic layers were dried (MgSO4) and concentrated. The 
residue was purified by chromatography on SiO2 (hexane/ethyl ether, 4:1) to give the desired 
product 93 (55 mg, 0.37 mmol, 74%) as a colorless oil: 1H NMR δ 7.38-7.26 (m, 5 H), 5.90-5.76 
(m, 1 H), 5.33-5.14 (m, 2 H), 4.76 (dd, 1 H, J = 5.4, 7.4 Hz), 2.60-2.45 (m, 2 H), 2.00 (br, 1 H). 
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(R)-Dimethyl-2-((benzyloxy)methoxy)pentanedioate (114). A solution of (R)-(–)-5-oxo-2-
tetrahydrofuran carboxylic acid 100 (15.0 g, 115 mmol) and concentrated HCl (15 drops) in 
MeOH (300 mL) was stirred at room temperature for 1 d. To the reaction mixture was added 
solid NaHCO3 at 0 ºC. The mixture was filtered, concentrated, then dissolved in H2O, and 
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 extracted with CH2Cl2 (3x40 mL). The combined organic layers were dried (MgSO4) and 
concentrated to give the desired product (19.6 g, 111 mmol, 97 %) as a yellow oil. The resulting 
residue (19.0 g, 108 mmol) was dissolved in CH2Cl2 (100 mL) and N,N-diisopropylethylamine 
(47.0 mL, 270 mmol) was added. To the mixture was added BOMCl (30.0 mL, 216 mmol) 
dropwise. After stirring for 1 d, the reaction mixture was washed with 1 N HCl, saturated 
aqueous NaHCO3, and brine at 0 ºC, dried (MgSO4), and concentrated. The residue was purified 
by chromatography on SiO2 (hexane/ethyl ether, 4:1) to give 114 (18.9 g, 63.8 mmol, 92% based 
on recovered starting material) and unreacted alcohol (6.86 g, 38.9 mmol, 35%): [α]D +46 (c 1.4, 
CHCl3); IR (neat) 2953, 2889, 1739, 1438, 1260, 1203, 1173, 1027 cm-1; 1H NMR δ 7.36-7.25 
(m, 5 H), 4.81, 4.79 (AB, 2 H, J = 7.2 Hz), 4.62 (s, 2 H), 4.25 (dd, 1 H, J = 4.9, 7.6 Hz), 3.69 (s, 
3 H), 3.65 (s, 3 H), 2.55-2.38 (m, 2 H), 2.20-1.99 (m, 2 H); 13C NMR δ 173.2, 172.5, 137.6, 
128.5, 127.9 (2C), 94.4, 74.5, 70.2, 52.1, 51.7, 29.6, 27.9; MS (ESI) m/z (relative intensity) 319 
([M+Na]+, 100); HRMS (ESI) m/z calculated for C15H20O6Na (M+Na) 319.1182, found 
319.1162. 
MeO H
OO
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(R)-Methyl-4-((benzyloxy)methoxy)-4-formylbutanoate (99). A solution of the protected 
diester 114 (18.6 g, 62.8 mmol) in CH2Cl2 (140 mL) and toluene (90 mL) was treated with a 
solution of MgBr2•OEt2 (24.3 g, 94.2 mmol) in ethyl ether (90 mL), stirred at room temperature 
for 1 h, and cooled to –78 ºC. DIBAL (1 M solution in hexane, 94.0 mL, 94.0 mmol) was added 
over 2 h dropwise via dropping funnel. After an additional 30 min, MeOH (80 mL) was added in 
the same manner and the reaction mixture was then allowed to warm to room temperature. 
Saturated aqueous Rochelle salt (100 mL) was added. The mixture was stirred overnight and the 
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 aqueous layer was extracted with CH2Cl2 (3x40 mL). The combined organic layers were dried 
(MgSO4) and concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl 
ether, 3:2) gave the desired aldehyde 99 (6.33 g, 23.8 mmol, 45% based on recovered starting 
material) along with over-reduced alcohol (6.28 g, 23.4 mmol, 37%) and starting material 114 
(2.84 g, 9.58 mmol, 15%): [α]D +25 (c 1.0, CHCl3); IR (neat) 2951, 2893, 1736, 1438, 1380, 
1256, 1198, 1162, 1027 cm-1; 1H NMR δ 9.63 (d, 1 H, J = 1.5 Hz), 7.35-7.27 (m, 5 H), 4.86, 4.81 
(AB, 2 H, J = 7.1 Hz), 4.68, 4.63 (AB, 2 H, J = 11.8 Hz), 4.06 (ddd, 1 H, J = 1.5, 5.1, 7.8 Hz), 
3.65 (s, 3 H), 2.46 (t, 2 H, J = 7.3 Hz), 2.12-1.91 (m, 2 H); 13C NMR δ 201.9, 173.2, 137.3, 
128.6, 128.0, 127.9, 94.9, 81.2, 70.3, 51.8, 29.2, 25.1; MS (EI) m/z (relative intensity) 207 ([M-
CO2Me]+, 4), 159 (3), 130 (6), 120 (5), 91 (100); HRMS (EI) m/z calculated for C12H15O3 (M-
CO2Me) 207.1021, found 207.1030. 
MeO
O
BOMO
OH  
 (4R,5R)-Methyl-4-((benzyloxy)methoxy)-5-hydroxy-6,6-dimethyloct-7-enoate (115). Indium 
powder (4.10 g, 35.7 mmol) was azeotropically dried with dry THF (1 mL) twice and then 
treated with THF (180 mL) and 4-bromo-2-methyl-2-butene (12.3 mL, 107 mmol). The mixture 
was stirred vigorously till it turned into a clear solution, then to which was added dropwise 
hexane (60 mL). The resulting clear solution was cooled to –78 ºC, followed by addition of the 
aldehyde 99 (6.34 g, 23.8 mmol) dropwise. The reaction mixture was stirred at –78 ºC for 2 h, 
allowed to warm up to room temperature over 4 h, and quenched with saturated aqueous 
NaHCO3. White emulsion was filtered and the aqueous layer was extracted with ethyl ether 
(3x50 mL). The combined organic layers were dried (MgSO4), concentrated, and purified by 
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 chromatography on SiO2 (hexane/ethyl ether, 85:15) to afford the desired product 115 (2.41 g, 
7.16 mmol, 30%) and the lactone 118 (3.34 g, 11.1 mmol, 46%) as a colorless oil.  
Or a solution of lactone 118 (6.42 g, 21.1 mmol) and concentrated HCl (3 drops) in MeOH (100 
mL) was stirred at room temperature for 3 h. To a reaction mixture was added solid NaHCO3 at 0 
ºC. The mixture was filtered, concentrated, then dissolved in H2O, and extracted with CH2Cl2 
(3x50 mL). The combined organic layers were dried (MgSO4), concentrated, and purified by 
chromatography on SiO2 (hexane/ethyl ether, 85:15) to afford 115 (5.42 g, 16.1 mmol, 76%) as a 
colorless oil. [α]D +16 (c 0.45, CH2Cl2); IR (neat) 3535, 2953, 1737, 1454, 1381, 1260, 1198, 
1163, 1097, 1027, 914 cm-1; 1H NMR (C6D6) δ 7.36-7.12 (m, 5 H), 5.90 (dd, 1 H, J = 10.5, 17.9 
Hz), 5.01 (dd, 1 H, J = 1.5, 5.1 Hz), 4.97 (dd, 1 H, J = 1.7, 2.1 Hz), 4.57 (s, 2 H), 4.54, 4.44 (AB, 
2 H, J = 12.1 Hz), 3.70 (dt, 1 H, J = 2.6, 5.6 Hz), 3.39 (s, 3 H), 3.19 (dd, 1 H, J = 2.6, 8.0 Hz), 
2.70 (d, 1 H, J = 8.0 Hz), 2.46-2.30 (m, 2 H), 2.19-2.07 (m, 1 H), 1.97-1.86 (m, 1 H), 1.15 (s, 3 
H), 1.09 (s, 3 H); 13C NMR (C6D6) δ 173.3, 145.4, 138.3, 128.6, 127.9, 127.8, 112.2, 94.9, 78.8, 
76.5, 70.3, 51.0, 41.6, 29.7, 29.5, 25.0, 22.5; MS (ESI) m/z (relative intensity) 359 ([M+Na]+, 
100), 289 (11); HRMS (ESI) m/z calculated for C19H28O5Na (M+Na) 359.1834, found 359.1830. 
O
BOMO
O
 
(4R,5R)-5-Benzyloxymethoxy-6-(1,1-dimethylallyl)tetrahydropyran-2-one (118): Mp 62 °C; 
[α]D –9.1 (c 0.11, CH2Cl2); IR (neat) 2960, 2924, 1734, 1455, 1362, 1204, 1096, 1022 cm-1; 1H 
NMR δ 7.39-7.30 (m, 5 H), 6.05 (dd, 1 H, J = 10.8, 17.5 Hz), 5.12-5.03 (m, 2 H), 4.82, 4.76 
(AB, 2 H, J = 7.2 Hz), 4.64 (s, 2 H), 4.17 (br. s, 1 H), 3.95 (br. s, 1 H), 2.70 (ddd, 1 H, J = 7.6, 
10.9, 18.3 Hz), 2.56 (ddd, 1 H, J = 2.2, 7.5, 18.0 Hz), 2.25 (tt, 1 H, J = 3.4, 10.6 Hz), 1.92-1.80 
100 
 (m, 1 H), 1.22 (s, 3 H), 1.20 (s, 3 H); 13C NMR δ 170.9, 144.2, 137.6, 128.7, 128.1, 127.9, 112.4, 
93.9, 88.2, 70.8, 69.4, 40.6, 25.7, 25.3, 24.9,23.4; MS (ESI) m/z (relative intensity) 327 
([M+Na]+, 100), 289 (5); HRMS (ESI) m/z calculated for C18H24O4Na (M+Na) 327.1572, found 
327.1572. 
 
MeO
O
BOMO
OTES  
(4R,5R)-Methyl-4-((benzyloxy)methoxy)-6,6-dimethyl-5-(triethylsilanyloxy)oct-7-enoate 
(116). To a solution of 115 (8.14 g, 24.2 mmol) and 2,6-lutidine (8.45 mL, 72.6 mmol) in 
CH2Cl2 (120 mL) was added TESOTf (8.21 mL, 36.3 mmol) at 0 ºC, and the solution was stirred 
for 2 h at 0 °C. The reaction mixture was quenched with brine and the aqueous layer was 
extracted with EtOAc (3x50 mL). The combined organic layers were dried (MgSO4) and 
concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl ether, 95:5) to 
yield the desired TES ether 116 (10.3 g, 22.9 mmol, 94%) as a colorless oil: [α]D +52 (c 1.0, 
CHCl3); IR (neat) 2954, 2911, 2877, 1741, 1458, 1437, 1379, 1358, 1239, 1160, 1119, 1039, 
912, 831 cm-1; 1H NMR δ 7.37-7.29 (m, 5 H), 6.02 (dd, 1 H, J = 11.0, 17.4 Hz), 5.02 (dd, 1 H, J 
= 1.4, 8.0 Hz), 4.98 (s, 1 H), 4.78, 4.73 (AB, 2 H, J = 7.0 Hz), 4.71, 4.57 (AB, 2 H, J = 11.9 Hz), 
3.65 (s, 3 H), 3.59 (qn, 1 H, J = 4.5 Hz), 3.45 (d, 1 H, J = 5.0 Hz), 2.56-2.34 (m, 2 H), 1.95-1.80 
(m, 2 H), 1.09 (s, 3 H), 1.06 (s, 3 H), 0.99 (t, 9 H, J = 8.1 Hz), 0.65 (q, 6 H, J = 7.5 Hz); 13C 
NMR δ 174.2, 145.8, 138.3, 128.6, 127.9, 127.8, 111.6, 95.2, 80.8, 78.3, 70.1, 51.6, 42.0, 31.4, 
29.4, 24.8, 24.7, 7.3, 5.6; MS (EI) m/z (relative intensity) 391 ([M-CO2Me]+, 1), 351 (4), 213 
(55), 115 (18), 91 (100); HRMS (EI) m/z calculated for C23H39O3Si (M-CO2Me) 391.2668, found 
391.2653. 
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(4R,5R)-Methyl-4-((benzyloxy)methoxy)-6-formyl-6-methyl-5-(triethylsilanyloxy) 
heptanoate (98). A stream of O3 was bubbled through a solution of 116 (5.4 g, 12 mmol) in 
MeOH (100 mL) at –78 ºC until the color of solution turned blue. After N2 was bubbled through 
the solution for 15 min, Me2S (5.0 L, 68 mmol) was added. The reaction mixture was allowed 
to warm to room temperature and stirred for 12 h. The solution was concentrated. The residue 
was purified by chromatography on SiO2 (hexane/ethyl ether, 10:1) to afford the desired 
aldehyde 98 (4.5 g, 9.9 mmol, 83%) as a colorless oil: [α]D +22 (c 1.0, CHCl3); IR (neat) 2955, 
2877, 1739, 1457, 1159, 1101, 1040, 821 cm-1; 1H NMR (C6D6) δ 9.83 (m, 1 H), 7.35-7.14 (m, 5 
H), 4.65, 4.60 (AB, 2 H, J = 7.0 Hz), 4.54, 4.46 (AB, 2 H, J = 12.1 Hz), 3.89 (d, 1 H, J = 3.8 
Hz), 3.73 (dt, 1 H, J = 3.9, 9.2 Hz), 3.38 (s, 3 H), 2.40 (dd, 2 H, J = 7.0, 7.6 Hz), 2.18-2.07 (m, 1 
H), 2.04-1.91 (m, 1 H), 1.14 (s, 3 H), 1.11 (s, 3 H), 1.02 (t, 9 H, J = 8.0 Hz), 0.65 (q, 6 H, J = 7.7 
Hz); 13C NMR (C6D6) δ 203.4, 173.0, 138.3, 128.5, 127.9, 127.7, 95.3, 80.1, 78.7, 70.2, 51.0, 
50.2, 31.2, 27.4, 20.34, 20.29, 7.1, 5.5; MS (EI) m/z (relative intensity) 393 ([M-CO2Me]+, 3), 
336 (6), 315 (7), 231 (37), 187 (45), 115 (40), 91 (100); HRMS (EI) m/z calculated for 
C19H32O3Si (M-C5H8O3) 336.2121, found 336.2123. 
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2-(2-((2R,3R)-3-((Benzyloxy)methoxy)tetrahydro-6-oxo-2H-pyran-2-yl)propan-2-yl)-2,3-
dihydro-6-methylpyran-4-one (110). To a solution of 98 (1.32 g, 2.92 mmol) and diene 109 
(3.0 mL) in CH2Cl2 (30 mL) was added BF3•OEt2 (0.50 mL, 3.9 mmol) dropwise. The mixture 
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 was stirred for 3 h at –78 ºC, quenched with saturated aqueous NaHCO3, warmed up to room 
temperature, and extracted with CH2Cl2 (3x50 mL). The combined organic layers were dried 
(MgSO4) and concentrated. To a solution of crude 123 (1.8 g) in CH2Cl2 (80 mL) was added 
TFA (3.0 mL) dropwise at 0 ºC. The reaction mixture was stirred for 1 h at room temperature, 
quenched with saturated aqueous NaHCO3, and extracted with CH2Cl2 (3x50 mL). The 
combined organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography on SiO2 (CH2Cl2/EtOAc, 10:1-4:1) to give the desired lactone 110 (773 mg, 
1.99 mmol, 68%) as a yellow oil: [α]D –74 (c 1.5, CHCl3); IR (neat) 1735, 1663, 1612, 1399, 
1335, 1243, 1200, 1167, 1061 cm-1; 1H NMR δ 7.38-7.28 (m, 5 H), 5.31 (s, 1 H), 4.87, 4.79 (AB, 
2 H, J = 7.2 Hz), 4.63 (s, 2 H), 4.41 (dd, 1 H, J = 3.2, 14.8 Hz), 4.30 (d, 1 H, J = 1.3 Hz), 4.25-
4.21 (m, 1 H), 2.75-2.52 (m, 3 H), 2.48-2.41 (m, 1 H), 2.36-2.26 (m, 1 H), 1.98 (s, 3 H), 1.96-
1.84 (m, 1 H), 1.23 (s, 3 H), 1.14 (s, 3 H); 13C NMR δ 193.1, 173.9, 170.3, 137.2, 128.7, 128.2, 
127.7, 105.3, 93.3, 84.5, 84.0, 71.1, 68.7, 40.9, 36.7, 25.5, 24.7, 21.0, 20.5, 19.5; MS (EI) m/z 
(relative intensity) 388 (M+, 1), 297 (2), 282 (1.4), 183 (8), 153 (10), 111 (75), 91 (100); HRMS 
(EI) m/z calculated for C22H28O6 388.1886, found 388.1881. 
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(5R,6R)-5-((Benzyloxy)methoxy)tetrahydro-6-(2-((2R,6R)-tetrahydro-6-methyl-4-oxo-2H-
pyran-2-yl)propan-2-yl)pyran-2-one (119). A suspension of 110 (385 mg, 0.991 mmol) and 
Pd/C (3 wt%, 70 mg) in THF (15 mL) was stirred for 10 h at room temperature under H2 gas, 
then filtered, and concentrated. The residue was purified by chromatography on SiO2 
(hexane/EtOAc, 10:1) to give 119 (249 mg 0.638 mmol, 64%) as a colorless oil: [α]D –14 (c 
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 0.50, CHCl3); IR (neat) 2927, 2868, 1774, 1722, 1455, 1365, 1244, 1167, 1102, 1024, 927 cm-1; 
1H NMR (acetone-d6) δ 7.37-7.26 (m, 5 H), 4.93, 4.87 (AB, 2 H, J = 7.0 Hz), 4.68, 4.63 (AB, 2 
H, J = 12.1 Hz), 4.39 (d, 1 H, J = 1.3 Hz), 4.29 (dt, 1 H, J = 1.4, 3.3 Hz), 3.71 (dd, 1 H, J = 2.6, 
11.6 Hz),  3.66-3.59 (m, 1 H), 2.61-2.49 (m, 2 H), 2.43 (dd, 1 H, J = 11.6, 14.0 Hz), 2.33-2.20 
(m, 4 H), 2.11-1.95 (m, 1 H), 1.23 (d, 2 H, J = 6.1 Hz), 1.13 (s, 3 H), 1.05 (s, 3 H); 13C NMR δ 
207.5, 170.8, 137.3, 128.7, 128.1, 127.7, 93.2, 84.9, 81.2, 73.2, 70.9, 68.8, 49.4, 42.5, 41.3, 25.6, 
24.6, 22.2, 20.1, 19.6; MS (EI) m/z (relative intensity) 299 ([M-C2H7]+, 1), 269 (3), 198 (4), 185 
(4), 91 (100); HRMS (EI) m/z calculated for C15H23O6 (M-C7H7) 299.1495, found 299.1482. 
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(5R,6R)-5-((Benzyloxy)methoxy)tetrahydro-6-(2-((2R,4S,6R)-tetrahydro-6-methyl-4-(tert-
butyldimethylsilanyloxy)-2H-pyran-2-yl)propan-2-yl)pyran-2-one (121). To a solution of 
119 (249 mg, 0.638 mmol) in THF (10 mL) was added NaBH4 (35 mg, 0.96 mmol) at 0 ºC and 
the mixture was stirred for 3 h at room temperature. The mixture was quenched with saturated 
aqueous NH4Cl and the aqueous layer was extracted with EtOAc (3x25 mL). The combined 
organic layers were dried (MgSO4) and concentrated to give a crude product 120 (300 mg) as a 
yellow oil: [α]D –17 (c 0.31, CHCl3); IR (neat) 3427, 2960, 2932, 2873, 1726, 1453, 1366, 1249, 
1024, 740 cm-1; 1H NMR δ 7.41-7.28 (m, 5 H), 4.88, 4.80 (AB, 2 H, J = 7.2 Hz), 4.69, 4.65 (AB, 
2 H, J = 12.9 Hz), 4.30 (br. s, 1 H), 4.20 (br. s, 1 H), 3.55 (tt, 1 H, J = 4.4, 10.9 Hz), 3.35-2.29 
(m, 1 H), 3.26 (dd, 1 H, J = 1.6, 11.3 Hz), 2.69 (ddd, 1 H, J = 7.6, 10.8, 18.2 Hz), 2.57 (ddd, 1 H, 
J = 3.1, 8.0, 18.2 Hz),  2.31-2.21 (m, 1 H), 1.95-1.81 (m, 3 H), 1.25 (q, 2 H, J = 11.6 Hz), 1.14 
(d, 3 H, J = 6.2 Hz), 1.10 (s, 3 H), 1.07 (s, 3 H); 13C NMR δ 171.3, 137.6, 128.8, 128.2, 127.7, 
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 93.5, 85.5, 80.1, 71.9, 70.9, 69.3, 68.9, 43.3, 41.0, 35.2, 25.8, 25.1, 21.9, 20.8, 19.7; MS (ESI) 
m/z (relative intensity) 415 ([M+Na]+, 100), 337 (25), 257 (14); HRMS (ESI) m/z calculated for 
C22H32O6Na (M+Na) 415.2097, found 415.2111. 
 
To a solution of crude 120 (300 mg) and imidazole (500 mg, 7.34 mmol) in DMF (5 L) was 
added TBSCl (300 mg, 1.99 mmol). The mixture was stirred overnight and water was added. The 
aqueous layer was extracted with EtOAc (3x30 mL). The combined organic layers were dried 
(MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(hexane/EtOAc, 10:1) to give 121 (272 mg, 0.537 mmol, 84% over 2 steps) as a colorless oil: 
[α]D –10 (c 0.71, CHCl3); IR (neat) 2956, 2932, 2856, 1736, 1454, 1363, 1250, 1153, 1025, 837 
cm-1; 1H NMR δ 7.40-7.29 (m, 5 H), 4.88, 4.81 (AB, 2 H, J = 7.2 Hz), 4.69, 4.64 (AB, 2 H, J = 
12.1 Hz), 4.28 (br. s, 1 H), 4.21 (br, 1 H), 3.69-3.60 (m, 1 H), 3.34-3.24 (m, 1 H), 3.26 (dd, 1 H, 
J = 1.3, 11.3 Hz), 2.68 (ddd, 1 H, J = 7.5, 10.5, 18.1 Hz), 2.56 (ddd, 1 H, J = 3.2, 8.0, 18.2 Hz),  
2.30-2.21 (m, 1 H), 1.94-1.85 (m, 1 H), 1.83-1.73 (m, 2 H), 1.34-1.18 (m, 2 H), 1.13 (d, 3 H, J = 
6.1 Hz), 1.10 (s, 3 H), 1.06 (s, 3 H), 0.88 (s, 9 H), 0.05 (s, 6 H); 13C NMR δ 171.4, 137.6, 128.8, 
128.1, 127.7, 93.6, 85.7, 80.0, 71.9, 70.9, 69.6, 69.3, 43.8, 41.0, 35.4, 26.1, 25.9, 25.1, 22.0, 20.9, 
19.4, 18.3, –4.3; MS (ESI) m/z (relative intensity) 529 ([M+Na]+, 100), 507 (5), 447 (8); HRMS 
(ESI) m/z calculated for C28H46O6NaSi (M+Na) 529.2961, found 529.2974. 
O
O
OTBSO
OH  
(5R,6R)-Tetrahydro-6-(2-((2R,4S,6R)-tetrahydro-6-methyl-4-(tert-butyldimethylsilanyloxy)-
2H-pyran-2-yl)propan-2-yl)-5-hydroxypyran-2-one (111). To a solution of 121 (246 mg, 
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 0.485 mmol) in THF (15 mL) was added Pd(OH)2/C (20 wt%, 60 mg). The mixture was stirred 
under H2 gas for 5 h and filtered through celite pad. The residue was concentrated and purified 
by chromatography on SiO2 (hexane/EtOAc, 4:1) to give 111 (188 mg, 0.486 mmol, 100%) as a 
white solid: Mp 51 °C; [α]D –12 (c 0.33, CHCl3); IR (neat) 3435, 2956, 2931, 2884, 1775, 1472, 
1385, 1253, 1152, 1070, 837 cm-1; 1H NMR δ 5.80 (d, 1 H, J = 1.4 Hz), 4.15 (t, 1 H, J = 2.8 Hz), 
3.92 (s, 1 H), 3.79 (tt, 1 H, J = 4.8, 10.7 Hz), 3.70 (dd, 1 H, J = 1.8, 11.9 Hz), 3.62-3.51 (m, 1 H), 
2.83 (ddd, 1 H, J = 8.3, 10.4, 18.6 Hz), 2.52 (ddd, 1 H, J = 2.4, 8.2, 18.3 Hz), 2.13-2.04 (m, 1 H), 
1.94-1.72 (m, 3 H), 1.31-1.23 (m, 2 H), 1.20 (d, 3 H, J = 6.2 Hz), 1.08 (s, 3 H), 1.03 (s, 3 H), 
0.89 (s, 9 H), 0.06 (s, 6 H); 13C NMR δ 171.8, 90.7, 75.4, 72.4, 68.9, 61.4, 43.2, 41.5, 35.6, 27.5, 
26.6, 26.1, 25.5, 21.2, 18.34, 18.30, –4.36, –4.38; MS (EI) m/z (relative intensity) 329 ([M-
C4H9]+, 35), 285 (15), 227 (13), 169 (36), 145 (88), 97 (54), 85 (100); HRMS (EI) m/z calculated 
for C16H29O5Si (M-C4H9) 329.1784, found 329.1780. 
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(2R,3R,5S,7R,9S)-9-(tert-Butyldimethylsilanyloxy)-(hexahydrofuro[3,2-b]pyran-5-onyl)-
4,4,7-trimethyl-1,6-dioxaspiro[4.5]decane (112). To a solution of 111 (337 mg, 0.872 mmol) in 
cyclohexane (60 mL) were added iodobenzene diacetate (560 mg, 1.74 mmol) and I2 (442 mg, 
1.74 mmol). The reaction mixture was stirred for 5 h at room temperature under irradiation by 
light (250 W), quenched with saturated aqueous Na2S2O3, and stirred for 30 min. The aqueous 
layer was extracted with EtOAc (2×25 mL). The combined organic layers were dried (MgSO4) 
and concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl ether, 
10:1) to give the major product 112 (159 mg, 0.413 mmol, 47%) as a white solid and the minor 
product 113 (66 mg, 0.17 mmol, 20%) as a colorless oil: [α]D +43 (c 1.0, CHCl3); IR (neat) 
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 2955, 2931, 2886, 2857, 1750, 1472, 1385, 1250, 1155, 1115, 1040, 837 cm-1; 1H NMR δ 4.71 
(d, 1 H, J = 7.6 Hz), 4.21 (dt, 1 H, J = 5.9, 7.3 Hz), 4.04 (tt, 1 H, J = 4.8, 11.0 Hz), 3.81-3.70 (m, 
1 H), 2.58 (ddd, 1 H, J = 4.2, 8.4, 16.9 Hz), 2.33 (ddd, 1 H, J = 4.1, 9.2, 16.9 Hz), 2.14-2.04 (m, 
1 H), 1.98-1.89 (m, 1 H), 1.88-1.79 (m, 2 H), 1.35-1.20 (m, 2 H), 1.14 (d, 3 H, J = 6.2 Hz), 1.137 
(s, 3 H), 0.93 (s, 3 H), 0.89 (s, 9 H), 0.08 (s, 6 H); 13C NMR δ 172.1, 108.8, 88.0, 69.5, 66.0, 
64.9, 49.8, 42.9, 36.9, 27.1, 26.0, 24.0, 21.5, 21.1, 18.9, 18.2, –4.4; MS (EI) m/z (relative 
intensity) 327 ([M-C4H9]+, 4), 185 (22), 169 (60), 140 (100), 97 (100); HRMS (EI) m/z 
calculated for C16H27O5Si (M-C4H9) 327.1628, found 327.1629. 
O
O
O
O
OTBS   
(2R,3R,5R,7R,9S)-9-(tert-Butyldimethylsilanyloxy)-(hexahydrofuro[3,2-b]pyran-5-onyl)-
4,4,7-trimethyl-1,6-dioxaspiro[4.5]decane (113): [α]D –37 (c 1.0, CHCl3); IR (neat) 2971, 
2931, 1723, 1384, 1247, 1185, 1102, 1066, 1042, 996, 883 cm-1; 1H NMR (500 MHz, 
CDCl3+C6D6): δ 4.09 (br. s, 1 H), 3.97 (d, 1 H, J = 5.3 Hz), 3.88 (dq, 1 H, J = 5.1, 14.9 Hz), 3.72 
(ddt, 1 H, J = 2.2, 6.1, 12.1 Hz), 2.89 (ddd, 1 H, J = 5.8, 13.7, 17.5 Hz), 2.24 (d, 1 H, J = 16.3 
Hz), 2.09 (dd, 1 H, J = 5.0, 13.8 Hz), 1.90-1.84 (m, 1 H), 1.72 (dt, 1 H, J = 2.4, 12.6 Hz), 1.64 
(dd, 1 H, J = 9.6, 13.9 Hz), 1.47 (ddt, 1 H, J = 2.5, 4.8, 14.1 Hz), 1.36 (q, 1 H, J = 11.8 Hz), 1.19 
(s, 3 H), 1.13 (d, 3 H, J = 6.1 Hz), 0.95 (s, 9 H), 0.84 (s, 3 H), 0.09 (s, 6 H); 13C NMR δ 171.3, 
109.5, 90.2, 71.0, 69.3, 65.7, 51.2, 42.1, 39.2, 26.0, 25.4, 25.0, 23.7, 22.1, 19.5, 18.3, –4.4; MS 
(EI) m/z (relative intensity) 369 ([M-CH3]+, 1), 327 (55), 283 (15), 213 (25), 171 (70), 140 (58), 
101 (50), 75 (100); HRMS (EI) m/z calculated for C19H33O5Si (M-CH3) 369.2097, found 
369.2099. 
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(2R,3R,5S,7R,9S)-9-(tert-Butyldimethylsilanyloxy)-2-((3S,4R)-3-hydroxy-4-methylhex-5-
enyl)-4,4,7-trimethyl-1,6-dioxaspiro[4.5]decan-3-ol (127). To a solution of 112 (225 mg, 0.585 
mmol) in CH2Cl2 (25 mL) was added DIBAL (1.0 M in hexane, 0.70 mL, 0.70 mmol) at –78 ºC 
and the mixture was stirred for 2 h at –78 ºC. The mixture was quenched with MeOH (1 mL), 
allowed to warm to room temperature, and treated with saturated aqueous Rochelle salt (2 mL). 
After stirred overnight at room temperature, the aqueous layer was extracted with CH2Cl2 (3x25 
mL). The combined organic layers were dried (MgSO4) and concentrated to give a crude 
aldehyde. Without further purification, this crude aldehyde was used for the next step. To a well-
stirred mixture of trans-2-butene (0.54 mL) and KOt-Bu (145 mg, 2.01 mmol) in THF (2 mL), n-
BuLi (1.6 M in hexane, 1.30 mL, 2.08 mmol) was added at –78 ºC. Following the completion of 
addition, the mixture was stirred at –45 ºC for 15 min and again cooled to –78 ºC. To the reaction 
mixture, a solution of B-methoxylbis(2-isocaranyl)borane (788 mg, 2.68 mmol) in ethyl ether (2 
mL) was added dropwise and the resulting mixture was stirred for 30 min at –78 ºC. The addition 
of BF3•etherate (0.34 mL, 2.7 mmol) and stirring the mixture at –78 ºC for 15 min afforded B-
[E]-crotyl(2-isocaranyl)borane 126. A solution of the crude aldehyde (40 mg, 0.10 mmol) in 
ethyl ether (0.7 mL) was added at –78 ºC and the resulting mixture was stirred for 3 h at –78 ºC. 
The reaction mixture was quenched with MeOH (0.4 mL), brought to room temperature, and 
oxidized with alkalin hydrogen peroxide (30% H2O2 (1.4 mL) and 3 N NaOH (0.74 mL) by 
refluxing for 3 h. The aqueous layer was extracted with EtOAc (3x30 mL). The combined 
organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography on SiO2 (hexane/ethyl ether, 10:1-4:1) to give 127 (35 mg, 0.079 mmol, 77% 
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 over 2 steps) as a colorless oil: [α]D +46 (c 1.0, CHCl3); IR (neat) 3478, 2956, 2930, 2885, 2857, 
1472, 1386, 1255, 1040, 836 cm-1; 1H NMR δ 5.87-5.74 (m, 1 H), 5.12 (br. s, 1 H), 5.08 (d, 1 H, 
J = 4.1 Hz), 4.23 (d, 1 H, J = 7.5 Hz), 4.09-3.98 (m, 1 H), 3.90 (dt, 1 H, J = 4.9, 7.8 Hz), 3.78-
3.68 (m, 1 H), 3.50-3.44 (m, 1 H), 2.28-2.17 (m, 1 H), 1.85-1.65 (m, 4 H), 1.62-1.40 (m, 1 H), 
1.33-1.15 (m, 3 H), 1.11 (d, 3 H, J = 6.1 Hz), 1.05 (d, 3 H, J = 7.0 Hz), 1.02 (s, 3 H), 0.89 (br. s, 
12 H), 0.07 (s, 6 H); 13C NMR δ 140.8, 116.0, 107.6, 79.6, 77.9, 75.0, 66.4, 64.8, 48.2, 44.3, 
43.4, 38.0, 31.7, 26.6, 26.1, 21.7, 20.9, 18.3, 18.2, 16.5, –4.3; MS (EI) m/z (relative intensity) 
385 ([M-C4H9]+, 0.1), 297 (33), 203 (40), 171 (47), 125 (33), 75 (100); HRMS (EI) m/z 
calculated for C20H37O5Si (M-C4H9) 385.2410, found 385.2418. 
HO
O
O
OTBS
OTBS  
(2R,3R,5S,7R,9S)-9-(tert-Butyldimethylsilanyloxy)-2-[(3S,4R)-3-(tert-
butyldimethylsilanyloxy)-4-methylhex-5-enyl]-4,4,7-trimethyl-1,6-dioxaspiro[4.5]decan-3-ol 
(123). To a solution of 127 (35 mg, 0.079 mmol) and imidazole (54 mg, 0.79 mmol) in DMF (1 
mL) was added TBSCl (60 mg, 0.40 mmol). The mixture was stirred overnight and quenched 
with water. The aqueous layer was extracted with EtOAc (3x20 mL). The combined organic 
layers were dried (MgSO4) and concentrated. The residue was purified by chromatography on 
SiO2 (hexane/ethyl ether, 10:1) to give 123 (43 mg, 0.077 mmol, 97%) as a colorless oil: [α]D 
+39 (c 1.0, CHCl3); IR (neat) 3462, 2956, 2930, 2885, 2857, 1472, 1386, 1255, 1112, 1069, 
1006, 836 cm-1; 1H NMR δ 5.87-5.75 (m, 1 H), 5.04-5.01 (m, 1 H), 4.99-4.97 (m, 1 H), 4.20 (d, 1 
H, J = 7.6 Hz), 4.05 (tt, 1 H, J = 4.9, 10.9 Hz), 3.87-3.80 (m, 1 H), 3.78-3.67 (m, 1 H), 3.59 (q, 1 
H, J = 4.7 Hz), 2.37-2.28 (m, 1 H), 1.83-1.75 (m, 2 H), 1.65-1.55 (m, 2 H), 1.49-1.35 (m, 2 H), 
1.31-1.15 (m, 2 H), 1.10 (d, 3 H, J = 6.3 Hz), 1.02 (s, 3 H), 1.00 (d, 3 H, J = 6.9 Hz), 0.90 (s, 9 
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 H), 0.89 (s, 9 H), 0.88 (s, 3 H), 0.07 (s, 9 H), 0.05 (s, 3 H); 13C NMR (125 MHz, CD2Cl2) δ 
141.7, 114.4, 107.6, 79.7, 77.5, 76.1, 66.7, 64.8, 48.3, 43.7, 43.2, 38.2, 30.9, 26.4, 26.14, 26.07, 
21.6, 20.9, 18.5, 18.4, 18.2, 15.9, –4.0, –4.4; MS (EI) m/z (relative intensity) 556 (M+, 0.2), 541 
(0.3), 499 (11), 367 (28), 271 (29), 237 (100), 203 (50), 145 (55), 73 (79); HRMS (EI) m/z 
calculated for C30H60O5Si2 (M) 556.3979, found 556.4000. 
O
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(2R,3R,5S,7R,9S)-Phosphoric acid 9-(tert-butyldimethylsilanyloxy)-2-[(3S,4R)-3-(tert-
butyldimethylsilanyloxy)-4-methylhex-5-enyl]-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl 
ester bis-[2-(trimethylsilanyl)-ethyl] ester (128). PCl3 (2 M in CH2Cl2, 0.50 mL, 1.0 mmol) 
was added to a solution of the alcohol 123 (140 mg, 0.252 mmol) in pyridine (4 mL) at 0 ºC by 
one portion. After 10 min, 2-trimethylsilylethanol (0.86 mL, 6.0 mmol) and DMAP (5.0 mg) 
were added and the mixture was warmed to room temperature over 1 h. CH2Cl2 (24 mL) and 
30% aqueous H2O2 (2.8 mL) were added and the stirring was continued for 1 h at room 
temperature. The reaction was quenched with saturated aqueous NaHCO3. The aqueous layer 
was extracted with EtOAc (3x25 mL). The combined organic layers were dried (MgSO4) and 
concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl ether, 10:1) to 
give 128 (145 mg, 0.173 mmol, 69%) as a colorless oil: [α]D +36 (c 1.0, CHCl3); IR (neat) 2956, 
2930, 2895, 2857, 1383, 1362, 1252, 997, 836 cm-1; 1H NMR (500 MHz, CD2Cl2) δ 5.82 (ddd, 1 
H, J = 7.8, 10.6, 18.2 Hz), 5.01 (d, 1 H, J = 7.5 Hz), 4.98 (s, 1 H), 4.78 (dd, 1 H, J = 7.8, 9.2 Hz), 
4.18-4.10 (m, 4 H), 4.09-4.02 (m, 1 H), 3.92-3.89 (m, 1 H), 3.75-3.69 (m, 1 H), 3.62 (q, 1 H, J = 
4.7 Hz), 2.31 (dt, 1 H, J = 6.7, 18.4 Hz), 1.80 (dd, 2 H, J = 4.5, 12.5 Hz), 1.71-1.59 (m, 2 H), 
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 1.50-1.42 (m, 2 H), 1.31-1.19 (m, 2 H), 1.12-1.08 (m, 7 H), 1.07 (s, 3 H), 1.00 (d, 3 H, J = 6.9 
Hz), 0.90 (br. s, 12 H), 0.88 (s, 9 H), 0.08-0.05 (m, 30 H); 13C NMR δ 141.3, 114.4, 107.4, 84.8, 
84.7, 76.3, 76.2, 75.6, 66.4, 66.3, 64.7, 48.3, 48.2, 43.3, 42.7, 37.4, 30.8, 26.23, 26.19, 26.1, 21.6, 
20.4, 19.93, 19.88, 18.7, 18.4, 18.3, 16.2, –1.3, –3.9, –4.3, –4.35, –4.39; MS (EI) m/z (relative 
intensity) 779 ([M-C4H9]+, 0.2), 723 (5), 649 (1.5), 573 (2.5), 461 (55), 407 (100), 349 (75), 243 
(82); HRMS (EI) m/z calculated for C36H76O8Si4P (M-C4H9) 779.4355, found 779.4320. 
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Desired structure
 
 (2R,3R,5S,7R,9S)-Phosphoric acid 9-(tert-butyldimethylsilanyloxy)-2-[(3S,4R,5R,6R)-3-
(tert-butyldimethylsilanyloxy)-5-hydroxy-4,6-dimethyloct-7-enyl]-4,4,7-trimethyl-1,6-
dioxaspiro[4.5]dec-3-yl ester bis-[2-(trimethylsilanyl)ethyl]ester (130). A stream of O3 was 
bubbled through a solution of 128 (36 mg, 0.043 mmol) in MeOH (5 mL) at –78 ºC until the 
color of solution turned blue. After N2 was bubbled through the solution for 15 min, Me2S (0.50 
L, 6.8 mmol) was added. Then the mixture was allowed to warm to room temperature and 
stirred for 12 h. The solution was concentrated. The residue was purified by chromatography on 
SiO2 (hexane/ethyl ether, 4:1) to give the crude aldehyde (32 mg, 0.038 mmol, 89 %) as colorless 
oil. To a suspension of Roush’s reagent 12954c (1 M in toluene, 1.0 mL, 1.0 mmol) and 4 Å MS 
(50 mg) was added a solution of the crude aldehyde (32 mg, 0.038 mmol) in toluene (1 mL) at –
78 ºC. After stirring at –78 ºC for 5 h, the reaction mixture was filtered through a SiO2 pad and 
washed with EtOAc and CH2Cl2. The filtrate was concentrated and the residue was purified by 
chromatography on SiO2 (hexane/ethyl ether, 10:1) to give 130 (29 mg, 0.032 mmol, 84%) as a 
colorless oil: [α]D +46 (c 1.0, CHCl3); IR (neat) 3434, 2956, 2930, 2896, 2857, 1471, 1384, 
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 1252, 1113, 1074, 998, 836, 774 cm-1; 1H NMR (500 MHz, C6D6) δ 6.09 (ddd, 1 H, J = 7.7, 10.3, 
17.6 Hz), 5.29 (dd, 1 H, J = 8.0, 8.9 Hz), 5.13 (d, 1 H, J = 17.3 Hz), 5.08 (d, 1 H, J = 10.3 Hz), 
4.36-4.23 (m, 6 H), 4.04-4.01 (m, 1 H), 3.88 (d, 1 H, J = 8.6 Hz), 3.86-3.80 (m, 1 H), 2.79 (d, 1 
H, J = 1.6 Hz), 2.38 (sx, 1 H, J = 7.4 Hz), 2.22-2.15 (m, 1 H), 2.12-2.06 (m, 2 H), 1.97-1.84 (m, 
3 H), 1.83-1.78 (m, 1 H), 1.51 (t, 1 H, J = 11.3 Hz), 1.38 (s, 3 H), 1.29 (q, 1 H, J = 11.6 Hz), 1.15 
(s, 3 H), 1.13-1.06 (m, 10 H), 1.03 (s, 3 H), 1.02 (s, 9 H), 1.01 (s, 9 H), 0.24 (s, 3 H), 0.17 (s, 3 
H), 0.16 (s, 3 H), 0.13 (s, 3 H), –0.04 (s, 9 H), –0.09 (s, 9 H); 13C NMR (CD2Cl2) δ 142.7, 113.4, 
107.1, 84.04, 83.97, 76.8, 75.2, 75.1, 73.3, 65.9, 65.8, 65.7, 64.4, 47.71, 47.65, 42.9, 41.1, 36.8, 
35.6, 30.6, 25.7, 25.4, 25.3, 20.9, 19.7, 19.4, 19.3, 18.0, 17.64, 17.59, 16.1, 10.2, –2.1, –4.7, –5.0, 
–5.1, –5.4; MS (ESI) m/z (relative intensity) 918 ([M+Na]+, 75), 896 (100); HRMS (ESI) m/z 
calculated for C43H92O9PSi4 (M+H) 895.5556, found 895.5508. 
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(2R,3R,5S,7R,9S)-Phosphoric acid mono-[2-((3S,4R,5R,6R)-3,5-dihydroxy-4,6-dimethyloct-
7-enyl)-9-hydroxy-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl] ester (131). A solution of 130 
(15 mg, 0.017 mmol) in HF solution (1.0 mL, from the stock solution with 48% HF (0.5 mL), 
CH3CN (4.5 mL), and water (0.5 mL)) was stirred at room temperature for 6 d. Argon gas was 
bubbled into the reaction mixture to remove the solvent and the mixture was dried under reduced 
pressure. The residue was washed with CHCl3 and water, and extracted with MeOH to give 131 
(5.5 mg, 0.012 mmol, 71%) as a white solid: Mp 136-140 °C (dec.); IR (neat) 3272, 2925, 2863, 
1668, 1447, 1372, 1241, 1149, 1049, 1025, 995, 940 cm-1; 1H NMR (600 MHz, CD3OD) δ 5.85 
(ddd, 1 H, J = 8.3, 10.1, 17.8 Hz), 5.05 (d, 1 H, J = 17.4 Hz), 5.01 (d, 1 H, J = 10.3 Hz), 4.76 
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 (dd, 1 H, J = 8.3, 9.0 Hz), 4.00-3.95 (m, 2 H), 3.79-3.74 (m, 1 H), 3.65 (dd, 1 H, J = 2.5, 8.1 Hz), 
3.63-3.60 (m, 1 H), 2.30-2.23 (m, 1 H), 1.94-1.87 (m, 3 H), 1.80-1.74 (m, 1 H), 1.72-1.66 (m, 1 
H), 1.54-1.43 (m, 2 H), 1.23 (t, 1 H, J = 12.0 Hz), 1.13 (d, 3 H, J = 6.1 Hz), 1.09 (s, 3 H), 1.05 
(q, 1 H, J = 11.8 Hz), 0.951 (s, 3 H), 0.946 (d, 3 H, J = 6.1 Hz), 0.92 (d, 3 H, J = 6.9 Hz); 13C 
NMR (150 MHz, CD3OD) δ 143.3, 115.0, 108.7, 85.21, 85.17, 78.24, 78.21, 75.6, 75.3, 66.0, 
65.9, 43.4, 42.9, 40.9, 37.7, 32.5, 30.8, 28.3, 21.8, 20.7, 19.2, 17.4, 10.2 (HMBC shows that one 
peak is inside the solvent peaks); MS (ESI) m/z (relative intensity) 489 ([M+Na]+, 80), 471 
(100), 453 (40), 413 (20), 382 (28); HRMS (ESI) m/z calculated for C21H39O9NaP (M+Na) 
489.2229, found 489.2244. 
Desired structure
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 General Procedure for the cross-metathesis reaction. To a solution of 130 (6.6 mg, 0.0074 
mmol) and 1-decene (14 µL, 0.074 mmol) in a sealed tube was added a solution of second 
generation Grubbs’ reagent (1.5 mg, 0.0018 mmol) in CH2Cl2 (0.5 mL). The reaction mixture 
was stirred at 40 °C for 1 d. After removing all volatiles, the residue was purified by 
chromatography on SiO2 (hexane/EtOAc, 10:1) to give the desired product 132a (5.0 mg, 0.0050 
mmol, 68%) as a colorless oil. 
R = phenyl; (2R,3R,5S,7R,9S)-Phosphoric acid 9-(tert-butyldimethylsilanyloxy)-2-
[(3S,4R,5R,6R)-3-(tert-butyldimethylsilanyloxy)-5-hydroxy-4,6-dimethyl-8-phenyloct-7-
enyl]-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl ester bis-[2-(trimethylsilanyl)-ethyl]ester 
(132a): 1H NMR (600 MHz, CD2Cl2) δ 7.36 (dd, 2 H, J = 1.2, 8.4 Hz), 7.28 (t, 2 H, J = 7.5 Hz), 
7.20-7.16 (m, 1 H), 6.42 (d, 1 H, J = 15.9 Hz), 6.27 (dd, 1 H, J = 8.1, 15.9 Hz), 4.79 (dd, 1 H, J = 
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 7.8, 9.2 Hz), 4.16-4.11 (m, 4 H), 4.10-4.05 (m, 1 H), 3.95 (ddd, 1 H, J = 3.0, 7.7, 10.7 Hz), 3.88-
3.85 (m, 1 H), 3.79 (dd, 1 H, J = 1.1, 9.0 Hz), 3.76-3.71 (m, 1 H), 3.25 (s, 1 H), 2.44-2.36 (m, 1 
H), 1.98-1.92 (m, 1 H), 1.84-1.78 (m, 3 H), 1.68-1.57 (m, 3 H), 1.52-1.47 (m, 1 H), 1.27 (t, 1 H, 
J = 11.7 Hz), 1.12 (d, 3 H, J = 6.3 Hz), 1.11-1.08 (m, 4 H), 1.07 (s, 3 H), 1.00 (d, 3 H, J = 4.5 
Hz), 0.99 (d, 3 H, J = 4.2 Hz), 0.91 (s, 3 H), 0.90 (s, 9 H), 0.88 (s, 9 H), 0.12 (s, 3 H), 0.10 (s, 3 
H), 0.06 (s, 6 H), 0.05 (s, 9 H), 0.048 (s, 9 H); 13C NMR (125 MHz, CD2Cl2) δ 137.5, 134.5, 
129.0, 128.1, 126.5, 125.6, 107.0, 83.9, 77.0, 75.0, 73.6, 65.82, 65.78, 65.7, 64.3, 47.62, 47.59, 
42.8, 40.5, 36.7, 35.4, 30.5, 25.7, 25.34, 25.27, 20.8, 19.6, 19.29, 19.25 19.2, 18.0, 17.6, 17.5, 
16.5, 10.3, –2.1, –2.2, –4.7, –5.11, –5.14, –5.5; MS (ESI) m/z (relative intensity) 993 ([M+Na]+, 
78), 537 (100); HRMS (ESI) m/z calculated for C49H95O9NaPSi4 (M+Na) 993.5689, found 
993.5652. 
R = 4-chlorophenyl; (2R,3R,5S,7R,9S)-Phosphoric acid 9-(tert-butyldimethylsilanyloxy)-2-
[(3S,4R,5R,6R)-3-(tert-butyldimethylsilanyloxy)-8-(4-chlorophenyl)-5-hydroxy-4,6-
dimethyloct-7-enyl]-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl ester bis-[2-
(trimethylsilanyl)-ethyl]ester (132b): 1H NMR δ 7.30 (d, 2 H, J = 8.7 Hz), 7.23 (d, 2 H, J = 8.6 
Hz), 6.42 (d, 1 H, J = 16.0 Hz), 6.30 (dd, 1 H, J = 7.5, 15.9 Hz), 4.84 (dd, 1 H, J = 7.8, 9.3 Hz), 
4.21-4.11 (m, 4 H), 4.09-4.00 (m, 1 H), 3.98-3.91 (m, 1 H), 3.89-3.80 (m, 2 H), 3.75-3.69 (m, 1 
H), 3.50 (br. s, 1 H), 2.48-2.40 (m, 1 H), 1.97-1.91 (m, 1 H), 1.84-1.78 (m, 3 H), 1.70-1.60 (m, 2 
H), 1.32-1.21 (m, 3 H), 1.17-1.07 (m, 10 H), 1.03 (d, 3 H, J = 7.1 Hz), 1.00 (d, 3 H, J = 6.8 Hz), 
0.92 (s, 3 H), 0.91 (s, 9 H), 0.89 (s, 9 H), 0.12-0.03 (m, 30 H); MS (ESI) m/z (relative intensity) 
1028 ([M+Na]+, 100), 431 (10), 353 (12); HRMS (ESI) m/z calculated for C49H94O9NaClPSi4 
(M+Na) 1027.5299, found 1027.5232. 
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 R = 4-methoxyphenyl; (2R,3R,5S,7R,9S)-Phosphoric acid 9-(tert-butyldimethylsilanyloxy)-
2-[(3S,4R,5R,6R)-3-(tert-butyldimethylsilanyloxy)-5-hydroxy-8-(4-methoxyphenyl)-4,6-
dimethyloct-7-enyl]-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl ester bis-[2-
(trimethylsilanyl)-ethyl]ester (132c): 1H NMR δ 7.32 (d, 2 H, J = 8.8 Hz), 6.82 (d, 2 H, J = 8.8 
Hz), 6.42 (d, 1 H, J = 16.0 Hz), 6.15 (dd, 1 H, J = 7.9, 16.0 Hz), 4.84 (dd, 1 H, J = 7.7, 9.0 Hz), 
4.20-4.12 (m, 4 H), 4.09-4.02 (m, 1 H), 3.95-3.90 (m, 1 H), 3.88-3.82 (m, 2 H), 3.78 (s, 3 H), 
3.75-3.67 (m, 1 H), 3.40 (s, 1 H), 2.44-2.36 (m, 1 H), 1.98-1.90 (m, 2 H), 1.84-1.77 (m, 3 H), 
1.70-1.60 (m, 2 H), 1.41-1.20 (m, 3 H), 1.14-1.07 (m, 10 H), 1.03-0.99 (m, 6 H), 0.92-0.88 (m, 
21 H), 0.11-0.05 (m, 30 H); MS (ESI) m/z (relative intensity) 1024 ([M+Na]+, 100), 1002 (12), 
850 (11), 682 (10); HRMS (ESI) m/z calculated for C50H97O10NaPSi4 (M+Na) 1023.5794, found 
1023.5745. 
R = cyclohexyl; (2R,3R,5S,7R,9S)-Phosphoric acid 9-(tert-butyldimethylsilanyloxy)-2-
[(3S,4R,5R,6R)-3-(tert-butyldimethylsilanyloxy)-8-cyclohexyl-5-hydroxy-4,6-dimethyloct-7-
enyl]-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl ester bis-[2-(trimethylsilanyl)-ethyl] ester 
(132d): 1H NMR δ 5.48 (dd, 1 H, J = 5.7, 15.6 Hz), 5.39 (dd, 1 H, J = 7.0, 15.5 Hz), 4.83 (dd, 1 
H, J = 7.8, 9.2 Hz), 4.20-4.10 (m, 4 H), 4.09-4.00 (m, 1 H), 3.96-3.88 (m, 1 H), 3.85-3.79 (m, 1 
H), 3.75-3.68 (m, 1 H), 3.65 (d, 1 H, J = 9.3 Hz), 3.05 (s, 1 H), 2.22-2.14 (m, 1 H), 2.01-1.85 (m, 
2 H), 1.85-1.60 (m, 10 H), 1.31-1.15 (m, 7 H), 1.14-1.04 (m, 14 H), 0.95 (d, 3 H, J = 7.0 Hz), 
0.90 (s, 9 H), 0.897 (br. s, 12 H), 0.11-0.04 (m, 30 H); MS (ESI) m/z (relative intensity) 1000 
([M+Na]+, 100), 918 (85), 861 (25); HRMS (ESI) m/z calculated for C49H101O9NaPSi4 (M+Na) 
999.6158, found 999.6201. 
R = butyl; (2R,3R,5S,7R,9S)-Phosphoric acid 9-(tert-butyldimethylsilanyloxy)-2-
[(3S,4R,5R,6R)-3-(tert-butyldimethylsilanyloxy)-5-hydroxy-4,6-dimethyldodec-7-enyl]-4,4,7-
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 trimethyl-1,6-dioxaspiro[4.5]dec-3-yl ester bis-[2-(trimethylsilanyl)-ethyl] ester (132e): 1H 
NMR δ 5.56-5.39 (m, 2 H), 4.83 (dd, 1 H, J = 8.0, 9.2 Hz), 4.20-4.10 (m, 4 H), 4.09-4.00 (m, 1 
H), 3.96-3.88 (m, 1 H), 3.86-3.79 (m, 1 H), 3.75-3.62 (m, 2 H), 3.21 (s, 1 H), 2.25-2.17 (m, 1 H), 
2.10-1.89 (m, 3 H), 1.84-1.70 (m, 3 H), 1.69-1.45 (m, 4 H), 1.40-1.23 (m, 7 H), 1.16-1.03 (m, 11 
H), 0.96 (d, 3 H, J = 6.9 Hz), 0.93-0.85 (m, 24 H), 0.12-0.04 (m, 30 H); MS (ESI) m/z (relative 
intensity) 974 ([M+Na]+, 100), 952 (30), 890 (10); HRMS (ESI) m/z calculated for 
C47H99O9NaPSi4 (M+Na) 973.6002, found 973.5988. 
R = octyl; (2R,3R,5S,7R,9S)-Phosphoric acid 9-(tert-butyldimethylsilanyloxy)-2-
[(3S,4R,5R,6R)-3-(tert-butyldimethylsilanyloxy)-5-hydroxy-4,6-dimethylhexadec-7-enyl]-
4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl ester bis-[2-(trimethylsilanyl)-ethyl] ester (132f): 
1H NMR δ 5.55-5.38 (m, 2 H), 4.83 (dd, 1 H, J = 7.9, 9.1 Hz), 4.19-4.10 (m, 4 H), 4.09-4.01 (m, 
1 H), 3.96-3.87 (m, 1 H), 3.85-3.80 (m, 1 H), 3.74-3.61 (m, 2 H), 3.20 (s, 1 H), 2.25-2.18 (m, 1 
H), 2.08-1.89 (m, 3 H), 1.85-1.71 (m, 3 H), 1.70-1.45 (m, 4 H), 1.40-1.20 (m, 13 H), 1.18-1.05 
(m, 12 H), 1.00-0.95 (m, 4 H), 0.92-0.87 (m, 24 H), 0.12-0.05 (m, 30 H); MS (ESI) m/z (relative 
intensity) 1030 ([M+Na]+, 100), 974 (35); HRMS (ESI) m/z calculated for C51H107O9NaPSi4 
(M+Na) 1029.6628, found 1029.6565. 
Desired structure
O
O
O
OH
OHHO
P
OHOHO
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General Procedure for the cross-metathesis reaction. A solution of 132f (5.0 mg, 0.0050 
mmol) in HF solution (0.4 mL, from the stock solution with 48% HF (0.5 mL), CH3CN (4.5 
mL), and water (0.5 mL)) was stirred at room temperature for 7 d. An additional HF solution (0.2 
mL) was added after 3 d. N2 gas was bubbled into the reaction mixture to remove the solvent and 
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 the mixture was dried under reduced pressure. The residue was washed with CHCl3 and water, 
and extracted with MeOH to give 133f (2.0 mg, 0.0035 mmol, 70%). 
R = phenyl; (2R,3R,5S,7R,9S)-Phosphoric acid mono-[2-((3S,4R,5R,6R)-3,5-dihydroxy-4,6-
dimethyl-8-phenyloct-7-enyl)-9-hydroxy-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl] ester 
(133a): 1H NMR (600 MHz, CD3OD) δ 7.37 (d, 2 H, J = 7.6 Hz), 7.25 (t, 2 H, J = 7.6 Hz), 7.15 
(t, 1 H, J = 7.2 Hz), 6.43 (d, 1 H, J = 15.8 Hz), 6.28 (dd, 1 H, J = 8.3, 15.8 Hz), 4.75 (br, 1 H), 
4.02-3.95 (m, 2 H), 3.80-3.75 (m, 2 H), 3.65 (br, 1 H), 2.45 (q, 1 H, J = 7.1 Hz), 1.98-1.88 (m, 3 
H), 1.80-1.73 (m, 2 H), 1.54-1.45 (m, 2 H), 1.23 (t, 1 H, J = 11.6 Hz), 1.13 (d, 3 H, J = 6.2 Hz), 
1.10 (s, 3 H), 1.07-1.03 (m, 1 H), 1.05 (d, 3 H, J = 6.8 Hz), 0.95 (d, 3 H, J = 6.5 Hz), 0.95 (s, 3 
H). 
R = 4-chlorophenyl; (2R,3R,5S,7R,9S)-Phosphoric acid mono-[2-((3S,4R,5R,6R)-8-(4-
chlorophenyl)-3,5-dihydroxy-4,6-dimethyloct-7-enyl)-9-hydroxy-4,4,7-trimethyl-1,6-
dioxaspiro[4.5]dec-3-yl] ester (133b): 1H NMR (600 MHz, CD3OD) δ 7.36 (d, 2 H, J = 8.5 Hz), 
7.26 (d, 2 H, J = 8.5 Hz), 6.41 (d, 1 H, J = 15.9 Hz), 6.29 (dd, 1 H, J = 8.3, 15.9 Hz), 4.76 (br, 1 
H), 4.05-3.95 (m, 2 H), 3.78-3.74 (m, 2 H), 3.68-3.63 (m, 1 H), 2.45 (q, 1 H, J = 7.3 Hz), 2.00-
1.88 (m, 3 H), 1.79-1.73 (m, 2 H), 1.55-1.45 (m, 2 H), 1.23 (t, 1 H, J = 11.5 Hz), 1.13 (d, 3 H, J 
= 6.2 Hz), 1.09 (s, 3 H), 1.08-1.02 (m, 1 H), 1.04 (d, 3 H, J = 6.8 Hz), 0.96-0.94 (m, 6 H). 
R = 4-methoxyphenyl; (2R,3R,5S,7R,9S)-Phosphoric acid mono-[2-((3S,4R,5R,6R)-3,5-
dihydroxy-4,6-dimethyloct-7-enyl)-9-hydroxy-8-(4-methoxyphenyl)-4,4,7-trimethyl-1,6-
dioxaspiro[4.5]dec-3-yl] ester (133c): 1H NMR (600 MHz, CD3OD) δ 7.30 (d, 2 H, J = 8.7 Hz), 
6.83 (d, 2 H, J = 8.6 Hz), 6.37 (d, 1 H, J = 15.6 Hz), 6.11 (dd, 1 H, J = 8.1, 15.6 Hz), 4.75 (br, 1 
H), 4.02-3.94 (m, 2 H), 3.80-3.72 (m, 3 H), 3.76 (s, 3 H), 2.41 (q, 1 H, J = 7.2 Hz), 1.97-1.87 (m, 
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 3 H), 1.80-1.74 (m, 2 H), 1.56-1.46 (m, 2 H), 1.23 (t, 1 H, J = 11.5 Hz), 1.13 (d, 3 H, J = 6.2 Hz), 
1.10 (s, 3 H), 1.06-1.03 (m, 4 H), 0.97-0.94 (m, 6 H). 
R = cyclohexyl; (2R,3R,5S,7R,9S)-Phosphoric acid mono-[2-((3S,4R,5R,6R)-8-cyclohexyl-
3,5-dihydroxy-4,6-dimethyloct-7-enyl)-9-hydroxy-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-
yl] ester (133d): 1H NMR (600 MHz, CD3OD) δ 5.49-5.37 (m, 2 H), 4.76 (dd, 1 H, J = 7.7, 9.8 
Hz), 4.00-3.95 (m, 2 H), 3.78-3.75 (m, 1 H), 3.65-3.58 (m, 2 H), 2.18 (q, 1 H, J = 6.2 Hz), 1.95-
1.87 (m, 4 H), 1.77-1.63 (m, 6 H), 1.55-1.44 (m, 2 H), 1.32-1.15 (m, 5 H), 1.13 (d, 3 H, J = 6.2 
Hz), 1.09 (s, 3 H), 1.07-1.01 (m, 3 H), 0.95-0.90 (m, 9 H). 
R = butyl; (2R,3R,5S,7R,9S)-Phosphoric acid mono-[2-((3S,4R,5R,6R)-3,5-dihydroxy-4,6-
dimethyldodec-7-enyl)-9-hydroxy-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl] ester (133e): 
1H NMR (600 MHz, CD3OD) δ 5.49-5.40 (m, 2 H), 4.76 (dd, 1 H, J = 7.3, 9.3 Hz), 4.00-3.95 (m, 
2 H), 3.80-3.74 (m, 1 H), 3.64-3.58 (m, 2 H), 2.21 (q, 1 H, J = 7.5 Hz), 2.04-1.98 (m, 2 H), 1.93-
1.88 (m, 3 H), 1.80-1.73 (m, 1 H), 1.71-1.66 (m, 1 H), 1.51-1.44 (m, 1 H), 1.41-1.28 (m, 5 H), 
1.23 (t, 1 H, J = 12.0 Hz), 1.13 (d, 3 H, J = 6.3 Hz), 1.09 (s, 3 H), 1.05 (q, 1 H, J = 12.0 Hz), 0.95 
(s, 3 H), 0.93-0.88 (m, 9 H). 
R = octyl; (2R,3R,5S,7R,9S)-Phosphoric acid mono-[2-((3S,4R,5R,6R)-3,5-dihydroxy-4,6-
dimethylhexadec-7-enyl)-9-hydroxy-4,4,7-trimethyl-1,6-dioxaspiro[4.5]dec-3-yl] ester 
(133f): 1H NMR (600 MHz, CD3OD) δ 5.49-5.40 (m, 2 H), 4.75 (br, 1 H), 4.00-3.95 (m, 2 H), 
3.79-3.75 (m, 1 H), 3.67-3.59 (m, 2 H), 2.21 (q, 1 H, J = 7.2 Hz), 2.09-1.96 (m, 2 H), 1.95-1.87 
(m, 3 H), 1.82-1.71 (m, 1 H), 1.70-1.65 (m, 1 H), 1.54-1.45 (m, 1 H), 1.39-1.28 (m, 13 H), 1.23 
(t, 1 H, J = 11.8 Hz), 1.13 (d, 3 H, J = 6.2 Hz), 1.09 (s, 3 H), 1.04 (q, 1 H, J = 11.8 Hz), 0.96-
0.87 (m, 12 H). 
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(5R,6R)-5-((Benzyloxy)methoxy)tetrahydro-6-(2-((2R,4R,6R)-tetrahydro-4-hydroxy-6-
methyl-2H-pyran-2-yl)propan-2-yl)pyran-2-one (134). To a solution of 119 (65 mg, 0. 17 
mmol) in THF (6.5 mL) was added L-Selectride (1 M in THF, 0.17 mL, 0.17 mmol) at –78 ºC, 
and the mixture was stirred for 1 h at –78 ºC. The reaction mixture was quenched with saturated 
aqueous NH4Cl and warmed up to room temperature. The aqueous layer was extracted with 
EtOAc (3x25 mL). The combined organic layers were dried (MgSO4) and concentrated. The 
residue was purified by chromatography on SiO2 (CH2Cl2/EtOAc, 20:1-10:1) to give the major 
product 134 (29 mg, 0.074 mmol, 44%) and the minor product 120 (16 mg, 0.046mmol, 27%) as 
colorless oils. 134: [α]D –8.9 (c 0.45, CHCl3); IR (neat) 3451, 2965, 2931, 2879, 1720, 1454, 
1365, 1250, 1025 cm-1; 1H NMR δ 7.38-7.29 (m, 5 H), 4.89, 4.83 (AB, 2 H, J = 7.2 Hz), 4.73, 
4.66 (AB, 2 H, J = 12.0 Hz), 4.35 (d, 1 H, J = 1.2 Hz), 4.30-4.24 (m, 2 H), 3.89-3.83 (m, 1 H), 
3.80 (dd, 1 H, J = 4.0, 9.7 Hz), 2.68 (ddd, 1 H, J = 7.5, 10.8, 18.2 Hz), 2.57 (ddd, 1 H, J = 3.1, 
7.9, 18.1 Hz), 2.32-2.23 (m, 1 H), 1.95-1.84 (m, 1 H), 1.68-1.58 (m, 3 H), 1.56-1.47 (m, 1 H), 
1.42 (ddd, 1 H, J = 2.8, 11.4, 14.0), 1.09 (d, 3 H, J = 6.5 Hz), 1.08 (s, 3 H), 1.05 (s, 3 H); 13C 
NMR δ 171.7, 137.7, 128.7, 128.1, 127.9, 93.5, 85.7, 76.2, 70.9, 69.2, 68.2, 65.1, 40.8, 40.4, 
32.5, 25.8, 25.0, 22.1, 20.5, 19.9; MS (ESI) m/z (relative intensity) 415 ([M+Na]+, 100), 381 
(20), 353 (11), 279 (6); HRMS (ESI) m/z calculated for C22H32O6Na (M+Na) 415.2097, found 
415.2117. 
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 (5R,6R)-5-((Benzyloxy)methoxy)tetrahydro-6-(2-((2R,4R,6R)-tetrahydro-6-methyl-4-(tert-
butyldimethylsilanyloxy)-2H-pyran-2-yl)propan-2-yl)pyran-2-one (135). To a solution of 
134 (29 mg, 0.074 mmol) and imidazole (40 mg, 0.59 mmol) in DMF (1 mL) was added TBSCl 
(40 mg, 0.27 mmol). The mixture was stirred overnight and water was added. The aqueous layer 
was extracted with EtOAc (3x25 mL). The combined organic layers were dried (MgSO4) and 
concentrated. The residue was purified by chromatography on SiO2 (hexane/EtOAc, 10:1) to 
give 135 (27 mg, 0.53 mmol, 72%) as a colorless oil: [α]D +26 (c 0.76, CHCl3); IR (neat) 2950, 
2929, 2856, 1740, 1471, 1361, 1249, 1099, 1036, 836 cm-1; 1H NMR δ 7.39-7.28 (m, 5 H), 4.86 
(s, 2 H), 4.72, 4.59 (AB, 2 H, J = 11.9 Hz), 4.33 (br. s, 1 H), 4.23-4.20 (m, 1 H), 4.18-4.16 (m, 1 
H), 3.89-3.78 (m, 1 H), 3.73 (dd, 1 H, J = 3.5, 9.5 Hz), 2.72 (ddd, 1 H, J = 7.7, 10.8, 18.3 Hz), 
2.57 (ddd, 1 H, J = 2.9, 7.8, 18.1 Hz),  2.34-2.24 (m, 1 H), 1.97-1.85 (m, 1 H), 1.59-1.49 (m, 3 
H), 1.34 (ddd, 1 H, J = 2.4, 11.3, 13.5 Hz), 1.08 (d, 3 H, J = 6.3 Hz), 1.05 (s, 3 H), 1.00 (s, 3 H), 
0.88 (s, 9 H), 0.03 (s, 6 H); 13C NMR δ 171.8, 137.6, 128.8, 128.1, 128.0, 95.0, 85.8, 71.2, 70.7, 
68.5, 65.5, 41.3, 40.7, 33.2, 26.1 (2C), 26.0, 22.2, 20.5, 19.9, 18.2, –4.7 (DEPT shows that one 
peak is overlapped with solvent); MS (ESI) m/z (relative intensity) 1036 ([2M+Na]+, 8), 529 
(100); HRMS (ESI) m/z calculated for C28H46O6NaSi (M+Na) 529.2961, found 529.2972. 
O
OO
O OTBS 
(2R,3R,5S,7R,9R)-9-(tert-Butyldimethylsilanyloxy)-(hexahydrofuro[3,2-b]pyran-5-onyl)-
4,4,7-trimethyl-1,6-dioxaspiro[4.5]decane (136). To a solution of 135 (39 mg, 0.077 mmol) in 
THF (5 mL) was added Pd(OH)2/C (20 wt%, 10 mg). The mixture was stirred under H2 gas for 5 
h and filtered through celite pad. The filtrate was concentrated and dried in vacuo. The alcohol 
was used without further purification. To a solution of the crude alcohol (35 mg) in cyclohexane 
120 
 (8 mL) were added iodobenzene diacetate (74 mg, 0.23 mmol) and I2 (59 mg, 0.23 mmol). The 
reaction mixture was stirred for 3 h at room temperature under irradiation by light (250 W), 
quenched with saturated aqueous Na2S2O3, and stirred for 30 min. The aqueous layer was 
extracted with EtOAc (3×25 mL). The combined organic layers were dried (MgSO4) and 
concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl ether, 10:1-
4:1) to give the major product 136 (17 mg, 0.044 mmol, 57% over 2 steps) as a waxy solid and 
the minor product 137 (5.0 mg, 0.013mmol, 17% over 2 steps) as a colorless oil. 136: [α]D +38 
(c 1.0, CHCl3); IR (neat) 2954, 2928, 2855, 1751, 1472, 1379, 1250, 1151, 1111, 1054, 996, 837 
cm-1; 1H NMR (acetone-d6) δ 4.67 (d, 1 H, J = 7.6 Hz), 4.32 (dd, 1 H, J = 5.8, 7.4 Hz), 4.29-4.21 
(m, 2 H), 2.44 (ddd, 1 H, J = 4.6, 7.8, 16.8 Hz), 2.34 (ddd, 1 H, J = 4.3, 9.1, 16.8 Hz), 2.14-2.07 
(m, 1 H), 1.87-1.75 (m, 1 H), 1.67-1.65 (m, 2 H), 1.62-1.54 (m, 1 H), 1.37 (ddd, 1 H, J = 2.8, 
11.2, 13.8 Hz), 1.08 (d, 3 H, J = 6.2 Hz), 1.07 (s, 3 H), 0.90 (s, 9 H), 0.85 (s, 3 H), 0.07 (s, 3 H), 
0.04 (s, 3 H); 13C NMR (150 MHz) δ 172.5, 107.3, 88.4, 69.3, 64.6, 61.1, 50.7, 40.4, 33.8, 27.2, 
25.9, 24.0, 21.6, 21.4, 18.9, 18.2, –4.5, –4.6; MS (ESI) m/z (relative intensity) 792 ([2M+Na]+, 
25), 407 (95); HRMS (ESI) m/z calculated for C20H36O5NaSi (M+Na) 407.2230, found 
407.2251. 
O
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(2R,3R,5R,7R,9R)-9-(tert-Butyldimethylsilanyloxy)-(hexahydrofuro[3,2-b]pyran-5-onyl)-
4,4,7-trimethyl-1,6-dioxaspiro[4.5]decane (137): [α]D –13 (c 0.50, CHCl3); IR (neat) 2950, 
2928, 2853, 1738, 1384, 1257, 1173, 1105, 1061, 1038, 958 cm-1; 1H NMR δ 4.49-4.45 (m, 1 H), 
4.34 (d, 1 H, J = 5.2 Hz), 4.29-4.18 (m, 1 H), 4.06-3.96 (m, 1 H), 2.82 (ddd, 1 H, J = 5.7, 13.1, 
17.8 Hz), 2.38 (dt, 1 H, J = 3.8, 17.3 Hz), 2.15-2.06 (m, 1 H), 1.98-1.80 (m, 3 H), 1.69 (dd, 1 H, 
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 J = 8.8, 13.5 Hz), 1.52-1.47 (m, 1 H), 1.19 (s, 3 H), 1.15 (d, 3 H, J = 6.3 Hz), 1.01 (s, 3 H), 0.90 
(s, 9 H), 0.08 (s, 6 H); 13C NMR (125 MHz) δ 171.2, 110.0, 89.2, 71.6, 67.3, 63.5, 50.8, 41.0, 
35.7, 26.1, 25.8, 23.9, 23.6, 21.7, 18.3, 17.5, -4.4; MS (ESI) m/z (relative intensity) 792 
([2M+Na]+, 5), 407 (48); HRMS (ESI) m/z calculated for C20H36O5NaSi (M+Na) 407.2230, 
found 407.2236. 
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(R)-2-(2-((2R,3R)-3-((Benzyloxy)methoxy)tetrahydro-6-oxo-2H-pyran-2-yl)propan-2-yl)-
2,3-dihydropyran-4-one (139). To a solution of 98 (1.80 g, 3.98 mmol) and the diene 138 (2.27 
g, 9.94 mmol) in toluene (30 mL) was added BF3•OEt2 (0.76 mL, 6.0 mmol) at –78 ºC dropwise. 
The reaction mixture was stirred for 3 h at –78 ºC, quenched with saturated aqueous NaHCO3, 
warmed up to room temperature, and extracted with CH2Cl2 (3x50 mL). The combined organic 
layers were dried (MgSO4) and concentrated. To a solution of crude 143 in CH2Cl2 (80 mL) was 
added TFA (4 mL) at 0 ºC dropwise. The reaction mixture was stirred for 2 h at room 
temperature, quenched with saturated aqueous NaHCO3, and extracted with CH2Cl2 (3x50 mL). 
The combined organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography on SiO2 (CH2Cl2/EtOAc, 10:1-4:1) to give 139 (450 mg, 1.20 mmol, 30%) as a 
yellow oil: [α]D –55 (c 0.50, CHCl3); IR (neat) 2925, 1736, 1676, 1596, 1454, 1406, 1368, 1234, 
1108, 1025 cm-1; 1H NMR δ 7.39-7.27 (m, 6 H), 5.42 (d, 1 H, J = 5.9 Hz), 4.87, 4.80 (AB, 2 H, J 
= 7.1 Hz), 4.64 (s, 2 H), 4.47 (dd, 1 H, J = 2.8, 15.0 Hz), 4.29 (br. s, 1 H), 4.25 (br. s, 1 H), 2.78-
2.49 (m, 4 H), 2.35-2.27 (m, 1 H), 1.96-1.84 (m, 1 H), 1.23 (s, 3 H), 1.15 (s, 3 H); 13C NMR δ 
192.9, 170.3, 162.9, 137.2, 128.8, 128.3, 127.8, 107.6, 93.3, 84.6, 84.3, 71.2, 68.8, 41.1, 37.8, 
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 25.6, 24.7, 20.5, 19.6; MS (ESI) m/z (relative intensity) 772 ([2M+Na]+, 38), 397 (100); HRMS 
(ESI) m/z calculated for C21H26O6Na (M+Na) 397.1627, found 397.1646. 
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(5R,6R)-5-((Benzyloxy)methoxy)-6-(2-((2R,6S)-6-butyltetrahydro-4-oxo-2H-pyran-2-
yl)propan-2-yl)tetrahydropyran-2-one (140). To a suspension of CuI (84 mg, 0.44 mmol) in 
THF (4 mL) was added n-BuLi (1.6 M in hexane, 0.55 mL, 0.88 mmol) at 0 ºC dropwise. After 
stirring for 5 min, the mixture was cooled to –78 ºC. A solution of 139 (110 mg, 0.294 mmol) in 
THF (1 mL) was added to this solution at –78 ºC dropwise. After an additional 30 min at –78 ºC, 
the mixture was quenched with saturated aqueous NH4Cl and warmed up to room temperature. 
The mixture was filtered through celite pad and washed with EtOAc. The organic filtrate was 
washed with brine, dried (MgSO4), and concentrated. The residue was purified by 
chromatography on SiO2 (CH2Cl2/EtOAc, 20:1) to give 140 (66 mg, 0.15 mmol, 51%) as a 
colorless oil: [α]D –7.4 (c 0.53, CHCl3); IR (neat) 2960, 2929, 2872, 2853, 1732, 1454, 1365, 
1260, 1024, 801 cm-1; 1H NMR (acetone-d6) δ 7.40-7.25 (m, 5 H), 4.87, 4.79 (AB, 2 H, J = 7.2 
Hz), 4.65 (s, 2 H), 4.40 (d, 1 H, J = 1.0 Hz), 4.29-4.24 (m, 1 H), 4.23-4.19 (m, 1 H), 3.85 (dd, 1 
H, J = 2.9, 11.8 Hz), 2.75-2.53 (m, 3 H), 2.46-2.39 (m, 1 H), 2.34-2.27 (m, 1 H), 2.22 (ddd, 1 H, 
J = 1.3, 3.8, 14.7 Hz), 1.97-1.85 (m, 1 H), 1.62-1.53 (m, 1 H), 1.43-1.23 (m, 6 H), 1.16 (s, 3 H), 
1.09 (s, 3 H), 0.89 (t, 3 H, J = 6.6 Hz); 13C NMR δ 208.4, 170.9, 137.3, 128.8, 128.2, 127.8, 
93.3, 84.3, 75.3, 73.9, 71.0, 69.1, 45.8, 43.0, 41.5, 32.8, 28.1, 25.6, 24.7, 22.5, 20.6, 20.0, 14.2; 
MS (ESI) m/z (relative intensity) 455 ([M+Na]+, 100), 403 (4), 399 (7); HRMS (ESI) m/z 
calculated for C25H36O6Na (M+Na) 455.2410, found 455.2425. 
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(5R,6R)-5-((Benzyloxy)methoxy)-6-(2-((2R,4S,6S)-6-butyltetrahydro-4-hydroxy-2H-pyran-
2-yl)propan-2-yl)tetrahydropyran-2-one (141). To a solution of 140 (65 mg, 0.15 mmol) in 
THF (6 mL) was added NaBH4 (11 mg, 0.30 mmol) at 0 ºC. The mixture was stirred for 7 h at 
room temperature, treated with saturated aqueous NH4Cl, and extracted with CH2Cl2 (3x20 mL). 
The combined organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography on SiO2 (CH2Cl2/EtOAc, 10:1-4:1) to give a 1:1 mixture of two separable 
diastereomers 141 and 158 (40 mg, 0.092 mmol, 81% based on recovered starting material) 
along with recovered 140 (16 mg, 0.037 mmol, 25 %) as a colorless oil. 
The alcohol 141 was also prepared by following procedure: to a solution of 146 (110 mg, 0.189 
mmol) in THF (5 mL) was added HF•pyridine (0.5 mL) at 0 ºC. The mixture was stirred at room 
temperature for 36 h and diluted with ethyl ether. The organic layer was washed with saturated 
aqueous NaHCO3. The aqueous layer was extracted with EtOAc (3x30 mL). The combined 
organic layers were washed with saturated aqueous NH4Cl, dried (MgSO4), and concentrated. 
The residue was purified by chromatography on SiO2 (CH2Cl2/EtOAc, 4:1) to give the desired 
lactone 141 (82 mg, 0.19 mmol, 100%) as a colorless oil: [α]D –32 (c 1.0, CHCl3); IR (neat) 
3391, 2930, 2868, 1736, 1454, 1366, 1249, 1024 cm-1; 1H NMR δ 7.40-7.29 (m, 5 H), 4.87, 4.79 
(AB, 2 H, J = 7.2 Hz), 4.65 (s, 2 H), 4.31 (br. s, 1 H), 4.27 (br. s, 1 H), 4.01-3.93 (m, 1 H), 3.72 
(dt, 1 H, J = 4.5, 11.0 Hz), 3.48 (dd, 1 H, J = 1.6, 11.7 Hz), 2.68 (ddd, 1 H, J = 7.7, 10.5, 18.1 
Hz), 2.57 (ddd, 1 H, J = 3.3, 8.3, 18.4 Hz), 2.29-2.20 (m, 1 H), 1.98-1.86 (m, 2 H), 1.85-1.79 (m 
,1 H), 1.68-1.47 (m, 2 H), 1.41-1.21 (m, 6 H), 1.12 (s, 3 H), 1.07 (s, 3 H), 0.90 (t, 3 H, J = 6.5 
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 Hz); 13C NMR (acetone-d6) δ 171.2, 139.5, 129.6, 128.8, 128.7, 94.4, 85.3, 74.8, 74.0, 71.6, 
70.0, 65.1, 42.0, 39.9, 37.2, 32.1, 26.6, 25.6, 23.6, 21.3, 20.5, 14.8 (DEPT shows that one peak is 
inside solvent); MS (ESI) m/z (relative intensity) 457 ([M+Na]+, 100), 413 (10); HRMS (ESI) 
m/z calculated for C25H38O6Na (M+Na) 457.2566, found 457.2587.      
O
BOMO
O
OTBSO
  
(5R,6R)-5-((Benzyloxy)methoxy)-6-(2-((2R,4S,6S)-6-butyltetrahydro-4-(tert-
butyldimethylsilanyloxy)-2H-pyran-2-yl)propan-2-yl)tetrahydropyran-2-one (142). To a 
solution of 141 (20 mg, 0.046 mmol) and imidazole (50 mg, 0.73 mmol) in DMF (0.5 mL) was 
added TBSCl (50 mg, 0.33 mmol). The mixture was stirred overnight and water was added. The 
aqueous layer was extracted with EtOAc (3x20 mL). The combined organic layers were dried 
(MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(hexane/EtOAc, 10:1) to give 142 (26 mg, 0.47 mmol, 100%) as a colorless oil: [α]D –21 (c 0.99, 
CHCl3); IR (neat) 2954, 2931, 2857, 1736, 1471, 1362, 1249, 1095, 1026, 836 cm-1; 1H NMR δ 
7.37-7.31 (m, 5 H), 4.87, 4.80 (AB, 2 H, J = 7.2 Hz), 4.66 (s, 2 H), 4.30 (br. s, 1 H), 4.28 (s, 1 
H), 3.96-3.88 (m, 1 H), 3.86-3.79 (m, 1 H), 3.51 (d, 1 H, J = 10.9 Hz), 2.68 (ddd, 1 H, J = 7.8, 
10.2, 18.5 Hz), 2.57 (ddd, 1 H, J = 3.1, 8.2, 18.1 Hz), 1.95-1.80 (m, 2 H), 1.76-1.53 (m, 3 H), 
1.40-1.20 (m, 6 H), 1.12 (s, 3 H), 1.06 (s, 3 H), 0.89 (br. s, 12 H), 0.06 (s, 3 H), 0.05 (s, 3 H); 13C 
NMR δ 171.2, 137.6, 128.7, 128.0, 127.6, 93.5, 84.9, 73.6, 73.4, 70.8, 69.2, 66.0, 41.1, 39.0, 
36.3, 31.1, 29.2, 26.0, 25.8, 25.0, 22.6, 20.7, 19.8, 18.3, 14.2, –4.3, –4.4; MS (ESI) m/z (relative 
intensity) 571 ([M+Na]+, 100), 555 (3), 467 (15); HRMS (ESI) m/z calculated for C31H52O6NaSi 
(M+Na) 571.3431, found 571.3444. 
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(E,4R,5R,7R)-Methyl-4-((benzyloxy)methoxy)-11-tert-butoxy-7-hydroxy-6,6-dimethyl-9-
oxo-5-(triethylsilanyloxy)undec-10-enoate (143). To a solution of 98 (0.40 g, 0.88 mmol) and 
the diene 138 (0.60 g, 2.7 mmol) in CH2Cl2 (10 mL) was added BF3•OEt2 (0.15 mL, 1.2 mmol) 
at –78 ºC dropwise. The reaction mixture was stirred for 2 h at –78 ºC, quenched with saturated 
aqueous NaHCO3, warmed up to room temperature, and extracted with CH2Cl2 (3x30 mL). The 
combined organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography on SiO2 (hexane/EtOAc, 10:1) to give 143 (0.20 g, 0.34 mmol, 39%) as a 
yellow oil: [α]D +41 (c 1.0, CHCl3); IR (neat) 3469, 2953, 2909, 2873, 1738, 1673, 1631, 1595, 
1373, 1163, 1027 cm-1; 1H NMR (acetone-d6) δ 7.79 (d, 1 H, J = 12.0 Hz), 7.34-7.25 (m, 5 H), 
5.66 (d, 1 H, J = 12.1 Hz), 4.84, 4.80 (AB, 2 H, J = 6.7 Hz), 4.68, 4.58 (AB, 2 H, J = 12.0 Hz), 
4.13 (ddd, 1 H, J = 2.1, 3.6, 9.8 Hz), 3.84-3.78 (m, 2 H), 3.58 (s, 3 H), 2.72 (dd, 1 H, J = 2.0, 
16.1 Hz), 2.56-2.33 (m, 3 H), 2.05-1.85 (m, 2 H), 1.35 (s, 9 H), 0.98 (t, 9 H, J = 8.0 Hz),  0.96 (s, 
3 H), 0.89 (s, 3 H), 0.66 (q, 6 H, J = 7.9 Hz); 13C NMR δ 193.6, 173.8, 163.4, 137.9, 128.6, 
127.9, 127.8, 107.4, 94.2, 83.2, 77.4, 76.9, 76.6, 70.2, 51.8, 42.1, 37.7, 31.6, 28.7, 28.4, 21.0, 
19.3, 7.2, 5.5; MS (ESI) m/z (relative intensity) 618 ([M+Na]+, 100), 561 (4), 544 (4); HRMS 
(ESI) m/z calculated for C32H54O8NaSi (M+Na) 617.3486, found 617.3502. 
TESO
BOMO
O
O
MeO2C
  
(4R,5R)-Methyl-4-((benzyloxy)methoxy)-6-((R)-3,4-dihydro-4-oxo-2H-pyran-2-yl)-6-
methyl-5-(triethylsilanyloxy)heptanoate (144). To a solution of 143 (122 mg, 0.205 mmol) in 
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 CH2Cl2 (5 mL) was added PPTS (26 mg, 0.11 mmol) at 0 ºC. The reaction mixture was stirred 
for 6 h at room temperature. The organic layer was washed with saturated aqueous NaHCO3, 
dried (MgSO4), and concentrated. The residue was purified by chromatography on SiO2 
(CH2Cl2/EtOAc, 10:1) to give the desired pyrone 144 (92 mg, 0.18 mmol, 86%) as a yellow oil: 
[α]D +48 (c 0.95, CHCl3); IR (neat) 2953, 2911, 2877, 1739, 1679, 1597, 1456, 1404, 1276, 1040 
cm-1; 1H NMR δ 7.38-7.26 (m, 6 H), 5.39 (d, 1 H, J = 5.9 Hz), 4.79, 4.71 (AB, 2 H, J = 6.9 Hz), 
4.69, 4.54 (AB, 2 H, J = 12.1 Hz), 4.60 (dd, 1 H, J = 3.1, 15.0 Hz), 3.80-3.75 (m, 2 H), 3.63 (s, 3 
H), 2.65-2.34 (m, 4 H), 2.00-1.81 (m, 2 H), 1.07 (s, 3 H), 0.98 (t, 9 H, J = 8.0 Hz),  0.96 (s, 3 H), 
0.63 (q, 6 H, J = 7.8 Hz); 13C NMR δ 193.4, 173.8, 163.3, 138.0, 128.6, 127.85, 127.78, 107.4, 
94.3, 83.3, 77.1, 76.7, 70.2, 51.7, 42.2, 37.8, 31.6, 28.7, 21.0, 19.4, 7.2, 5.6; MS (ESI) m/z 
(relative intensity) 543 ([M+Na]+, 100), 479 (4), 339 (9); HRMS (ESI) m/z calculated for 
C28H44O7NaSi (M+Na) 543.2754, found 543.2778. 
TESO
BOMO
O
O
MeO2C
  
(4R,5R)-Methyl-4-((benzyloxy)methoxy)-6-((2R,6S)-6-butyl-tetrahydro-4-oxo-2H-pyran-2-
yl)-6-methyl-5-(triethylsilanyloxy)heptanoate (145). To a suspension of CuI (146 mg, 0.767 
mmol) in THF (8 mL) was added n-BuLi (1.42 M in hexane, 1.08 mL, 1.53 mmol) at 0 ºC 
dropwise. After stirring for 5 min, the mixture was cooled to –78 ºC. A solution of 144 (200 mg, 
0.384 mmol) in THF (2 mL) was added to this solution at –78 ºC dropwise. After an additional 
30 min at –78 ºC, the mixture was quenched with saturated aqueous NH4Cl and warmed up to 
room temperature. The mixture was filtered through celite pad and washed with EtOAc. The 
organic filtrate was washed with brine, dried (MgSO4), and concentrated. The residue was 
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 purified by chromatography on SiO2 (hexane/EtOAc, 20:1) to give 145 (180 mg, 0.311 mmol, 
81%) as a yellow oil: [α]D +62 (c 1.0, CHCl3); IR (neat) 2955, 2930, 2876, 1736, 1716, 1457, 
1363, 1239, 1162, 1037, 825 cm-1; 1H NMR δ 7.35-7.26 (m, 5 H), 4.78, 4.75 (AB, 2 H, J = 7.0 
Hz), 4.70, 4.56 (AB, 2 H, J = 12.0 Hz), 4.20 (dt, 1 H, J = 4.9, 13.4 Hz), 3.96 (dd, 1 H, J = 4.3, 
10.2 Hz), 3. 75 (qn, 1 H, J = 4.3 Hz), 3.63 (s, 3 H), 3.626 (d, 1 H, J = 3.8 Hz), 2.57 (dd, 1 H, J = 
5.9, 15.0 Hz), 2.52-2.35 (m, 3 H), 2.26 (dd, 1 H, J = 4.6, 15.0 Hz), 1.97-1.83 (m, 2 H), 1.62-1.51 
(m, 1 H), 1.40-1.24 (m, 6 H), 1.03 (s, 3 H), 0.98 (t, 9 H, J = 8.0 Hz), 0.92 (s, 3 H), 0.89 (t, 3 H, J 
= 6.7 Hz), 0.64 (q, 6 H, J = 8.0 Hz); 13C NMR δ 209.1, 173.9, 138.1, 128.5, 127.8, 94.7, 77.5, 
76.5, 73.9, 73.3, 70.2, 51.6, 46.0, 42.8, 42.5, 33.4, 31.4, 29.5, 28.0, 22.6, 20.5, 18.8, 14.1, 7.2, 
5.7; MS (ESI) m/z (relative intensity) 601 ([M+Na]+, 100), 598 (10); HRMS (ESI) m/z calculated 
for C32H54O7NaSi (M+Na) 601.3537, found 601.3558. 
TESO
BOMO
O
MeO2C
OH
  
(4R,5R)-Methyl-4-((benzyloxy)methoxy)-6-((2R,4S,6S)-6-butyl-tetrahydro-4-hydroxy-2H-
pyran-2-yl)-6-methyl-5-(triethylsilanyloxy)heptanoate (146). To a solution of 145 (175 mg, 
0.302 mmol) and CeCl3•7H2O (113 mg, 0.302 mmol) in MeOH (10 mL) was added NaBH4 (12.3 
mg, 0.332 mmol) at –78 ºC and the mixture was stirred for 30 min at –78 ºC. The reaction 
mixture was quenched with saturated aqueous NH4Cl and warmed up to room temperature. The 
organic layer was extracted with CH2Cl2 (3x25 mL). The combined organic layers were dried 
(MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(CH2Cl2/EtOAc, 10:1-4:1) to give a 3.7:1 mixture of two separable diastereomers 146 and 158 
(125 mg, 0.215 mmol, 90% based on recovered starting material) with the recovered 145 (34 mg, 
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 0.059 mmol, 19%) as a colorless oil: [α]D +30 (c 1.5, CHCl3); IR (neat) 3453, 2953, 2873, 1741, 
1455, 1364, 1240, 1148, 1120, 1037, 828 cm-1; 1H NMR δ 7.36-7.29 (m, 5 H), 4.79 (s, 2 H), 
4.70, 4.59 (AB, 2 H, J = 12.0 Hz), 4.01-3.94 (m, 1 H), 3.87 (tt, 1 H, J = 4.4, 10.9 Hz), 3. 74 (dt, 1 
H, J = 4.6, 6.3 Hz), 3.65 (s, 3 H), 3.60 (d, 1 H, J = 4.4 Hz), 3.50 (dd, 1 H, J = 1.3, 11.4 Hz), 2.53 
(dt, 1 H, J = 7.5, 16.3 Hz), 2.40 (dt, 1 H, J = 7.7, 16.3 Hz), 1.94-1.80 (m, 4 H), 1.69-1.61 (m, 1 
H), 1.51 (dt, 1 H, J = 6.0, 12.0 Hz), 1.43-1.22 (m, 6 H), 1.18 (q, 1 H, J = 11.3 Hz), 0.99 (t, 9 H, J 
= 8.1 Hz), 0.99 (s, 3 H), 0.90 (s, 3 H), 0.89 (t, 3 H, J = 6.6 Hz), 0.65 (q, 6 H, J = 7.7 Hz); 13C 
NMR δ 174.0, 138.3, 128.5, 127.8, 127.7, 94.9, 77.7, 76.7, 73.2, 72.2, 70.2, 65.5, 51.6, 42.2, 
38.5, 36.3, 31.5, 31.3, 29.7, 28.7, 22.7, 20.7, 19.0, 14.2, 7.3, 5.8; MS (ESI) m/z (relative 
intensity) 604 ([M+Na]+, 100), 541 (10), 463 (5); HRMS (ESI) m/z calculated for C32H56O7NaSi 
(M+Na) 603.3693, found 603.3710 
O
OTBS
OO
O
   
(2R,3R,5S,7S,9S)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-(hexahydrofuro[3,2-b]pyran-5-
onyl)-4,4-dimethyl-1,6-dioxaspiro[4.5]decane (147). To a solution of 142 (105 mg, 0.191 
mmol) in THF (10 mL) was added Pd(OH)2/C (20 wt %, 20 mg). The mixture was stirred under 
H2 gas for 3 h and then filtered through celite pad. The filtrate was concentrated and dried in 
vacuo. The alcohol was used without further purification. To a solution of crude alcohol (86 mg) 
in cyclohexane (15 mL) were added iodobenzene diacetate (203 mg, 0.630 mmol) and I2 (163 
mg, 0.630 mmol). The reaction mixture was stirred for 3 h at room temperature under irradiation 
by light (250 W), quenched with saturated aqueous Na2S2O3, and stirred for 30 min. The aqueous 
layer was extracted with EtOAc (2×30 mL). The combined organic layers were dried (MgSO4) 
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 and concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl ether, 
10:1-4:1) to give the major product 147 (51 mg, 0.12 mmol, 63%) as a white solid and the minor 
product 148 (20 mg, 0.047mmol, 25%) as a colorless oil. 147: Mp 57-59 °C; [α]D +25 (c 1.0, 
CHCl3); IR (neat) 2955, 2930, 2857, 1754, 1469, 1383, 1251, 1158, 1050, 836, 776 cm-1; 1H 
NMR δ 4.71 (d, 1 H, J = 7.5 Hz), 4.36 (dt, 1 H, J = 5.9, 7.6 Hz), 4.19 (tt, 1 H, J = 5.0, 9.5 Hz), 
3.99-3.91 (m, 1 H), 2.57 (ddd, 1 H, J = 4.1, 7.6, 16.9 Hz), 2.31 (ddd, 1 H, J = 4.2, 10.0, 16.9 Hz), 
2.15-2.05 (m, 1 H), 1.97-1.81 (m, 3 H), 1.70-1.52 (m, 3 H), 1.47 (dd, 1 H, J = 10.1, 13.0 Hz), 
1.38-1.24 (m, 4 H), 1.12 (s, 3 H), 0.94 (s, 3 H), 0.92-0.89 (m, 12 H), 0.09 (s, 6 H); 13C NMR δ 
172.0, 109.8, 87.9, 73.8, 70.0, 62.6, 50.7, 38.0, 37.7, 34.9, 29.3, 27.2, 26.1, 24.3, 22.9, 21.6, 19.0, 
18.3, 14.3, –4.4; MS (EI) m/z (relative intensity) 369 ([M-C4H9]+, 15), 276 (10), 208 (23), 140 
(27), 75 (100); HRMS (EI) m/z calculated for C19H33O5Si (M-C4H9) 369.2097, found 369.2101. 
O
OTBS
OO
O  
(2R,3R,5R,7S,9S)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-(hexahydrofuro[3,2-b]pyran-5-
onyl)-4,4-dimethyl-1,6-dioxaspiro[4.5]decane (148): [α]D –75 (c 1.4, CHCl3); IR (neat) 2955, 
2927, 2858, 1743, 1470, 1383, 1248, 1173, 1112, 1070, 836 cm-1; 1H NMR δ 4.51 (dd, 1 H, J = 
3.6, 8.2 Hz), 4.30 (d, 1 H, J = 5.2 Hz), 4.24-4.12 (m, 2 H), 2.54-2.35 (m, 2 H), 2.14-2.03 (m, 1 
H), 1.97-1.85 (m, 1 H), 1.67-1.51 (m, 2 H), 1.48-1.17 (m, 8 H), 1.11 (s, 3 H), 0.96 (s, 3 H), 0.90 
(s, 9 H), 0.89 (t, 3 H, J = 7.4 Hz), 0.04 (s, 3 H), 0.03 (s, 3 H); 13C NMR δ 171.1, 108.0, 88.6, 
71.8, 65.0, 64.3, 51.4, 37.4, 35.2, 34.8, 27.0, 25.9, 25.5, 24.2, 23.2, 23.0, 18.2, 17.3, 14.3, –4.5, –
4.6; MS (ESI) m/z (relative intensity) 449 ([M+Na]+, 100), 403 (5), 365 (28), 317 (14); HRMS 
(ESI) m/z calculated for C23H42O5NaSi (M+Na) 449.2699, found 449.2721. 
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(2R,3R,5R,7S,9S)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-2-((3S,4R)-3-hydroxy-4-
methylhex-5-enyl)-4,4-dimethyl-1,6-dioxaspiro[4.5]decan-3-ol (149). To a solution of 148 (54 
mg, 0.13 mmol) in CH2Cl2 (10 mL) was added DIBAL (1.0 M in hexane, 0.17 mL, 0.17 mmol) 
at –78 ºC and the mixture was stirred for 2 h at –78 ºC. The reaction mixture was quenched with 
MeOH/EtOAc (1 mL/1 mL), allowed to warm to room temperature, and treated with 5 mL of 
saturated aqueous Rochelle salt. After stirred for 5 h at room temperature, the aqueous layer was 
extracted with CH2Cl2 (3x20 mL). The combined organic layers were dried (MgSO4) and 
concentrated to give a crude aldehyde. Without further purification, this aldehyde was used for 
the next step. To a well-stirred mixture of trans-2-butene (0.2 mL) and KOt-Bu (112 mg, 1.00 
mmol) in THF (1 mL), n-BuLi (1.6 M in hexane, 0.63 mL, 1.0 mmol) was added at –78 ºC. 
Following completion of addition, the mixture was stirred at –45 ºC for 15 min and again cooled 
to –78 ºC. To the mixture, a solution of B-methoxylbis(2-isocaranyl)borane (380 mg, 1.20 mmol) 
in ethyl ether (0.5 mL) was added dropwise and the resulting mixture was stirred for 30 min at –
78 ºC. The addition of BF3•etherate (0.16 mL, 1.3 mmol) and stirring the mixture at –78 ºC for 
15 min afforded B-[E]-crotyl(2-isocaranyl)borane. A solution of crude aldehyde (52 mg) in ethyl 
ether (1 mL) was added at –78 ºC and the mixture was stirred for 3 h at –78 ºC. MeOH (0.16 
mL) was added, the mixture was brought to room temperature and oxidized with alkaline 
hydrogen peroxide (30% H2O2 (0.8 mL) and 3N NaOH (0.4 mL)) at reflux for 3 h. The aqueous 
layer was extracted with EtOAc (3x25 mL). The combined organic layers were dried (MgSO4) 
and concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl ether, 
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 10:1-4:1) to give 149 (48 mg, 0.099 mmol, 78%) as a colorless oil: [α]D –27 (c 1.0, CHCl3); IR 
(neat) 3507, 2955, 2928, 2853, 1463, 1253, 1108, 1083, 998, 836, 773 cm-1; 1H NMR δ 5.83 
(ddd, 1 H, J = 8.0, 9.7, 17.8 Hz), 5.13-5.05 (m, 2 H), 4.28-4.19 (m, 1 H), 4.17-4.09 (m, 2 H), 
3.56-3.46 (m, 2 H), 3.35 (d, 1 H, J = 11.8 Hz), 2.26 (sx, 1 H, J = 6.8 Hz), 1.85-1.63 (m, 4 H), 
1.59 (d, 1 H, J = 3.1 Hz), 1.54-1.24 (m, 10 H), 1.09 (s, 3 H), 1.06 (d, 3 H, J = 6.9 Hz), 0.91 (br. s, 
15 H), 0.05 (s, 3 H), 0.04 (s, 3 H); 13C NMR δ 140.9, 115.7, 108.5, 82.3, 80.7, 75.1, 65.0, 64.7, 
50.1, 44.2, 38.8, 35.8, 34.4, 31.6, 28.1, 28.0, 26.1, 23.0, 22.7, 18.4, 17.3, 16.4, 14.1, –4.5, –4.6; 
MS (ESI) m/z (relative intensity) 507 ([M+Na]+, 100), 451 (10); HRMS (ESI) m/z calculated for 
C27H52O5NaSi (M+Na) 507.3482, found 507.3497. 
O
OTBS
O
HO
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(2R,3R,5R,7S,9S)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-2-[(3S,4R)-3-(tert-
butyldimethylsilanyloxy)-4-methylhex-5-enyl]-4,4-dimethyl-1,6-dioxaspiro[4.5]decan-3-ol 
(150). To a solution of 149 (44 mg, 0.091 mmol) and imidazole (100 mg, 1.47 mmol) in DMF 
(1.4 L) was added TBSCl (100 mg, 0.663 mmol). The mixture was stirred overnight and water 
was added. The aqueous layer was extracted with EtOAc (3x20 mL). The combined organic 
layers were dried (MgSO4) and concentrated. The residue was purified by chromatography on 
SiO2 (hexane/EtOAc, 10:1) to give 150 (49 mg, 0.082 mmol, 90%) as a colorless oil: [α]D –24 (c 
0.70, CHCl3); IR (neat) 3512, 2956, 2929, 2857, 1471, 1361, 1255, 1106, 1060, 835 cm-1; 1H 
NMR δ 5.83 (ddd, 1 H, J = 7.8, 10.4, 17.6 Hz), 5.03-4.97 (m, 2 H), 4.27-4.18 (m, 1 H), 4.16-4.12 
(m, 1 H), 4.06-4.01 (m, 1 H), 3.59-3.54 (m, 1 H), 3.50 (dd, 1 H, J = 4.5, 12.2 Hz), 3.31 (d, 1 H, J 
= 12.1 Hz), 2.33 (dt, 1 H, J = 6.9, 17.9 Hz), 1.65-1.45 (m, 7 H), 1.41-1.23 (m, 7 H), 1.08 (s, 3 H), 
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 1.01 (d, 3 H, J = 6.8 Hz), 0.91 (br. s, 24 H), 0.06 (s, 3 H), 0.05 (s, 3 H), 0.04 (s, 3 H), 0.02 (s, 3 
H); 13C NMR (CD2Cl2) δ 141.4, 114.4, 108.3, 82.6, 80.5, 76.6, 64.9, 64.5, 50.0, 43.4, 38.8, 35.9, 
34.4, 30.9, 28.2, 28.1, 26.2, 26.0, 23.1, 22.7, 18.4, 18.2, 17.3, 15.9, 14.2, –4.0, –4.3, –4.5, –4.7; 
MS (EI) m/z (relative intensity) 556 (M, 0.2), 541 (0.3), 499 (11), 367 (28), 271 (29), 237 (100), 
203 (50), 145 (55), 73 (79); MS (ESI) m/z (relative intensity) 621 ([M+Na]+, 100), 541 (22), 413 
(17); HRMS (ESI) m/z calculated for C33H66O5NaSi2 (M+Na) 621.4347, found 621.4333. 
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(2R,3R,5R,7S,9S)-Phosphoric acid 7-butyl-9-(tert-butyldimethylsilanyloxy)-2-[(3S,4R)-3-
(tert-butyldimethylsilanyloxy)-4-methylhex-5-enyl]-4,4-dimethyl-1,6-dioxaspiro[4.5]dec-3-yl 
ester bis-[2-(trimethylsilanyl)-ethyl]ester (151). PCl3 (2 M in CH2Cl2, 70 µL, 0.14 mmol) was 
added to a solution of 150 (32 mg, 0.054 mmol) in pyridine (0.6 mL) at 0 ºC in one portion. 
After 10 min, 2-trimethylsilylethanol (0.13 mL, 0.90 mmol) and DMAP (1.0 mg, 0.0082 mmol) 
were added and the mixture was warmed to room temperature over 1 h. CH2Cl2 (5.4 mL) and 
30% aqueous H2O2 (0.54 mL) were added and the stirring was continued for 1 h at room 
temperature. The reaction mixture was quenched with saturated aqueous NaHCO3. The aqueous 
layer was extracted with EtOAc (3x20 mL). The combined organic layers were dried (MgSO4) 
and concentrated. The residue was purified directly by chromatography on SiO2 (hexane/ethyl 
ether, 10:1) to give 151 (33 mg, 0.038 mmol, 70%) as a colorless oil: [α]D –22 (c 1.0, CHCl3); IR 
(neat) 2955, 2925, 2889, 2857, 1472, 1373, 1252, 998, 861 cm-1; 1H NMR (CD3CN) δ 5.83 (ddd, 
1 H, J = 7.6, 10.3, 17.5 Hz), 5.04-4.94 (m, 2 H), 4.32 (dd, 1 H, J = 5.8, 10.1 Hz), 4.18-4.04 (m, 7 
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 H), 3.58 (ddd, 1 H, J = 3.1, 4.5, 7.7 Hz), 2.32 (dt, 1 H, J = 3.3, 7.0 Hz), 1.89-1.79 (m, 1 H), 1.64-
1.46 (m, 5 H), 1.45-1.20 (m, 8 H), 1.09-1.04 (m, 4 H), 1.03 (s, 3 H), 0.99 (d, 3 H, J = 6.9 Hz), 
0.89 (s, 21 H), 0.88 (t, 3 H, J = 6.9 Hz), 0.07 (s, 3 H), 0.06 (s, 3 H), 0.02 (s, 24 H); 13C NMR 
(CD3CN) δ 142.0, 115.1, 107.7, 85.9, 85.8, 82.0, 81.9, 77.9, 66.70, 66.66, 66.62, 66.57, 65.9, 
64.9, 51.4, 51.3, 44.4, 39.3, 36.9, 35.6, 32.5, 29.8, 28.6, 26.5, 26.4, 24.0, 23.8, 20.5, 20.4, 20.3, 
20.2, 18.81, 18.77, 17.8, 16.0, 14.6, –1.3, –3.6, –4.1, –4.4, –4.6; MS (ESI) m/z (relative intensity) 
902 ([M+Na]+, 100), 786 (5), 748 (3); HRMS (ESI) m/z calculated for C43H91O8NaSi4P (M+Na) 
901.5426, found 901.5450. 
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(2R,3R,5R,7S,9S)-Phosphoric acid 7-butyl-9-(tert-butyldimethylsilanyloxy)-2- 
[(3S,4R,5S,6S)-3-(tert-butyldimethylsilanyloxy)-5-hydroxy-4,6-dimethyloct-7-enyl]-4,4-
dimethyl-1,6-dioxaspiro[4.5]dec-3-yl ester bis-[2-(trimethylsilanyl)-ethyl] ester (152). A 
stream of O3 was bubbled through a solution of 151 (20 mg, 0.023 mmol) in MeOH (8 mL) at –
78 ºC until the color of the solution turned blue. After N2 was bubbled through the solution for 15 
min, Me2S (0.50 L, 6.8 mmol) was added. The mixture was allowed to warm to room 
temperature and stirred for 6 h. The solution was concentrated. The crude aldehyde was used 
without further purification. To a suspension of Roush’s crotylation reagent (1 M in toluene, 1.0 
mL, 1.0 mmol) and 4 Å MS (60 mg) was added a solution of crude aldehyde (21 mg) in toluene 
(0.5 mL) at –78 ºC. After stirring at –78 ºC for 5 h, the reaction mixture was filtered through 
SiO2 and washed with EtOAc and CH2Cl2. The filtrate was concentrated and the residue was 
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 purified by chromatography on SiO2 (hexane/ethyl ether, 10:1) to give 152 (10 mg, 0.011 mmol, 
48%) as a colorless oil: Mp 78-80 °C; [α]D –15 (c 1.5, CH2Cl2); IR (neat) 3428, 2955, 2928,  
2857, 1472, 1385, 1251, 1110, 1003, 835 cm-1; 1H NMR (600 MHz, acetone-d6) δ 5.98 (ddd, 1 
H, J = 8.2, 10.4, 17.4 Hz), 5.04 (dd, 1 H, J = 1.3, 17.5 Hz), 5.00 (dd, 1 H, J = 2.0, 10.4 Hz), 4.39 
(dd, 1 H, J = 5.7, 10.2 Hz), 4.24 (qn, 1 H, J = 3.0 Hz), 4.21-4.10 (m, 6 H), 3.85 (dt, 1 H, J = 4.2, 
7.3 Hz), 3.57 (dd, 1 H, J = 5.5, 9.6 Hz), 3.38 (d, 1 H, J = 4.0 Hz), 2.29 (sx, 1 H, J = 6.6 Hz), 
1.95-1.90 (m, 1 H), 1.77-1.70 (m, 2 H), 1.66-1.47 (m, 6 H), 1.60 (d, 1 H, J = 3.2 Hz), 1.40-1.28 
(m, 6 H), 1.13-1.08 (m, 4 H), 1.10 (s, 3 H), 1.02 (d, 3 H, J = 6.9 Hz), 1.00 (d, 3 H, J = 6.9 Hz), 
0.94-0.91 (m, 24 H), 0.14 (s, 3 H), 0.10 (s, 3 H), 0.07 (s, 3 H), 0.059 (s, 9 H), 0.057 (s, 9 H), 0.05 
(s, 3 H); 13C NMR (150 MHz) δ 142.8, 114.3, 106.9, 85.61, 85.57, 81.29, 81.27, 80.0, 74.1, 66.1, 
66.0, 64.9, 64.3, 50.70, 50.68, 41.7, 38.6, 36.8, 36.3, 35.1, 33.6, 28.7, 27.7, 26.2, 26.1, 23.5, 23.4, 
20.0, 19.94, 19.86, 19.8, 18.3, 18.2, 17.6, 17.3, 14.3, 11.7, –1.3, –3.9, –4.4, –4.5, –4.6; MS (ESI) 
m/z (relative intensity) 960 ([M+Na]+, 100), 844 (20), 758 (4), 563 (27); HRMS (ESI) m/z 
calculated for C46H97O9NaPSi4 (M+Na) 959.5845, found 959.5804. 
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(2R,3R,5R,7S,9S)-Phosphoric acid 7-butyl-mono-[2-((3S,4R,5S,6S)-3,5-dihydroxy-4,6-
dimethyloct-7-enyl)-9-hydroxy-4,4-dimethyl-1,6-dioxaspiro[4.5]dec-3-yl] ester (153). A 
solution of 152 (5.0 mg, 0.0053 mmol) in HF (0.5 mL, from stock solution with 48% HF (0.5 
mL), CH3CN (4.5 mL) and water (0.5 mL)) was stirred at room temperature for 8 d. N2 gas was 
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 bubbled into the reaction mixture to remove the solvent and the mixture was dried under 
vacuum, washed with hexane, and extracted with CH2Cl2. The residue was purified by 
chromatography on SiO2 (CH3CN/MeOH, 10:1-3:1) to give an inseparable mixture of the 
product 153 and side products (2.0 mg) as a colorless solid: IR (neat) 3350, 2958, 2929, 2876, 
1462, 1377, 1217, 1144, 1107, 1058, 1015, 984, 858 cm-1; 1H NMR δ 5.93-5.82 (m, 1 H), 5.08-
4.90 (m, 2 H), 4.40-4.24 (m, 1 H), 4.23-4.08 (m, 1 H), 4.06-3.89 (m, 1 H), 3.70-3.58 (m, 3 H), 
2.31-2.23 (m, 1 H), 2.03-1.81 (m, 2 H), 1.79-1.60 (m, 3 H), 1.55-1.41 (m, 3 H), 1.40-1.19 (m, 7 
H), 1.12 (s, 3 H), 1.20-0.85 (m, 12 H); MS (ESI) m/z (relative intensity) 1039 ([2M+Na]+, 30), 
531 (52), 513 (100), 495 (60), 427 (35); HRMS (ESI) m/z calculated for C24H45O9NaP (M+Na) 
531.2699, found 531.2722. 
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(2R,3R,5R,7S,9S)-Phosphoric acid 7-butyl-9-(tert-butyldimethylsilanyloxy)-2- 
[(3S,4R,5R,6R)-3-(tert-butyldimethylsilanyloxy)-5-hydroxy-4,6-dimethyloct-7-enyl]-4,4-
dimethyl-1,6-dioxaspiro[4.5]dec-3-yl ester bis-[2-(trimethylsilanyl)-ethyl] ester (154). A 
stream of O3 was bubbled through a solution of 145 (65 mg, 0.074 mmol) in MeOH (10 mL) at –
78 ºC until the color of the solution turned blue. After N2 was bubbled through the solution for 15 
min, Me2S (0.50 mL, 6.8 mmol) was added, and the mixture was allowed to warm to room 
temperature, and stirred for 7 h. The solution was concentrated in vacuo. The crude aldehyde (65 
mg) was used without further purification.  To a well-stirred mixture of trans-2-butene (0.2 mL), 
THF (1.5 mL) and KOt-Bu (74 mg, 0.66 mmol), n-BuLi (1.6 M in hexane, 0.41 mL, 0.66 mmol) 
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 was added at –78 ºC. Following completion of addition, the mixture was stirred at –45 ºC for 15 
min and again cooled to –78 ºC. To the mixture, a solution of B-methoxylbis(2-isocaranyl)borane 
(0.25 g, 0.79 mmol) in ethyl ether (0.5 mL) was added dropwise and the resulting mixture was 
stirred for 0.5 h at –78 ºC. The addition of BF3•etherate (0.11 mL, 0.86 mmol) and stirring the 
mixture at –78 ºC for 15 min afforded B-[E]-crotyl(2-isocaranyl)borane. A solution of crude 
aldehyde (30 mg, 0.034 mmol) in ethyl ether (0.5 mL) was added at –78 ºC and the mixture was 
stirred for 3 h at –78 ºC. The reaction mixture was quenched with MeOH (0.16 mL), brought to 
room temperature, and oxidized with 30% H2O2 (0.4 mL) at reflux for 3 h. The aqueous layer 
was extracted with EtOAc (3x25 mL). The combined organic layers were dried (MgSO4) and 
concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl ether, 10:1-
4:1) to give the borate compound (21 mg, 0.017 mmol). The solution of the borate compound 
(3.5 mg, 0.0029 mmol) in THF/ethyl ether (1 mL/1 mL) was oxidized with 30% H2O2 (0.8 mL) 
at reflux for 2 d. The aqueous layer was extracted with EtOAc (2x10 mL). The combined organic 
layers were dried (MgSO4) and concentrated. The residue was purified by chromatography on 
SiO2 (hexane/ethyl ether, 20:1-10:1) to give 154 (1.2 mg, 0.0024 mmol) in 41% yield over 2 
steps as a colorless oil: [α]D –4.6 (c 0.21, CH2Cl2); IR (neat) 3428, 2955, 2929, 2856, 1472, 
1381, 1252, 1107, 1070, 1003, 858, 836 cm-1; 1H NMR δ 5.96-5.85 (m, 1 H), 5.11-5.01 (m, 2 H), 
4.40 (dd, 1 H, J = 5.5, 9.6 Hz), 4.22-4.06 (m, 7 H), 3.96-3.89 (m, 1 H), 3.33 (d, 1 H, J = 9.9 Hz), 
2.44-2.33 (m, 1 H), 1.85-1.57 (m, 6 H), 1.56-1.40 (m, 5 H), 1.39-1.22 (m, 8 H), 1.14-1.05 (m, 9 
H), 0.94-0.86 (m, 21 H), 0.82 (d, 3 H, J = 6.7 Hz), 0.10-0.03 (m, 30 H); 13C NMR (100 MHz) δ 
139.3, 115.5, 106.6, 85.4, 80.5, 74.9, 66.14, 66.08, 66.0, 65.0, 64.2, 50.8, 42.9, 40.4, 38.9, 36.2, 
34.9, 30.6, 28.5, 27.9, 26.2, 26.1, 23.6, 23.2, 20.0, 19.9, 19.82, 19.77, 18.3, 18.2, 17.6, 14.4, 11.8, 
–1.26, –1.30, –4.0, –4.2, –4.5, –4.7; MS (ESI) m/z (relative intensity) 960 ([M+Na]+, 100), 806 
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 (35), 727 (15); HRMS (ESI) m/z calculated for C46H97O9NaPSi4 (M+Na) 959.5845, found 
959.5811. 
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(2R,3R,5S,7S,9S)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-2-((3S,4R)-3-hydroxy-4-
methylhex-5-enyl)-4,4-dimethyl-1,6-dioxaspiro[4.5]decan-3-ol (155). To a solution of 147 
(243 mg, 0.570 mmol) in CH2Cl2 (25 mL) was added DIBAL (1.0 M in hexane, 0.68 mL, 0.68 
mmol) at –78 ºC and the mixture was stirred for 2 h at –78 ºC. The reaction mixture was 
quenched with MeOH/EtOAc (8 mL/8 mL), allowed to warm to room temperature, and treated 
with saturated aqueous Rochelle salt (15 mL). After stirring for 6 h at room temperature, the 
aqueous layer was extracted with CH2Cl2 (3x30 mL). The combined organic layers were dried 
(MgSO4) and concentrated in vacuo to give crude aldehyde. Without further purification, this 
aldehyde was used for the next step. To a well-stirred mixture of trans-2-butene (0.5 mL) and 
KOt-Bu (224 mg, 2.00 mmol) in THF (3 mL), n-BuLi (1.6 M in hexane, 1.26 mL, 2.02 mmol) 
was added at –78 ºC. Following completion of addition, the mixture was stirred at –45 ºC for 15 
min and again cooled to –78 ºC. To the mixture, a solution of B-methoxylbis(2-isocaranyl)borane 
(760 mg, 2.40 mmol) in ethyl ether (1.0 mL) was added dropwise and the resulting mixture was 
stirred for 30 min at –78 ºC. The addition of BF3•etherate (0.25 mL, 2.0 mmol) and stirring the 
mixture at –78 ºC for 15 min afforded B-[E]-crotyl(2-isocaranyl)borane. A solution of crude 
aldehyde (250 mg) in ethyl ether (4 mL) was added at –78 ºC and the mixture was stirred for 3 h 
at –78 ºC. MeOH (0.32 mL) was added, then the mixture was brought to room temperature and 
oxidized with alkaline hydrogen peroxide (30% H2O2 (1.6 mL) and 3 N NaOH (0.8 mL)) at 
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 reflux for 2 h. The aqueous layer was extracted with EtOAc (3x25 mL). The combined organic 
layers were dried (MgSO4) and concentrated. The residue was purified by chromatography on 
SiO2 (hexane/ethyl ether, 10:1-4:1) to give 149 (90 mg, 0.19 mmol, 33% over 2 steps) and 155 
(80 mg, 0.17 mmol, 30% over 2 steps) as a colorless oil. 155 was contaminated with an 
inseparable impurity and used without further purification. 
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(2R,3R,5S,7S,9S)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-2-[(3S,4R)-3-(tert-
butyldimethylsilanyloxy)-4-methylhex-5-enyl]-4,4-dimethyl-1,6-dioxaspiro[4.5]decan-3-ol 
(156). To a solution of crude 155 (80 mg, 0.17 mmol) and imidazole (50 mg, 0.73 mmol) in 
DMF (3 mL) was added TBSCl (50 mg, 0.33 mmol). The mixture was stirred overnight and 
water was added. The aqueous layer was extracted with EtOAc (3x20 mL). The combined 
organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography on SiO2 (hexane/EtOAc, 10:1) to give 156 (80 mg, 0.13 mmol, 76%) as a 
colorless oil: [α]D +21 (c 1.0, CHCl3); IR (neat) 3462, 2956, 2925, 2858, 1472, 1383, 1255, 
1107, 1053, 1004, 836 cm-1; 1H NMR δ 5.87-5.74 (m, 1 H), 5.03-4.97 (m, 2 H), 4.27-4.19 (m, 1 
H), 4.19 (d, 1 H, J = 7.5 Hz), 4.00-3.86 (m, 2 H), 3.59 (q, 1 H, J = 4.7 Hz), 2.34-2.28 (m, 1 H), 
1.93-1.82 (m, 2 H), 1.80-1.69 (m, 1 H), 1.61-1.50 (m, 5 H), 1.46-1.20 (m, 7 H), 1.01 (s, 3 H), 
1.00 (d, 3 H, J = 7.1 Hz), 0.90 (br. s, 21 H), 0.88 (s, 3 H), 0.08 (s, 6 H), 0.07 (s, 3 H), 0.06 (s, 3 
H); 13C NMR δ 141.3, 114. 4, 108.6, 79.7, 77.9, 76.0, 73.7, 63.1, 49.2, 43.1, 39.2, 38.7, 35.4, 
30.8, 29.5, 26.4, 26.2, 22.9, 21.5, 18.41, 18.39, 18.2, 15.8, 14.3, –3.9, –4.3, –4.4; MS (ESI) m/z 
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 (relative intensity)  621 ([M+Na]+, 95), 571 (35), 467 (100), 413 (48), 287 (92); HRMS (ESI) 
m/z calculated for C33H66O5NaSi2 (M+Na) 621.4347, found 621.4389. 
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(2R,3R,5S,7S,9S)-Phosphoric acid 7-butyl-9-(tert-butyldimethylsilanyloxy)-2-[(3S,4R)-3-
(tert-butyldimethylsilanyloxy)-4-methylhex-5-enyl]-4,4-dimethyl-1,6-dioxaspiro[4.5]dec-3-yl 
ester bis-[2-(trimethylsilanyl)ethyl] ester (157). PCl3 (2 M in CH2Cl2, 70 µL, 0.14 mmol) was 
added to a solution of 156 (32 mg, 0.054 mmol) in pyridine (0.6 mL) at 0 ºC in one portion. 
After 10 min, 2-trimethylsilylethanol (0.13 mL, 0.90 mmol) and DMAP (1 mg, 0.0082 mmol) 
were added and the mixture was warmed to room temperature over 1 h. CH2Cl2 (5.4 mL) and 
30% aqueous H2O2 (0.54 mL) were added and the stirring was continued for 1 h at room 
temperature. The reaction mixture was quenched with saturated aqueous NaHCO3. The aqueous 
layer was extracted with EtOAc (3x20 mL). The combined organic layers were dried (MgSO4) 
and concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl ether, 
10:1) to give 157 (38 mg, 0.043 mmol, 80%) as a colorless oil: [α]D +31 (c 1.0, CHCl3); IR 
(neat) 2955, 2929, 2894, 2857, 1471, 1386, 1252, 1109, 1002, 856 cm-1; 1H NMR (500 MHz, 
C6D6) δ 6.00 (ddd, 1 H, J = 7.9, 10.3, 17.6 Hz), 5.33 (dd, 1 H, J = 7.7, 9.1 Hz), 5.16 (d, 1 H, J = 
17.4 Hz),  5.12 (dd, 1 H, J = 1.9, 10.4 Hz), 4.48 (tt, 1 H, J = 4.7, 10.1 Hz), 4.38 (ddd, 1 H, J = 
2.9, 7.7, 10.6 Hz), 4.34-4.26 (m, 4 H), 3.95 (dq, 1 H, J = 2.8, 7.2 Hz), 3.75 (dt, 1 H, J = 4.2, 5.8 
Hz), 2.52-2.46 (m, 1 H), 2.21-2.18 (m, 1 H), 2.15-2.08 (m, 1 H),  2.00-1.93 (m, 2 H), 1.89-1.79 
(m, 2 H), 1.76-1.67 (m, 3 H), 1.63 (dd, 1 H, J = 10.6, 12.4 Hz), 1.38 (s, 3 H), 1.35-1.28 (m, 4 H), 
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 1.15 (s, 3 H), 1.13 (d, 3 H, J = 6.9 Hz),  1.12-1.06 (m, 4 H), 1.05 (s, 9 H), 1.02 (s, 9 H), 0.91 (t, 3 
H, J = 6.9 Hz), 0.24 (s, 3 H), 0.16 (s, 3 H), 0.15 (s, 3 H), 0.14 (s, 3 H), –0.06 (s, 9 H), –0.09 (s, 9 
H); 13C NMR (CD3CN) δ 142.0, 114.9, 109.4, 85.2, 85.1, 77.63, 77.57, 76.3, 74.9, 67.1, 67.03, 
66.99, 66.9, 63.6, 49.8, 49.7, 43.4, 39.5, 39.2, 35.9, 31.7, 30.2, 27.1, 26.4, 26.3, 23.5, 21.2, 20.4, 
20.29, 20.26, 20.2, 18.9, 18.84, 18.80, 16.5, 14.5, –1.4, –3.7, –4.2, –4.26, –4.32; MS (ESI) m/z 
(relative intensity) 902 ([M+Na]+, 100), 783 (20), 538 (23); HRMS (ESI) m/z calculated for 
C43H91O8NaSi4P (M+Na) 901.5426, found 901.5450. 
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(4R,5R)-Methyl-4-((benzyloxy)methoxy)-6-((2R,4R,6S)-6-butyltetrahydro-4-hydroxy-2H-
pyran-2-yl)-6-methyl-5-(triethylsilanyloxy)heptanoate (158). To a solution of 145 (18 mg, 0. 
031 mmol) in THF (1 mL) was added L-Selectride (1 M in THF, 80 µL, 0.080 mmol) at –78 ºC 
and the mixture was stirred for 1 h at –78 ºC, quenched with saturated aqueous NH4Cl and 
warmed up to room temperature. The organic layer was extracted with CH2Cl2 (3x20 mL). The 
combined organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography on SiO2 (CH2Cl2/EtOAc, 4:1) to give 158 (13 mg, 0.022 mmol, 71%) as a 
colorless oil: [α]D +35 (c 1.0, CHCl3); IR (neat) 3493, 2953, 2876, 1740, 1455, 1379, 1240, 
1161, 1118, 1040, 827 cm-1; 1H NMR δ 7.36-7.27 (m, 5 H), 4.81, 4.78 (AB, 2 H, J = 6.9 Hz), 
4.72, 4.58 (AB, 2 H, J = 12.0 Hz), 4.19 (ddd, 1 H, J = 4.1, 4.6, 8.7 Hz), 3.93 (dd, 1 H, J = 3.2, 
11.1 Hz), 3.79-3.68 (m, 2 H), 3.65 (d, 1 H, J = 5.5 Hz), 3.64 (s, 3 H), 2.58-2.38 (m, 2 H), 2.07-
1.83 (m, 3 H), 1.82-1.72 (m, 1 H), 1.69-1.63 (m, 2 H), 1.54-1.20 (m, 7 H), 0.99 (t, 9 H, J = 8.0 
Hz), 0.96 (s, 3 H), 0.89 (t, 3 H, J = 6.8 Hz), 0.88 (s, 3 H), 0.66 (q, 6 H, J = 8.0 Hz); 13C NMR δ 
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 174.2, 138.4, 128.5, 127.9, 127.7, 94.8, 78.1, 76.4, 71.6, 70.2, 69.2, 65.3, 51.6, 42.6, 36.8, 34.7, 
32.9, 31.5, 29.6, 28.9, 22.9, 21.3, 19.1, 14.3, 7.3, 5.8; MS (ESI) m/z (relative intensity) 604 
([M+Na]+, 100), 541 (10), 463 (5); HRMS (ESI) m/z calculated for C32H56O7NaSi (M+Na) 
603.3693, found 603.3715. 
O
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O
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(5R,6R)-5-((Benzyloxy)methoxy)-6-(2-((2R,4R,6S)-6-butyltetrahydro-4-hydroxy-2H-pyran-
2-yl)propan-2-yl)tetrahydropyran-2-one (159). To a solution of 158 (90 mg, 0.17 mmol) in 
THF (5 mL) was added HF•pyridine (0.5 mL) at 0 ºC. The mixture was stirred at room 
temperature for 36 h and diluted with ethyl ether (50 mL). The organic layer was washed with 
saturated aqueous NaHCO3. The aqueous layer was extracted with EtOAc (3x20 mL). The 
combined organic layers were washed with saturated aqueous NH4Cl, dried (MgSO4), and 
concentrated. The residue was purified by chromatography on SiO2 (CH2Cl2/EtOAc, 4:1) to give 
the desired lactone 159 (64 mg, 0.15 mmol, 88%) as a colorless oil: [α]D –19 (c 1.1, CHCl3); IR 
(neat) 3448, 2950, 2929, 2873, 1718, 1456, 1364, 1248, 1205, 1025 cm-1; 1H NMR δ 7.38-7.29 
(m, 5 H), 4.86, 4.80 (AB, 2 H, J = 7.1 Hz), 4.69, 4.64 (AB, 2 H, J = 12.0 Hz), 4.34-4.30 (m, 2 
H), 4.22 (qn, 1 H, J = 4.0 Hz), 3.92 (dd, 1 H, J = 2.6, 11.2 Hz), 3.83-3.75 (m, 1 H), 2.66 (ddd, 1 
H, J = 7.7, 10.4, 18.1 Hz), 2.53 (ddd, 1 H, J = 3.1, 8.0, 18.1 Hz), 2.24 (tt, 1 H, J = 3.2, 11.1 Hz), 
1.94-1.85 (m, 3 H), 1.83-1.77 (m, 1 H), 1.74-1.61 (m, 2 H), 1.60-1.50 (m, 2 H), 1.35-1.20 (m, 4 
H), 1.10 (s, 3 H), 1.06 (s, 3 H), 0.89 (t, 3 H, J = 6.8 Hz); 13C NMR δ 171.4, 137.7, 128.7, 128.0, 
127.8, 93.6, 85.0, 72.5, 70.9, 69.8, 69.3, 65.0, 41.2, 35.8, 34.0, 33.2, 29.3, 25.8, 25.0, 22.8, 20.53, 
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 20.45, 14.3; MS (ESI) m/z (relative intensity) 457 ([M+Na]+, 100), 377 (10); HRMS (ESI) m/z 
calculated for C25H38O6Na (M+Na) 457.2566, found 457.2579. 
O
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(5R,6R)-5-((Benzyloxy)methoxy)-6-(2-((2R,4R,6S)-6-butyltetrahydro-4-(tert-
butyldimethylsilanyloxy)-2H-pyran-2-yl)propan-2-yl)tetrahydropyran-2-one (160). To a 
solution of 159 (80 mg, 0.18 mmol) and imidazole (50 mg, 0.73 mmol) in DMF (1 mL) was 
added TBSCl (55 mg, 0.37 mmol). The mixture was stirred overnight and water was added. The 
aqueous layer was extracted with EtOAc (3x20 mL). The combined organic layers were dried 
(MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(hexane/EtOAc, 10:1) to give 160 (74 mg, 0.13 mmol, 72%) as a colorless oil: [α]D +2.9 (c 1.6, 
CHCl3); IR (neat) 2954, 2928, 2856, 1741, 1469, 1360, 1251, 1090, 1036, 835 cm-1; 1H NMR δ 
7.37-7.31 (m, 5 H), 4.86, 4.82 (AB, 2 H, J = 7.1 Hz), 4.70, 4.62 (AB, 2 H, J = 11.9 Hz), 4.38 (s, 
1 H), 4.27 (br. s, 1 H), 4.19 (qn, 1 H, J = 3.3 Hz), 3.83 (dd, 1 H, J = 3.3, 9.8 Hz), 3.81-3.78 (m, 1 
H), 2.69 (ddd, 1 H, J = 7.8, 10.5, 18.2 Hz), 2.56 (ddd, 1 H, J = 3.0, 8.0, 18.1 Hz), 2.32-2.23 (m, 1 
H), 1.98-1.89 (m, 2 H), 1.81 (ddd, 1 H, J = 3.4, 6.5, 14.0 Hz), 1.73-1.62 (m, 2 H), 1.37-1.22 (m, 
6 H), 1.08 (s, 3 H), 1.05 (s, 3 H), 0.90 (t, 3 H, J = 6.7 Hz), 0.89 (s, 9 H), 0.04 (s, 6 H); 13C NMR 
δ 171.5, 137.6, 128.7, 128.0, 127.9, 94.2, 84.6, 73.2, 70.4, 69.8, 65.5, 40.8, 35.4, 33.8, 33.5, 29.5, 
25.9, 25.8, 25.6, 22.9, 21.0, 20.3, 18.1, 14.3, –4.8; MS (ESI) m/z (relative intensity) 571 
([M+Na]+, 100), 549 (15), 519 (28), 441 (10), 387 (17); HRMS (ESI) m/z calculated for 
C31H52O6NaSi (M+Na) 571.3431, found 571.3439. 
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(2R,3R,5S,7S,9R)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-(hexahydrofuro[3,2-b]pyran-5-
onyl)-4,4-dimethyl-1,6-dioxaspiro[4.5]decane (161). To a solution of 160 (90.0 mg, 0.178 
mmol) in THF (10 mL) was added Pd(OH)2/C (20 wt%, 20 mg). The mixture was stirred under 
H2 gas for 3 h and then filtered through celite pad. The filtrate was concentrated and dried in 
vacuo. The alcohol was used without further purification. To a solution of the crude alcohol (71 
mg) in cyclohexane (15 mL) were added iodobenzene diacetate (160 mg, 0.497 mmol) and I2 
(126 mg, 0.497 mmol). The reaction mixture was stirred for 3 h at room temperature under 
irradiation by light (250 W), quenched with saturated aqueous Na2S2O3, and stirred for 30 min.  
The aqueous layer was extracted with ethyl ether (2×20 mL). The combined organic layers were 
dried (MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(hexane/EtOAc, 10:1) to give the major product 161 (42 mg, 0.098 mmol, 55% over 2 steps) as a 
colorless oil and the minor product 162 (16 mg, 0.070 mmol, 39% over 2 steps) as a white solid. 
161: [α]D +17 (c 0.95, CHCl3); IR (neat) 2955, 2930, 2857, 1749, 1470, 1383, 1250, 1155, 1113, 
1039, 836 cm-1; 1H NMR δ 4.53-4.45 (m, 2 H), 4.00-3.90 (m, 1 H), 3.62-3.56 (m, 1 H), 2.61 
(ddd, 1 H, J = 5.6, 8.7, 17.1 Hz), 2.34 (ddd, 1 H, J = 5.2, 7.0, 17.0 Hz), 2.15 (dd, 1 H, J = 5.7, 
13.7 Hz), 2.10-1.97 (m, 2 H), 1.83-1.77 (m, 1 H), 1.64-1.44 (m, 5 H), 1.36-1.25 (m, 4 H), 1.15 (s, 
3 H), 1.12 (s, 3 H), 0.88 (br. s, 12 H), 0.06 (s, 6 H); 13C NMR δ 171.2, 109.5, 89.9, 72.9, 69.6, 
65.7, 50.6, 40.8, 39.1, 37.0, 28.2, 26.3, 26.0, 23.8, 22.9, 22.3, 20.1, 18.3, 14.3, –4.3, –4.4; MS 
(ESI) m/z (relative intensity) 876 ([2M+Na]+, 2), 509 (100), 449 (70), 365 (10); HRMS (ESI) m/z 
calculated for C23H42O5NaSi (M+Na) 449.2699, found 449.2718. 
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(2R,3R,5R,7S,9R)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-(hexahydrofuro[3,2-b]pyran-5-
onyl)-4,4-dimethyl-1,6-dioxaspiro[4.5]decane (162): Mp 101 °C; [α]D –47 (c 1.5, CHCl3); IR 
(neat) 2953, 2928, 2857, 1722, 1471, 1386, 1249, 1186, 1110, 1071, 837, 774 cm-1; 1H NMR 
(600 MHz, acetone-d6) δ 4.62 (q, 1 H, J = 4.9 Hz), 4.40 (d, 1 H, J = 5.3 Hz), 4.05 (ddd, 1 H, J = 
4.6, 10.9, 15.6 Hz),  3.73 (dqn, 1 H, J = 2.0, 5.7 Hz), 2.33-2.24 (m, 2 H), 2.09-2.05 (m, 1 H), 
1.95 (dq, 1 H, J = 5.1, 14.0 Hz), 1.89-1.83 (m ,2 H), 1.45-1.34 (m, 2 H), 1.32-1.24 (m, 5 H), 
1.12-1.06 (m, 1 H), 1.10 (s, 3 H), 1.02 (s, 3 H), 0.88 (s, 9 H), 0.87 (t, 3 H, J = 7.2 Hz), 0.08 (s, 3 
H), 0.07 (s, 3 H); 13C NMR δ 170.7, 109.6, 88.5, 72.4, 69.5, 66.4, 50.7, 40.3, 38.8, 35.0, 27.0, 
26.1, 25.4, 24.1, 23.5, 23.0, 18.3, 17.1, 14.2, –4.25, –4.33; MS (ESI) m/z (relative intensity) 449 
([M+Na]+, 100), 427 (15), 335 (18), 295 (20); HRMS (ESI) m/z calculated for C23H42O5NaSi 
(M+Na) 449.2699, found 449.2712. 
HO
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(2R,3R,7S,9R)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-2-((3S,4R)-3-hydroxy-4-methylhex-
5-enyl)-4,4-dimethyl-1,6-dioxaspiro[4.5]decan-3-ol (163). To a solution of 161 (30 mg, 0.70 
mmol) in CH2Cl2 (7 mL) was added DIBAL (1.0 M in hexane, 90 µL, 0.090 mmol) at –78 ºC 
and the mixture was stirred for 2 h at –78 ºC. The reaction mixture was quenched with 
MeOH/EtOAc (2 mL/2 mL), allowed to warm to room temperature, and treated with saturated 
aqueous Rochelle salt (3 mL). After stirred for 5 h at room temperature, the aqueous layer was 
extracted with CH2Cl2 (3x20 mL). The combined organic layers were dried (MgSO4) and 
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 concentrated to give crude aldehyde. Without further purification, this aldehyde was used for the 
next step. To a well-stirred mixture of trans-2-butene (0.2 mL) and KOt-Bu (112 mg, 1.00 
mmol) in THF (1 mL), n-BuLi (1.4 M in hexane, 0.70 mL, 1.0 mmol) was added at –78 ºC. 
Following the completion of addition, the mixture was stirred at –45 ºC for 15 min and again 
cooled to –78 ºC. To the mixture, a solution of B-methoxylbis(2-isocaranyl)borane (380 mg, 1.20 
mmol) in ethyl ether (0.5 mL) was added dropwise and the resulting mixture was stirred for 30 
min at –78 ºC. The addition of BF3•etherate (0.16 mL, 1.3 mmol) and stirring the mixture at –78 
ºC for 15 min afforded B-[E]-crotyl(2-isocaranyl)borane. A solution of crude aldehyde (30 mg) 
in ethyl ether (0.5 mL) was added at –78 ºC and the mixture was stirred for 3 h at –78 ºC. MeOH 
(0.16 mL) was added, then the mixture was brought to room temperature and oxidized with 
alkaline hydrogen peroxide (30% H2O2 (0.8 mL) and 3N NaOH (0.4 mL)) at reflux for 3 h. The 
aqueous layer was extracted with EtOAc (3x25 mL). The combined organic layers were dried 
(MgSO4) and concentrated. The residue was purified by chromatography on SiO2 (hexane/ethyl 
ether, 10:1-4:1) to give 163 (18 mg, 0.037 mmol, 53% over 2 steps) as a colorless oil: [α]D –30 
(c 1.0, CHCl3); IR (neat) 3510, 2955, 2929, 2858, 1467, 1388, 1252, 1143, 1111, 1076, 1050, 
1001, 963, 933, 866 cm-1; 1H NMR δ 5.86-5.74 (m, 1 H), 5.13 (s, 1 H), 5.10-5.07 (m, 1 H), 4.15 
(dt, 1 H, J = 4.5, 6.8 Hz), 4.02 (tt, 1 H, J = 4.7, 11.0 Hz),  3.82-3.75 (m, 1 H), 3.59 (br. s, 1 H), 
3.47 (ddd, 1 H, J = 3.3, 6.0, 8.6 Hz), 3.30 (br, 1 H), 2.26 (sx, 1 H, J = 6.8 Hz), 1.84-1.63 (m, 6 
H), 1.57-1.40 (m, 3 H), 1.37-1.22 (m, 5 H), 1.23-1.15 (m, 1 H), 1.12 (s, 3 H), 1.06 (d, 3 H, J = 
6.8 Hz), 0.96 (s, 3 H), 0.90 (t, 3 H, J = 6.9 Hz), 0.89 (s, 9 H), 0.07 (s, 6 H); 13C NMR δ (125 
MHz) 140.8, 116.1, 109.9, 82.5, 80.5, 74.9, 69.0, 66.2, 49.5, 44.1, 41.5, 37.8, 35.8, 30.9, 28.1, 
27.2, 26.1, 23.0, 22.9, 18.3, 17.0, 16.5, 14.2, –4.2; MS (ESI) m/z (relative intensity) 507 
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 ([M+Na]+, 100), 480 (10), 353 (12); HRMS (ESI) m/z calculated for C27H52O5NaSi (M+Na) 
507.3482, found 507.3490. 
HO
O
O
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OTBS  
(2R,3R,7S,9R)-7-Butyl-9-(tert-butyldimethylsilanyloxy)-2-[(3S,4R)-3-(tert-
butyldimethylsilanyloxy)-4-methylhex-5-enyl]-4,4-dimethyl-1,6-dioxaspiro[4.5]decan-3-ol 
(164). To a solution of 163 (14 mg, 0.029 mmol) and imidazole (27 mg, 0.43 mmol) in DMF (0.5 
L) was added TBSCl (44 mg, 0.29 mmol). The mixture was stirred overnight and water was 
added. The aqueous layer was extracted with EtOAc (3x20 mL). The combined organic layers 
were dried (MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(hexane/EtOAc, 10:1) to give 164 (17 mg, 0.028 mmol, 97%) as a colorless oil: [α]D –21 (c 1.2, 
CHCl3); IR (neat) 3515, 2956, 2929, 2857, 1463, 1389, 1254, 1110, 1081, 1052, 1004, 865, 836 
cm-1; 1H NMR δ 5.88-5.77 (m, 1 H), 5.04-4.98 (m, 2 H), 4.10-3.98 (m, 2 H), 3.82-3.73 (m, 1 H), 
3.60-3.55 (m, 1 H), 3.54 (dd, 1 H, J = 4.3, 12.1 Hz), 3.19 (d, 1 H, J = 12.2 Hz), 2.37-2.28 (m, 1 
H), 1.82-1.73 (m, 2 H), 1.66-1.40 (m, 7 H), 1.37-1.26 (m, 4 H),  1.22-1.14 (m, 1 H), 1.11 (s, 3 
H), 1.02 (d, 3 H, J = 6.9 Hz), 0.95 (s, 3 H), 0.94-0.89 (m, 21 H), 0.075 (m, 6 H), 0.069 (s, 3 H), 
0.06 (s, 3 H); 13C NMR δ 141.4, 114.5, 109.7, 82.6, 80.5, 76.3, 68.9, 66.3, 49.6, 43.1, 41.5, 37.8, 
35.9, 30.5, 28.2, 27.6, 26.2, 26.1, 23.1, 22.9, 18.4, 18.3, 17.0, 16.1, 14.2, –4.0, –4.2, –4.26, –
4.32; MS (ESI) m/z (relative intensity) 622 ([M+Na]+, 100), 566 (8), 413 (13); HRMS (ESI) m/z 
calculated for C33H66O5NaSi2 (M+Na) 621.4347, found 621.4370. 
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(2R,3R,7S,9R)-Phosphoric acid 7-butyl-9-(tert-butyldimethylsilanyloxy)-2-[(3S,4R)-3-(tert-
butyldimethylsilanyloxy)-4-methylhex-5-enyl]-4,4-dimethyl-1,6-dioxaspiro[4.5]dec-3-yl 
ester bis-[2-(trimethylsilanyl)ethyl] ester (165). PCl3 (2 M in CH2Cl2, 50 µL, 0.10 mmol) was 
added to a solution of 164 (17 mg, 0.028 mmol) in pyridine (0.6 mL) at 0 ºC in one portion. 
After 10 min, 2-trimethylsilylethanol (86 µL, 0.60 mmol) and DMAP (1 mg) were added and the 
mixture was warmed to room temperature over 1 h. CH2Cl2 (3.6 mL) and 30% aqueous H2O2 
(0.36 mL) were added and the stirring was continued for 1 h at room temperature. The reaction 
was quenched with saturated aqueous NaHCO3. The aqueous layer was extracted with EtOAc 
(3x15 mL). The combined organic layers were dried (MgSO4) and concentrated. The residue was 
purified by chromatography on SiO2 (hexane/ethyl ether, 10:1) to give 165 (16 mg, 0.018 mmol, 
64%) as a white solid: Mp 49 °C; [α]D –11 (c 1.0, CHCl3); IR (neat) 2956, 2929, 2894, 2857, 
1472, 1385, 1252, 1005, 860, 836 cm-1; 1H NMR (600 MHz, C6D6) δ 6.04 (ddd, 1 H, J = 7.7, 
10.3, 17.8 Hz), 5.16 (d, 1 H, J = 17.3 Hz), 5.12 (dd, 1 H, J = 1.3, 10.4 Hz), 4.66 (dd, 1 H, J = 5.6, 
10.2 Hz), 4.40-4.30 (m, 5 H), 4.21-4.17 (m, 1 H), 3.97-3.92 (m, 1 H), 3.81 (dt, 1 H, J = 3.2, 5.2 
Hz), 2.55-2.50 (m, 1 H), 2.07-2.01 (m, 2 H), 1.99-1.93 (m, 2 H), 1.87 (q, 1 H, J = 10.2 Hz), 1.79-
1.70 (m, 2 H), 1.64-1.58 (m, 1 H), 1.50-1.34 (m, 6 H), 1.38 (s, 3 H), 1.20 (t, 2 H, J = 8.6 Hz), 
1.17 (d, 3 H, J = 6.9 Hz), 1.14 (t, 2 H, J = 8.6 Hz), 1.06 (s, 9 H), 1.03 (t, 3 H, J = 7.2 Hz), 1.01 (s, 
9 H), 0.84 (s, 3 H), 0.28 (s, 3 H), 0.16 (s, 3 H), 0.12 (s, 3 H), 0.11 (s, 3 H), –0.03 (s, 9 H), –0.05 
(s, 9 H); 13C NMR δ 141.1, 114.5, 108.2, 85.64, 85.56, 80.6, 80.5, 76.3, 68.4, 66.9, 66.2, 66.1, 
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 50.3, 50.2, 43.1, 41.6, 38.5, 36.1, 31.4, 28.2, 27.9, 26.2, 26.1, 23.8, 23.2, 20.1, 20.0, 19.94, 19.86, 
18.4, 18.3, 17.4, 16.1, 14.3, –1.3, –3.8, –4.2, –4.3, –4.4; MS (ESI) m/z (relative intensity) 902 
([M+Na]+, 100), 880 (6), 817 (5), 747 (6); HRMS (ESI) m/z calculated for C43H91O8NaSi4P 
(M+Na) 901.5426, found 901.5460. 
149 
 6. References 
1. a) Kobayashi, S.; Nagayama, S. J. Am. Chem. Soc. 1996, 118, 8977. b) Tunoori, A. R.; 
Dutta, D.; Georg, G. I. Tetrahedron Lett. 1998, 39, 8751. c) Bhalay, G.; Dunstan, A.; 
Glen, A. Synlett 2000, 1846. d) Clapham, B.; Reger, T. S.; Janda, K. D. Tetrahedron 
2001, 57, 4637. e) Booth, R. J.; Hodges, J. C. Acc. Chem. Res. 1999, 32, 18. 
2. a) Hosokawa, T.; Nakahira, T.; Takano, M.; Murahashi, S. J. Mol. Cat. 1992, 74, 489. b) 
Shibata, I.; Fukuoka, S.; Yoshimura, N.; Matsuda, H.; Baba, A. J. Org. Chem. 1997, 62, 
3790. c) Sikorski, W. H.; Reich, H. J. J. Am. Chem. Soc. 2001, 123, 6527. 
3. Reich, H. J.; Kulicke, K. J. J. Am. Chem. Soc. 1996, 118, 273. 
4. Reich, H. J.; Sikorski, W. H. J. Org. Chem. 1999, 64, 14. 
5. Zapp, J. A. Jr. Science 1975, 190, 422. 
6. a) Mukhopadhyay, T.; Seebach, D. Helv. Chim. Acta 1982, 65, 385. b) Seebach, D.; 
Henning, R.; Mukhopadhyay, T. Chem. Ber. 1982, 115, 1705. 
7. a) Ishii, K.; Aoki, S.; Koga, K. Tetrahedron Lett. 1997, 38, 6563. b) Juaristi, E.; 
Hernández-Rodríguez, M.; López-Ruiz, H.; Aviña, J.; Muñoz-Muñiz, O. Helv. Chim. 
Acta 2002, 85, 1999. 
8. a) O’neil, I. A.; Lai, J. Y. Q.; Wynn, D. Chem. Commun. 1999, 59. b) Shimada, T.; Kina, 
A.; Ikeda, S.; Hayashi, T. Org. Lett. 2002, 4, 2799. 
9. Reich, H. J.; Green, D. P.; Medina, M. A.; Goldenberg, W. S.; Gudmundsson, B. O.; 
Dykstra, R. R.; Phillips, N. H. J. Am. Chem. Soc. 1998, 120, 7201. 
10. (a) Kobayashi, S.; Nishio, K. Tetrahedron Lett. 1993, 34, 3453. b) Kobayashi, s.; Nishio, 
K. J. Org. Chem. 1994, 59, 6620. c) Ogawa, C.; Sugiura, M.; Kobayashi, S. Chem. 
Commun. 2003, 192. 
150 
 11. Chen, H.; M.S. Thesis, University of Pittsburgh, 1999. 
12. a) Wang, J.; Zhang, H.; Huang, W.; Jiang, X. Tetrahedron 1994, 50, 10459. b) 
McCrindle, R.; McAlees, A. J. J. Chem. Soc. Perkin Trans. 1 1981, 741. 
13. Butler, A. R.; Hussain, I. J. Chem. Soc. Perkin Trans. 2 1981, 317. 
14. Faure, R.; Vincent, E. J.; Assef, G.; Kister, J.; Metzger, J. Org. Magn. Reson. 1977, 9, 
688. 
15. Herzog, H. Organic Syntheses, Wiley: New York, 1963; Coll. Vol. IV, p753. 
16. Tamaru, Y.; Hojo, M.; Higashimura, H.; Yoshida, Z. J. Am. Chem. Soc. 1988, 110, 3994. 
17. Yoo, S.; Lee, S. Synlett 1990, 419. 
18. Carlier, P. R.; Lo, C. W.; Lo, M. M.; Wan, N. C.; Williams, I. D. Org. Lett. 2000, 2, 
2443. 
19. a) Ostrowski, P. C.; Kane, V. V. Tetrahedron Lett. 1977, 18, 3549. b) Ager, D. J.; East, 
M. B. J. Org. Chem. 1986, 51, 3983. 
20. Butler, A. R.; Hussain, I. J. Chem. Soc. Perkin Trans. 2 1981, 317. 
21. Faure, R.; Vincent, E. J.; Assef, G.; Kister, J.; Metzger, J. Org. Magn. Reson. 1977, 9, 
688. 
22. Frater, G.; Mueller, U. Tetrahedron Lett. 1981, 22, 4221. 
23. a) Hosokawa, T.; nakahira, T.; Takano, M.; Murahashi, S. J. Mol. Cat. 1992, 74, 489. b) 
Shibata, I.; Fukuoka, S.; Yoshimura, N.; Matsuda, H.; Baba, A. J. Org. Chem. 1997, 62, 
3790. c) Sikorski, W. H.; Reich, H. J. J. Am. Chem. Soc. 2001, 123, 6527. 
24. Barrett, A. G. M.; Cramp, S. M.; Roberts, R. S.; Zecri, F. J. Org. Lett. 2000, 2, 261. 
151 
 25. a) Arnauld, T.; Barrett, A. G. M.; Hopkins, B. T. Tetrahedron Lett. 2002, 43, 1081. b) 
Arnauld, T.; Barrett, A. G. M.; Hopkins, B. T.; Zécri, F. J. Tetrahedron Lett. 2001, 42, 
8215. 
26. Arcadi, A.; Marinelli, F.; Bernocchi, E.; Cacchi, S.; Ortar, G. J. Organomet. Chem. 1989, 
368, 249. 
27. Hanessian, S.; Xie, F. Tetrahedron Lett. 1998, 39, 733. 
28. Denmark, S. E.; Stravenger, R. A. J. Am. Chem. Soc. 2000, 122, 8837. 
29. Tomoi, M.; Ikeda, M.; Kakiuchi, H. Tetrahedron Lett. 1978, 19, 3757. 
30. Nee, G.; Leroux, Y.; Seyden-Penne, J. Tetrahedron 1981, 37, 1541. 
31. Flowers, R. A. II; Xu, X.; Timmons, C.; Li, G. Eur. J. Org. Chem. 2004, 2988. 
32. a) Hodges, J. C.; Harikrishnan, L. S.; Ault-Justus, S. J. Comb. Chem. 2000, 2, 80. b) 
Lindsely, C. W.; Hodges, J. C.; Filzen, G. F.; Watson, B. M.; Geyer, A. G. J. Comb. 
Chem. 2000, 2, 550. c) McAlpine, S. R.; Lindsley, C. W.; Hodges, J. C.; Leonard, D. M.; 
Filzen, G. F. J. Comb. Chem. 2001, 3, 1. 
33. a) Altava, B.; Burguete, M. I.; Garcia-Verdugo, E.; Luis, S. V.; Salvador, R. V.; Vicent, 
M. J. Tetrahedron 1999, 55, 12897. b) Sherrington, D. C. Chem. Commun. 1998, 2275. c) 
Hultzsch, K. C.; Jernelius, J. A.; Hoveyda, A. H.; Schrock, R. R. Angew. Chem. Int. Ed. 
Engl. 2002, 41, 589. d) Kamahori, K.; Tada, S.; Ito, K.; Itsuno, S. Tetrahedron: 
Asymmetry 1995, 6, 2547. 
34. a) Toy, P. H.; Reger, T. S.; Garibay, P.; Garno, J. C.; Malikayil, J. A.; Liu, G.; Janda, K. 
D. J. Comb. Chem. 2001, 3, 117. b) Shimomura, O.; Clapham, B.; Spanka, C.; Mahajan, 
S.; Janda, K. D. J. Comb. Chem. 2002, 4, 436. c) Crivello, J. V.; Ramdas, A. J. 
152 
 Macromol. Sci. Pure. Appl. Chem. 1992, A29, 754. d) Toy, P. H.; Janda, K. D. 
Tetrahedron Lett. 1999, 40, 6329.  
35. Itsuno, S.; Sakurai, Y.; Ito, K.; Maruyama, T.; Nakahama, S.; Frechet, J. M. J. J. Org. 
Chem. 1990, 55, 304. 
36. Tomoi, M.; Takubo, T.; Ikeda, M.; Kakiuchi, H. Chem. Lett. 1976, 5, 473. 
Cl N
P
O
NMe2
NMe2
Na
N
P
O
NMe2
NMe2
 
37. a) Denmark, S. E.; Coe, D. M.; Pratt, N. E.; Griedel, B. D. J. Org. Chem. 1994, 59, 6161. 
b) Denmark, S. C.; Fu, J. J. Am. Chem. Soc. 2000, 122, 12021. c) Denmark, S. C.; Fu, J. 
Chem. Commun. 2003, 167. 
38. Sheppeck, J. E. II; Gauss, C-M.; Chamberlin, A. R. Bioorg. Med. Chem. 1997, 5, 1739. 
39. a) Signorile, A.; Sardanelli, M. S.; Nuzzi, R.; Papa, S. FEBS Lett. 2002, 512, 91. b) 
Mccluskey, A.; Sim, A. T. R.; Sakoff, J. A. J. Med. Chem. 2002, 45, 1151. 
40. a) Cohen, P. Annu. Rev. Biochem. 1989, 58, 453. b) Shenolikar, S.; Nairn, A. C. Adv. 
Second Messenger Phosphoprotein Res. 1991, 23, 1. 
41. Namikoshi, M. N.; Rinehart, K. L.; Sakai, R.; Stotts, R. R.; Dahlem, A. M.; Beasley, V. 
R.; Carmichael, W. W.; Evans, W. R. J. Org. Chem. 1992, 57, 866. 
42. a) Botes, D. P.; Wessels, P. L.; Kruger, H.; Runnegar, M. T. C.; Santikarn, S.; Smith, R. 
J.; Barna, R. J.; Williams, D. H. J. Chem. Soc. Perkin Trans. 1 1985, 2747. b) Rinehart, 
K. L.; Harada, K.; Namikoshi, M.; Chen, C.; Harvis, C. A.; Munro, M. H. G.; Blunt, J. 
W.; Mulligan, P. E.; Beasley, V. R.; Dahlem, A. M.; Carmichael, W. W. J. Am. Chem. 
Soc. 1988, 110, 8557. 
153 
 43. a) Dilip de Silva, E.; Williams, D. E.; Anderson, R. J.; Klix, H.; Holmes, C. F.; Allen, T. 
M. Tetrahedron Lett. 1992, 33, 1561. b) Valentekovich, R. J.; Schreiber, S. L. J. Am. 
Chem. Soc. 1995, 117, 9069. 
44. a) Blunt, J. W.; Hartshorn, M. P.; McLennan, T. J.; Munro, M. H. G.; Robinson, W. T.; 
Yorke, S. C. Tetrahedron Lett. 1978, 19, 69. b) Hashimoto, M.; Kan, T.; Nozaki, K.; 
Yanagiya, M.; Shirahama, H.; Matsumoto, T. J. Org. Chem. 1990, 55, 5088. c) 
Matsuzawa, S-I.; Suzuki, T.; Suzuki, M.; Matsuda, A.; Kawamura, T.; Mizuno, Y.; 
Kikiuchi, K. FEBS Lett. 1994, 356, 272. 
45. a) Li, Y.-M.; Casida, J. E. Biochem. Pharm. 1993, 46, 1435. b) McCluskey, A.; Taylor, 
C.; Quinn, R. J.; Suganuma, M.; Fujiki, H. Bioorg. Med. Chem. Lett. 1996, 6, 1025. 
46. Lewy, D. S.; Gauss, C.–M.; Soenen, D. R.; Boger, D. L. Curr. Med. Chem. 2002, 9, 
2005. 
47. Dounay, A. B.; Forsyth, C. J. Curr. Med. Chem. 2002, 9, 1939. 
48. Oikawa, H. Curr. Med. Chem. 2002, 9, 2033. 
49. a) Isobe, M.; Ichikawa, Y.; Goto, T. Tetrahedron Lett. 1986, 27, 963. b) Isobe, M.; 
Ichikawa, Y.; Bai, D.-L.; Masaki, H.; Goto, T. Tetrahedron 1987, 43, 4767. c) Forsyth, 
C. J.; Sabes, S. F.; Urbanek, R. A. J. Am. Chem. Soc. 1997, 119, 838. d) Sheppeck, J. E., 
III; Liu, W.; Chamberlin, A. R. J. Org. Chem. 1997, 62, 387. e) Oikawa, M.; Ueno, T.; 
Oikawa, H.; Ichihara, A. J. Org. Chem. 1995, 60, 5048. 
50. a) Evans, D. A.; Gage, J. R.; Leighton, J. L. J. Am. Chem. Soc. 1992, 114, 9434. b) 
Tanimoto, N.; Gerritz, S. W.; Sawabe, A.; Noda, T.; Filla, S. A.; Masamune, S. Angew. 
Chem. Int. Ed. Engl. 1994, 33, 673. c) Smith III, A. B.; Freistad, G. K.; Barbosa, J.; 
154 
 Bertounque, E.; Hull, K. G.; Iwashima, M.; Qiu, Y.; Salvatore, B. A.; Spoos, P. G.; Duan, 
J. J.-W. J. Am. Chem. Soc. 1999, 121, 10468 and 10478. 
51. Kita, A.; Matsunaga, S.; Takai, A.; Kataiwa, H.; Wakimoto, T.; Fusetani, N.; Isobe, M.; 
Miki, K. Structure 2002, 10, 715.  
52. Wakimoto, T.; Matsunaga, S.; Takai, A.; Fusetani, N. Chem. Biol. 2002, 9, 309. 
53. Matsunaga, S.; Wakimoto, T.; Fusetani, N. Tetrahedron Lett. 1997, 38, 3763. 
54. (a) Brown, H. C.; Bhat, K. S. J. Am. Chem. Soc. 1986, 108, 5919. (b) Brown, H. C.; Bhat, 
K. S.; Randad, R. S. J. Org. Chem, 1989, 54, 1570. (c) Roush, W. R.; Ando, K.; Powers, 
D. B.; Palkwoitz, A. D.; Halterman, R. L. J. Am. Chem. Soc. 1990, 112, 6339. 
55.  (a) Kay, I. T.; Williams, E. G. Tetrahedron Lett. 1983, 24, 5915. (b) Kay, I. T.; 
Bartholomew, D. Tetrahedron Lett. 1984, 25, 2035. (c) Martin, A.; Salazar, J. A.; Suarez, 
E. Tetrahedron Lett. 1995, 36, 4489. (d) Martin, A.;Salazar, J. A.; Suarez, E. J. Org. 
Chem. 1996, 61, 3999. (e) Dorta, R, L.; Martin, A.; Salazar, J. A.; Suarez, E.; Prange, T. 
J. Org. Chem. 1998, 63, 2251. (f) Marko, I. E. Tetrahedron Lett. 2000, 41, 4383. 
56. (a) Danishefsky, S. J.; Kitahara, T. J. Am. Chem. Soc. 1974, 96, 7807. (b) Danishefsky, S. 
J.; Kerwin, Jr., J. F. J. Org. Chem. 1982, 47, 3803. (c) Danishefsky, S. J.; DeNinno, S.; 
Lartey, P. J. Am. Chem. Soc. 1987, 109, 2082. (d) Danishefsky, S. J.; Armistead, D. M.; 
Wincott, F. E.; Selnick, H. G.; Hungate, R. J. Am. Chem. Soc. 1989, 111, 2967. 
57. Loh, T.; Zhou, J.; Yin, Z. Org. Lett. 1999, 11, 1855. 
58. Keck, G. E.; Andrus, M. B.; Romer, D. R. J. Org. Chem. 1991, 56, 417. 
59. Dr. Wakimoto, T., unpublished results, University of Pittsburgh, 2002. 
60. Connon, S. J.; Blechert, S. Angew. Chem. Int. Ed. Engl. 2003, 42, 1900. 
155 
 61. a) Guy, R.; Paul, B. J. Chem. Soc. Perkin Trans. 1 1978, 9, 1041. b) Guy, R.; Paul, B. J. 
Org. Chem. 1981, 46, 4161. c) Tsutomu, I.; Masamitsu, O.; Tomoko, M. J. Org. Chem. 
2001, 66, 8059. 
62. By Theresa Nguyen, a graduate student in the Lazo group. 
63. www.promega.com/faq/profluor.html 
64. (a) Huang, Y.; Rawal, V. H. J. Am. Chem. Soc. 2002, 124, 9662. (b) Huang, Y.; Rawal, 
V. H. Org. Lett. 2000, 2, 3321. (c) Kozmin, S. A.; Janey, J. M.; Rawal, V. H. J. Org. 
Chem. 1999, 64, 3039. 
65. Yamashita, Y.; Saito, S.; Ishitani, H.; Kobayashi, S. J. Am. Chem. Soc. 2003, 125, 3793. 
66. a) Evans, D. A.; Duffy, J. L.; Dart, M. J. Tetrahedron Lett. 1994, 35, 8537. b) Evans, D. 
A.; Dart, M. J.; Duffy, J. L.; Yang, M. G. J. Am. Chem. Soc. 1996, 118, 4322. 
67. Roush, W. R. J. Org. Chem. 1991, 56, 4151. 
O
B
Me
LRH
R
R
CHO
OTBS TBSO OH
B O
O
+
 
68. Masamune, S.; Choy, W.; Petersen, J. S.; Sita, L. R. Angew. Chem. Int. Ed. Engl. 1985, 
24, 1. 
69. a) Roush, W. R.; Palkowitz, A. D.; Palmer, M. A. J. J. Org. Chem. 1987, 52, 316. b) 
Roush, W. R.; Palkowitz, A. D. J. Am. Chem. Soc. 1987, 109, 953. c) Roush, W. R.; 
Yakelis, N. A. J. J. Org. Chem. 2003, 68, 3838.  
156 
 TBSO
CHO
B
O
O CO2
iPr
CO2
iPr
TBSO TBSO
mismatched matched8:1
+
toluene, -78 oC, 4 h
BocHN
CHO
B
O
O CO2
iPr
CO2
iPr
BocHN BocHN
mismatched matched95:5
+
toluene, -78 oC, 15  h
 
157 
 APPENDIX A 
 
 
 
X-ray crystal data for 111 
 
Table 1.  Crystal data and structure refinement for gm0524m. 
Identification code  gm0524m 
Empirical formula  C20 H38 O5 Si 
Formula weight  386.59 
Temperature  295(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P21 
Unit cell dimensions a = 6.820(3) Å a= 90°. 
 b = 6.419(3) Å b= 92.122(10)°. 
 c = 26.668(12) Å g = 90°. 
Volume 1166.6(9) Å3 
Z 2 
Density (calculated) 1.101 Mg/m3 
Absorption coefficient 0.125 mm-1 
158 
 F(000) 424 
Crystal size 0.07 x 0.07 x 0.24 mm3 
Theta range for data collection 1.53 to 23.00°. 
Index ranges -7<=h<=7, -6<=k<=7, -29<=l<=29 
Reflections collected 7260 
Independent reflections 3050 [R(int) = 0.3388] 
Completeness to theta = 23.00° 99.9 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3050 / 1 / 210 
Goodness-of-fit on F2 0.940 
Final R indices [I>2sigma(I)] R1 = 0.1218, wR2 = 0.2322 
R indices (all data) R1 = 0.3016, wR2 = 0.3322 
Absolute structure parameter 1.4(8) 
Extinction coefficient 0.009(5) 
Largest diff. peak and hole 0.341 and -0.269 e.Å-3 
 
159 
  Table 2. Atomic coordinates (x104) and equivalent  isotropic displacement parameters (Å2x103) 
for gm0524m. U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
Si 8711(8) 10036(9) 1325(2) 64(2) 
O(1) 9487(17) 8069(15) 1694(3) 61(4) 
C(1) 13860(20) 3930(20) 2798(7) 69(6) 
O(2) 11559(13) 6411(15) 3104(3) 41(3) 
C(2) 12940(20) 6020(20) 2727(6) 46(4) 
O(3) 9344(14) 8753(16) 5263(3) 47(3) 
C(3) 11810(20) 6230(30) 2204(6) 66(5) 
O(4) 9672(12) 8638(15) 4458(3) 37(3) 
C(4) 10700(20) 8210(30) 2131(6) 59(5) 
C(5) 9400(20) 8520(30) 2596(6) 63(5) 
O(5) 12904(16) 11324(17) 4023(4) 57(3) 
C(6) 10658(19) 8360(20) 3081(5) 32(3) 
C(7) 9460(20) 8620(20) 3573(6) 39(4) 
C(8) 10893(18) 8150(20) 4018(4) 29(3) 
C(9) 10430(20) 8610(20) 4928(5) 30(3) 
C(10) 12620(20) 8780(30) 5005(6) 61(5) 
C(11) 13840(20) 8360(30) 4560(5) 54(5) 
C(12) 12839(19) 9190(20) 4073(5) 30(4) 
C(13) 8690(20) 10890(20) 3570(6) 59(5) 
C(14) 7760(19) 7050(20) 3577(5) 48(5) 
C(15) 10760(30) 11650(30) 1156(7) 94(7) 
C(16) 6860(30) 11680(40) 1662(9) 134(9) 
C(17) 7400(40) 8710(30) 797(7) 87(7) 
C(18) 9040(40) 7400(40) 505(7) 155(14) 
C(19) 6570(30) 10380(30) 413(7) 104(8) 
C(20) 5740(40) 7350(40) 994(9) 149(12) 
________________________________________________________________________  
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  Table 3. Bond lengths [Å] and angles [°] for gm0524m. 
___________________________________________________
 
________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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 Table 4. Anisotropic displacement parameters (Å2x103) for gm0524m. The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
Si 83(4)  66(3) 43(3)  4(3) -5(3)  8(3) 
O(1) 122(10)  39(7) 21(5)  9(5) -33(6)  18(7) 
C(1) 80(13)  38(11) 92(14)  -27(10) 17(11)  27(10) 
O(2) 48(6)  37(6) 37(6)  -17(5) 12(5)  8(5) 
O(3) 51(7)  51(7) 40(6)  1(5) 18(6)  -13(6) 
C(3) 77(12)  75(14) 46(11)  -22(10) 5(9)  -5(12) 
O(4) 21(5)  52(7) 40(6)  -13(5) 11(4)  -10(5) 
C(4) 88(13)  19(10) 69(12)  -2(9) -6(11)  20(10) 
C(5) 76(12)  48(12) 64(11)  -12(10) -14(10)  47(10) 
O(5) 54(7)  41(7) 78(9)  7(6) 40(6)  -18(6) 
C(7) 36(9)  19(9) 64(10)  -6(8) 20(8)  14(7) 
C(10) 85(12)  64(13) 34(9)  -18(9) 11(9)  6(11) 
C(11) 62(11)  51(12) 48(10)  -24(9) -19(9)  22(10) 
C(14) 33(9)  59(12) 52(10)  -15(8) 8(8)  29(9) 
C(15) 93(15)  95(17) 93(16)  25(13) -8(13)  3(14) 
C(17) 180(20)  21(11) 57(11)  7(10) -33(13)  15(14) 
C(18) 300(30)  120(20) 43(12)  -18(13) -17(17)  140(20) 
C(19) 190(20)  53(14) 62(11)  16(11) -59(13)  29(15) 
C(20) 240(30)  80(20) 120(20)  14(17) -70(20)  -80(20) 
________________________________________________________________________  
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  Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x103) for 
gm0524m. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________  
H(1A) 14879 4015 3057 104 
H(1B) 14422 3498 2490 104 
H(1C) 12889 2947 2893 104 
H(2) 13968 7089 2751 55 
H(3A) 12757 6113 1942 79 
H(3B) 10905 5074 2165 79 
H(4) 11615 9382 2103 71 
H(5A) 8769 9874 2577 76 
H(5B) 8379 7463 2594 76 
H(5) 12387 11870 4262 85 
H(6) 11676 9435 3078 38 
H(8) 11127 6643 4021 34 
H(10A) 13026 7814 5270 73 
H(10B) 12926 10171 5125 73 
H(11A) 14051 6866 4529 65 
H(11B) 15115 9015 4610 65 
H(12) 13610 8636 3800 36 
H(13A) 7658 11040 3318 88 
H(13B) 9743 11826 3499 88 
H(13C) 8192 11221 3893 88 
H(14A) 8244 5684 3500 71 
H(14B) 6768 7441 3330 71 
H(14C) 7210 7030 3903 71 
H(15A) 11552 11962 1451 141 
H(15B) 10278 12916 1007 141 
H(15C) 11536 10913 920 141 
H(16A) 7527 12527 1910 201 
H(16B) 5943 10781 1822 201 
H(16C) 6162 12553 1423 201 
H(18A) 8997 7778 157 233 
H(18B) 8781 5932 536 233 
163 
 H(18C) 10320 7701 650 233 
H(19A) 7622 10964 230 156 
H(19B) 5929 11474 593 156 
H(19C) 5636 9739 183 156 
H(20A) 5222 7988 1287 224 
H(20B) 6243 5993 1080 224 
H(20C) 4715 7217 739 224 
________________________________________________________________________ 
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 APPENDIX B 
 
 
 
X-ray crystal data for 147 
 
Table 1.  Crystal data and structure refinement for gm0514s. 
Identification code  gm0514s 
Empirical formula  C23 H42 O5 Si 
Formula weight  426.66 
Temperature  295(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 6.659(2) Å α= 90°. 
 b = 10.646(4) Å β= 99.486(7)°. 
 c = 17.916(6) Å γ = 90°. 
Volume 1252.6(7) Å3 
Z 2 
Density (calculated) 1.131 Mg/m3 
165 
 Absorption coefficient 0.122 mm-1 
F(000) 468 
Crystal size 0.12 x 0.12 x 0.24 mm3 
Theta range for data collection 2.23 to 24.00°. 
Index ranges -7<=h<=7, -12<=k<=12, -20<=l<=20 
Reflections collected 8906 
Independent reflections 3929 [R(int) = 0.1087] 
Completeness to theta = 24.00° 100.0 %  
Absorption correction Sadabs 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3929 / 1 / 247 
Goodness-of-fit on F2 1.404 
Final R indices [I>2sigma(I)] R1 = 0.1280, wR2 = 0.2392 
R indices (all data) R1 = 0.2061, wR2 = 0.2564 
Absolute structure parameter 0.1(5) 
Largest diff. peak and hole 1.219 and -0.258 e.Å-3 
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  Table 2. Atomic coordinates (x104) and equivalent isotropic displacement parameters (Å2x103) for 
gm0514s. U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
Si 1701(4) 4058(3) 4166(2) 51(1) 
O(1) -4223(14) -1758(10) 393(5) 105(4) 
C(1) -2910(20) -976(17) 532(6) 68(3) 
O(2) 323(10) 1477(6) 1503(4) 44(2) 
C(2) -3316(18) 428(14) 520(6) 78(4) 
O(3) 3731(11) 980(6) 1908(4) 48(2) 
C(3) -1648(18) 1220(12) 263(6) 64(4) 
O(4) -942(13) -1318(7) 657(4) 71(3) 
C(4) 381(17) 926(11) 792(5) 55(3) 
O(5) 2336(12) 2716(7) 3821(4) 67(2) 
C(5) 1738(15) 754(9) 2043(5) 36(3) 
C(6) 4720(16) 2147(10) 2121(6) 47(3) 
C(7) 4563(16) 2511(11) 2904(6) 59(3) 
C(8) 2428(16) 2464(10) 3054(5) 45(3) 
C(9) 1532(17) 1218(10) 2840(5) 50(3) 
C(10) 1303(15) -595(10) 1842(5) 47(3) 
C(11) 698(17) -467(9) 962(6) 52(3) 
C(12) 3139(19) -1559(13) 2134(7) 91(4) 
C(14) -653(17) -1048(12) 2179(6) 68(3) 
C(15) 3967(15) 3186(11) 1520(6) 51(3) 
C(16) 5230(20) 4403(11) 1645(6) 77(4) 
C(17) 7366(19) 4265(13) 1482(10) 114(6) 
C(18) 8580(20) 5513(15) 1607(9) 127(7) 
C(19) -1053(15) 4158(16) 3938(7) 102(5) 
C(20) 2894(19) 5412(10) 3755(6) 72(4) 
C(21) 2681(17) 3919(12) 5202(5) 53(3) 
C(22) 2180(20) 5053(13) 5673(9) 117(6) 
C(23) 4935(18) 3820(15) 5380(7) 97(5) 
C(24) 1730(20) 2835(15) 5514(7) 108(5) 
______________________________________________________________________________ 
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  Table 3. Bond lengths [Å] and angles [°] for gm0514s. 
_____________________________________________________    
 
__________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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  Table 4. Anisotropic displacement parameters (Å2x 103) for gm0514s. The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
Si 50(2)  52(2) 50(2)  -28(2) 5(1)  -1(2) 
O(1) 91(7)  135(10) 87(7)  -19(6) 9(6)  -59(8) 
C(1) 64(9)  89(11) 48(7)  -21(9) -1(6)  -5(10) 
O(2) 42(4)  41(5) 52(5)  -18(4) 11(4)  -10(4) 
C(2) 59(9)  126(14) 41(8)  -15(8) -17(7)  -4(9) 
O(3) 55(5)  35(4) 57(5)  -3(4) 20(4)  2(4) 
C(3) 74(9)  85(10) 37(7)  -23(7) 20(6)  -18(8) 
O(4) 65(6)  75(7) 73(6)  -23(5) 8(4)  -3(5) 
C(4) 61(8)  82(9) 26(6)  4(6) 19(5)  28(7) 
O(5) 86(6)  72(6) 41(5)  -1(4) 6(4)  -1(5) 
C(6) 48(7)  54(8) 41(7)  -14(6) 15(6)  -35(6) 
C(7) 46(7)  86(10) 42(7)  7(7) -6(6)  -29(7) 
C(8) 58(8)  45(7) 23(6)  -4(5) -16(5)  -5(6) 
C(9) 64(8)  55(8) 30(6)  -4(5) 5(5)  2(6) 
C(11) 54(7)  37(7) 68(8)  -19(6) 14(6)  -14(6) 
C(14) 100(9)  54(7) 56(7)  -18(7) 29(6)  -38(8) 
C(15) 47(7)  68(9) 44(7)  -14(6) 21(5)  -18(6) 
C(16) 124(13)  56(10) 48(7)  14(6) 3(7)  0(9) 
C(17) 51(8)  56(10) 225(17)  10(11) -7(10)  -22(8) 
C(18) 89(12)  104(14) 182(17)  63(12) 7(11)  -2(11) 
C(19) 38(7)  146(15) 115(10)  -24(13) -12(7)  6(10) 
C(20) 113(11)  53(8) 48(7)  -18(6) 6(7)  4(8) 
C(21) 71(8)  45(7) 42(6)  -19(6) 4(5)  -33(7) 
C(22) 133(14)  89(12) 145(15)  -64(11) 69(12)  -33(11) 
C(23) 69(9)  144(15) 72(9)  -29(10) -4(7)  13(10) 
C(24) 150(14)  127(14) 47(9)  -7(9) 16(9)  6(13) 
________________________________________________________________________ 
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  Table 5. Hydrogen coordinates (x104) and isotropic displacement parameters (Å2x10 3) 
for gm0514s. 
_________________________________________________________________________ 
 x  y  z  U(eq) 
_________________________________________________________________________ 
H(2A) -3482 692 1024 94 
H(2B) -4589 591 185 94 
H(3A) -1971 2106 291 77 
H(3B) -1534 1020 -256 77 
H(4A) 1530 1262 576 66 
H(6A) 6171 2019 2107 56 
H(7A) 5087 3357 2997 71 
H(7B) 5400 1952 3253 71 
H(8A) 1630 3104 2742 53 
H(9A) 96 1247 2878 60 
H(9B) 2168 607 3206 60 
H(11A) 1892 -723 744 63 
H(12A) 4335 -1307 1938 137 
H(12B) 2753 -2391 1960 137 
H(12C) 3421 -1552 2677 137 
H(14A) -1742 -459 2041 103 
H(14B) -324 -1096 2721 103 
H(14C) -1068 -1861 1979 103 
H(15A) 4035 2861 1019 62 
H(15B) 2553 3379 1541 62 
H(16A) 4543 5056 1322 93 
H(16B) 5293 4672 2166 93 
H(17A) 7314 3993 963 137 
H(17B) 8069 3622 1810 137 
H(18A) 9947 5379 1516 190 
H(18B) 8618 5793 2119 190 
H(18C) 7933 6140 1264 190 
H(19A) -1649 3452 4154 154 
H(19B) -1460 4152 3399 154 
H(19C) -1506 4922 4142 154 
H(20A) 2395 5456 3221 108 
170 
 H(20B) 4346 5306 3837 108 
H(20C) 2559 6174 3993 108 
H(22A) 2714 4911 6197 176 
H(22B) 729 5157 5612 176 
H(22C) 2781 5797 5502 176 
H(23A) 5350 3759 5918 145 
H(23B) 5538 4551 5195 145 
H(23C) 5373 3084 5142 145 
H(24A) 2217 2779 6048 162 
H(24B) 2080 2081 5271 162 
H(24C) 280 2938 5427 162 
_______________________________________________________________________ 
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 APPENDIX C 
 
 
 
X-ray crystal data for 152 
 
Table 1.  Crystal data and structure refinement for gilma2s. 
Identification code  gilma2s 
Empirical formula  C46 H97 O9 P Si4 
Formula weight  937.57 
Temperature  295(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 12.3756(6) Å α= 90°. 
 b = 14.1440(7) Å β= 90°. 
 c = 35.1624(17) Å γ = 90°. 
Volume 6154.8(5) Å3 
Z 4 
Density (calculated) 1.012 Mg/m3 
172 
 Absorption coefficient 0.165 mm-1 
F(000) 2064 
Crystal size 0.13 x 0.15 x 0.22 mm3 
Theta range for data collection 1.55 to 24.00°. 
Index ranges -14<=h<=14, -16<=k<=16, -40<=l<=40 
Reflections collected 45522 
Independent reflections 9665 [R(int) = 0.0720] 
Completeness to theta = 24.00° 99.9 %  
Absorption correction Sadabs 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9665 / 4 / 541 
Goodness-of-fit on F2 1.172 
Final R indices [I>2sigma(I)] R1 = 0.0717, wR2 = 0.1632 
R indices (all data) R1 = 0.1295, wR2 = 0.1798 
Absolute structure parameter 0.00(15) 
Largest diff. peak and hole 0.409 and -0.431 e.Å-3 
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  Table 2. Atomic coordinates (x104) and equivalent isotropic displacement parameters (Å2x103) for 
gilma2s. U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________________ 
 x y z U(eq) 
_____________________________________________________________________________   
P 6372(1) 10490(1) 8579(1) 78(1) 
Si(1) 10683(3) 5766(2) 9320(1) 176(1) 
Si(2) 6029(2) 13608(1) 8874(1) 136(1) 
Si(3) 5070(2) 11587(2) 7276(1) 103(1) 
Si(4) 10797(1) 11657(1) 8165(1) 88(1) 
O(1) 8770(2) 7944(2) 8890(1) 60(1) 
O(2) 8415(2) 8820(2) 9438(1) 62(1) 
O(3) 10154(3) 6780(2) 9388(1) 88(1) 
O(4) 7174(2) 9860(2) 8807(1) 62(1) 
O(5) 5254(3) 10174(3) 8570(1) 119(2) 
O(6) 6586(4) 11474(3) 8755(1) 108(1) 
O(7) 6903(3) 10574(3) 8179(1) 96(1) 
O(8) 10862(2) 10501(2) 8140(1) 69(1) 
O(9) 13794(3) 8717(3) 8708(1) 113(2) 
C(1) 9507(4) 8785(4) 9591(1) 70(1) 
C(2) 9646(5) 7940(5) 9844(2) 98(2) 
C(3) 9335(4) 7035(5) 9647(2) 88(2) 
C(4) 8232(4) 7127(4) 9456(2) 78(2) 
C(5) 8127(3) 8014(3) 9223(1) 61(1) 
C(6) 6971(4) 8240(3) 9063(1) 66(1) 
C(7) 7245(3) 8859(3) 8719(1) 55(1) 
C(8) 8392(3) 8586(3) 8602(1) 55(1) 
C(9) 9678(5) 9712(5) 9801(2) 104(2) 
C(10) 9499(6) 10582(5) 9581(2) 115(2) 
C(11) 9632(10) 11484(8) 9804(4) 230(6) 
C(12) 9000(20) 12004(12) 9893(8) 500(20) 
C(13) 10228(16) 4843(6) 9653(4) 328(11) 
C(14) 12177(7) 5835(11) 9469(5) 344(12) 
C(15) 10665(8) 5531(7) 8834(3) 242(8) 
C(16) 9459(10) 5331(12) 8749(5) 349(11) 
C(17) 11139(10) 6301(7) 8620(2) 185(4) 
174 
 C(18) 11447(13) 4621(10) 8819(5) 312(8) 
C(19) 6245(4) 8703(4) 9355(2) 89(2) 
C(20) 6456(5) 7326(4) 8904(2) 108(2) 
C(21) 6187(10) 11700(6) 9117(3) 170(4) 
C(22) 6444(11) 12714(6) 9207(3) 209(5) 
C(23) 4706(8) 13297(8) 8670(5) 274(8) 
C(24) 5987(13) 14723(6) 9120(4) 270(8) 
C(25) 6929(9) 13633(6) 8472(3) 179(4) 
C(26) 6288(6) 10605(5) 7814(2) 124(2) 
C(27) 5828(6) 11510(5) 7742(2) 117(2) 
C(28) 4000(6) 10669(6) 7253(2) 150(3) 
C(29) 4512(7) 12779(5) 7266(2) 145(3) 
C(30) 6022(7) 11428(6) 6871(2) 155(3) 
C(31) 9183(3) 9412(3) 8550(1) 58(1) 
C(32) 10319(3) 9089(3) 8464(1) 60(1) 
C(33) 11122(3) 9892(3) 8454(1) 55(1) 
C(34) 9873(6) 12031(4) 8556(2) 117(2) 
C(35) 12172(6) 12171(5) 8244(2) 135(3) 
C(36) 10256(5) 12056(5) 7707(2) 117(2) 
C(37) 9131(6) 11578(8) 7637(2) 192(5) 
C(38) 10193(10) 13170(6) 7706(3) 213(5) 
C(39) 11016(7) 11720(7) 7377(2) 169(4) 
C(40) 12315(4) 9562(4) 8418(2) 74(2) 
C(41) 12684(4) 8975(4) 8751(2) 83(2) 
C(42) 12495(4) 9415(5) 9137(2) 99(2) 
C(43) 13072(6) 10321(7) 9193(2) 126(3) 
C(44) 12675(9) 11103(10) 9328(3) 218(6) 
C(45) 12493(5) 9048(5) 8039(2) 102(2) 
C(46) 12788(6) 8731(7) 9464(2) 178(4) 
________________________________________________________________________
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  Table 3. Bond lengths [Å] and angles [°] for gilma2s. 
_____________________________________________________  
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_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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  Table 4. Anisotropic displacement parameters (Å2x103) for gilma2s.  The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
P 54(1)  72(1) 108(1)  22(1) 4(1)  6(1) 
Si(1) 184(3)  122(2) 221(3)  22(2) 39(3)  54(2) 
Si(2) 127(2)  76(1) 203(2)  -2(1) 14(2)  1(1) 
Si(3) 91(1)  124(2) 93(1)  30(1) -12(1)  -8(1) 
Si(4) 83(1)  88(1) 92(1)  27(1) 5(1)  5(1) 
O(1) 54(2)  54(2) 71(2)  5(2) 5(2)  2(2) 
O(2) 49(2)  74(2) 62(2)  5(2) 1(2)  1(2) 
O(3) 75(2)  78(2) 111(3)  21(2) 17(2)  19(2) 
O(4) 52(2)  61(2) 72(2)  7(2) 1(2)  -2(2) 
O(5) 46(2)  126(3) 184(4)  57(3) -5(2)  7(2) 
O(6) 124(3)  74(3) 127(4)  5(2) 29(3)  17(2) 
O(7) 72(2)  127(3) 88(3)  31(3) -9(2)  10(2) 
O(8) 62(2)  78(2) 68(2)  20(2) -2(2)  0(2) 
O(9) 57(2)  96(3) 187(5)  26(3) -12(3)  3(2) 
C(1) 53(3)  102(4) 54(3)  1(3) 1(2)  -2(3) 
C(2) 82(4)  147(6) 66(4)  22(4) -8(3)  18(4) 
C(3) 72(4)  99(5) 92(4)  46(4) 4(3)  17(3) 
C(4) 68(3)  73(4) 92(4)  27(3) 6(3)  -1(3) 
C(5) 45(3)  59(3) 79(3)  9(3) 4(3)  -4(2) 
C(6) 52(3)  64(3) 82(3)  20(3) -9(3)  -11(3) 
C(7) 44(3)  53(3) 68(3)  -2(2) -9(2)  -4(2) 
C(8) 55(3)  56(3) 54(3)  0(2) 0(2)  -3(2) 
C(9) 89(4)  147(7) 75(4)  -25(4) -13(3)  -11(4) 
C(10) 116(5)  101(5) 129(6)  -45(5) -6(4)  -26(4) 
C(11) 215(12)  179(11) 297(14)  -148(11) 17(10)  12(9) 
C(12) 550(40)  300(20) 650(40)  -350(30) -320(30)  240(30) 
C(13) 620(30)  97(7) 269(14)  64(8) 136(19)  31(12) 
C(14) 179(11)  390(20) 470(20)  -185(19) -160(14)  187(13) 
C(15) 163(9)  166(9) 400(20)  152(12) -148(12)  -43(8) 
C(16) 190(12)  420(20) 440(20)  -217(19) -184(14)  1(13) 
C(17) 263(12)  155(8) 138(7)  -13(6) 58(8)  19(8) 
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 C(19) 50(3)  123(5) 93(4)  34(3) 11(3)  6(3) 
C(20) 92(4)  85(4) 147(6)  25(4) -20(4)  -41(4) 
C(21) 249(11)  96(6) 166(8)  24(6) 46(8)  20(7) 
C(22) 307(15)  108(7) 212(10)  -36(7) 45(10)  34(8) 
C(23) 135(8)  197(11) 490(20)  -97(14) -6(11)  -6(8) 
C(24) 351(19)  110(7) 349(17)  -57(9) 117(15)  -48(9) 
C(25) 216(10)  125(7) 196(9)  15(6) 4(8)  -11(7) 
C(26) 133(6)  116(6) 124(6)  20(5) -14(5)  7(5) 
C(27) 114(5)  99(5) 139(6)  21(4) -18(4)  2(4) 
C(28) 126(6)  157(7) 169(7)  -3(6) -30(6)  -22(6) 
C(29) 151(7)  133(6) 151(7)  49(5) -17(5)  7(5) 
C(30) 171(8)  174(8) 120(6)  26(5) 36(6)  25(6) 
C(31) 50(3)  61(3) 62(3)  11(2) -5(2)  -2(2) 
C(32) 52(3)  70(3) 58(3)  2(2) 3(2)  0(2) 
C(33) 48(3)  64(3) 54(3)  6(2) 0(2)  -7(2) 
C(34) 141(6)  97(5) 114(5)  8(4) 21(4)  30(4) 
C(35) 115(6)  121(6) 168(7)  26(5) -23(5)  -30(5) 
C(36) 98(5)  139(6) 114(5)  59(5) 15(4)  0(4) 
C(37) 90(5)  346(14) 141(6)  83(8) -55(5)  -42(7) 
C(38) 307(14)  137(8) 196(9)  81(7) -30(9)  76(9) 
C(39) 185(9)  244(10) 78(5)  40(6) 5(5)  2(8) 
C(40) 52(3)  82(4) 88(4)  24(3) 7(3)  -9(3) 
C(41) 44(3)  94(4) 112(5)  33(4) -9(3)  -6(3) 
C(42) 47(3)  140(6) 109(5)  40(5) -13(3)  -10(4) 
C(43) 80(5)  185(9) 114(6)  -20(6) 4(4)  -21(6) 
C(44) 151(9)  287(16) 217(12)  -112(11) 42(8)  -99(10) 
C(45) 73(4)  121(5) 111(5)  -4(4) 33(3)  15(3) 
C(46) 91(5)  262(11) 181(8)  139(8) -27(5)  22(6) 
______________________________________________________________________________  
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  Table 5. Hydrogen coordinates (x104) and isotropic displacement parameters (Å2x10 3) 
for gilma2s. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
  
H(9C) 14250(60) 9210(50) 8689(18) 130(30) 
H(1A) 10023 8745 9380 84 
H(2A) 9202 8018 10069 118 
H(2B) 10394 7900 9925 118 
H(3A) 9285 6536 9839 105 
H(4A) 8114 6583 9293 93 
H(4B) 7676 7125 9651 93 
H(7A) 6747 8711 8511 66 
H(8A) 8352 8240 8361 66 
H(9A) 9199 9722 10019 124 
H(9B) 10413 9722 9897 124 
H(10A) 8774 10566 9476 138 
H(10B) 10001 10591 9369 138 
H(11A) 9990 11298 10037 277 
H(11B) 10157 11852 9662 277 
H(12A) 9340 12534 10015 754 
H(12B) 8510 11707 10068 754 
H(12C) 8609 12218 9674 754 
H(13A) 9472 4724 9615 492 
H(13B) 10347 5051 9910 492 
H(13C) 10628 4273 9608 492 
H(14A) 12547 6280 9309 516 
H(14B) 12505 5223 9442 516 
H(14C) 12226 6035 9729 516 
H(16A) 9045 5896 8791 524 
H(16B) 9203 4840 8915 524 
H(16C) 9380 5135 8489 524 
H(17A) 10680 6847 8636 278 
H(17B) 11216 6117 8358 278 
H(17C) 11837 6451 8723 278 
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 H(18A) 11172 4140 8986 468 
H(18B) 12160 4799 8899 468 
H(18C) 11474 4381 8564 468 
H(19A) 5547 8818 9245 133 
H(19B) 6557 9291 9435 133 
H(19C) 6168 8292 9571 133 
H(20A) 5744 7462 8811 162 
H(20B) 6413 6860 9102 162 
H(20C) 6893 7087 8699 162 
H(21A) 6514 11290 9306 204 
H(21B) 5411 11604 9124 204 
H(22A) 7220 12765 9239 250 
H(22B) 6117 12863 9451 250 
H(23A) 4174 13280 8869 410 
H(23B) 4750 12688 8551 410 
H(23C) 4504 13762 8485 410 
H(24A) 6690 14864 9221 405 
H(24B) 5474 14688 9324 405 
H(24C) 5776 15213 8946 405 
H(25A) 7644 13791 8556 268 
H(25B) 6684 14099 8293 268 
H(25C) 6938 13023 8352 268 
H(26A) 6769 10440 7607 149 
H(26B) 5716 10137 7823 149 
H(27A) 6401 11978 7742 141 
H(27B) 5338 11666 7948 141 
H(28A) 3636 10709 7012 226 
H(28B) 3489 10769 7454 226 
H(28C) 4320 10055 7280 226 
H(29A) 4107 12866 7035 217 
H(29B) 5090 13231 7275 217 
H(29C) 4045 12868 7481 217 
H(30A) 5628 11447 6636 233 
H(30B) 6380 10828 6895 233 
H(30C) 6549 11926 6874 233 
H(31A) 8931 9811 8344 69 
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 H(31B) 9189 9790 8781 69 
H(32A) 10542 8637 8656 72 
H(32B) 10325 8769 8220 72 
H(33A) 11050 10257 8690 66 
H(34A) 9168 11767 8515 176 
H(34B) 9824 12708 8561 176 
H(34C) 10152 11810 8795 176 
H(35A) 12646 11973 8043 202 
H(35B) 12451 11955 8483 202 
H(35C) 12125 12849 8246 202 
H(37A) 8841 11793 7399 289 
H(37B) 8646 11746 7839 289 
H(37C) 9217 10904 7630 289 
H(38A) 9905 13383 7468 320 
H(38B) 10904 13428 7741 320 
H(38C) 9732 13378 7909 320 
H(39A) 10732 11934 7138 254 
H(39B) 11056 11042 7377 254 
H(39C) 11726 11979 7414 254 
H(40A) 12765 10132 8413 89 
H(41A) 12265 8387 8744 100 
H(42A) 11720 9549 9157 118 
H(43A) 13798 10332 9125 152 
H(44A) 11953 11131 9402 262 
H(44B) 13112 11635 9352 262 
H(45A) 13236 8861 8019 153 
H(45B) 12315 9464 7833 153 
H(45C) 12039 8498 8029 153 
H(46A) 12436 8135 9423 267 
H(46B) 12553 8995 9701 267 
H(46C) 13556 8640 9470 267 
______________________________________________________________________________ 
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